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Zusammenfassung
Die Heterogenität von zellulären Reaktionen auf Zelltodinduktoren ist enorm und
daher wichtig zu analysieren. Endpunktmessungen mit gemittelten Ergebnissen von
Gesamtzellpopulationen können Heterogenität in komplexen Signalnetzwerken nicht
auflösen. In dieser Arbeit wurden Methoden zu Ereigniszeit-Korrelationen von Fluo-
reszenzmarkern auf Einzelzellebene etabliert und in einer Nanotoxizitätsstudie sowie
in einer kombinatorischen Chemotherapiestudie (in vitro) angewendet. Die paar-
weisen Zeitkorrelationen von Ereignissen in Fluoresenzzeitverläufen einzelner Zellen
ermöglichen es, die zeitliche Reihenfolge von apoptotischen Schlüsselereignissen in
Signalkaskaden festzulegen und die Wirkungsweise und Synergie von Kombinatio-
nen von zelltodinduzierenden Agentien zu quantifizieren.
Fluoreszenzmarker sind ein wichtiges Werkzeug um biologische Ereignisse sichtbar zu
machen. In dieser Studie wurden die Marker für paarweise Ereigniszeit-Korrelationen
verwendet. Die Marker zeigen apoptotische Veränderungen in Lysosomen, Mitochon-
drien (MOMP), im oxidativen Stresslevel (OxBurst), der Kalziumfreisetzung, der
Caspase-Aktivität, dem Flip von Phosphatidylserin und die Permeabilisierung der
Plasmamembran an. Nach der Untersuchung der Photochemie, Wirkungsweise sowie
die Funktionalität der Marker für Zeitraffer-Messungen, wurden die gewonnenen
Erkenntnisse in der automatisierten Lebendzellmikroskopie auf Einzelzell-Feldern
(LISCA) angewendet. Dies ist ein Raster-Zeitraff Verfahren, um parallele Bildreihen
mit hunderten von Einzelzell-Fluoreszenzsignalen aufzunehmen. Spezifische Merk-
male der Einzelzell-Zeitspuren wurden dann mit phänomenologischen Funktionen
gefittet, um Ereigniszeiten zu extrahieren.
Nanotoxizitätsstudien auf Einzelzellebene geben Einblick in Wechselwirkungen zwis-
chen Nanopartikeln (NP) und Zellen. Zeitkorrelationen und Verzögerungszeit-Vertei-
lungsfunktionen legten dar, dass in der durch 58 nm amino-modifizierte Polystyrol-
nanopartikel (PS-NH2) induzierten Signalkaskade in menschlichen Lungenkrebszellen
(A549) der lysosomale Weg ausgelöst wurde. Darüber hinaus konnte erstmals gezeigt
werden, dass bei einer hohen Konzentration an NPs ein sekundärer, mitochondrialer
Weg existiert. Der zweite Signalweg ist in Huh7, einer Leberkrebs-Zelllinie, nicht zu
beobachten.
Chemosensibilisatoren ermöglichen es, die Dosis von Zytostatika, welche starke Neben-
wirkungen und Zytotoxizität verursachen, zu senken. Daher wurden die Signal-
wege und Auswirkungen des neuartigen Sensibilisators PS89 im kombinatorischen
Chemotherapieansatz mit dem Zytostatika Etoposid (ETO) untersucht. Die apop-
totische Signalabfolge beinhaltet in allen drei Expositionen ETO, PS89 und der Kom-
bination von beiden, die gleiche Reihenfolge von Ereignissen: MOMP und OxBurst
wurden fast gleichzeitig induziert, gefolgt von der Freisetzung von Ca2+ Ionen.
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Zusammenfassung
Zudem wurde durch den Vergleich mit einer Modellierung unabhängiger Ereignisse
(Bliss) die Synergie der Ereignisse evaluiert, welche vermutlich bei der Auswertung
der Plasmamembranpermeabilisierung indiziert wurde.
Um das Verhalten von nicht-adhärenten Zellen im Hochdurchsatz zu untersuchen, ist
der Bedarf an mikrostrukturierten Plattformen zur Positionierung einzelner Zellen,
z.B. definierte Vertiefungen, sogenannte Mikrowells, offensichtlich. Aus diesem Grund
wurden verschiedene Materialien auf ihre Eignung als Mikrowellmaterial untersucht.
Zwei kritische Parameter wurden identifiziert: Geringe Autofluoreszenz für ein ein-
deutiges Signal und hohe Biokompatibilität.
Als erste Machbarkeitsstudie zu PDMS-Mikrowells wurde die Proliferation und Apop-
tose gesunder Stammzellen und Stammzellen mit myelodysplastischem Syndrom
(MDS) untersucht, was Aufschluss über die Entwicklung der Krankheit gibt. Vorläu-
fige Ergebnisse zeigen, dass die Zeit bis zur ersten Teilung sowie die Zellzyklusdauer
beider Zelltypen ähnlich waren, während die apoptotische Rate bei MDS-Zellen leicht
erhöht war.
Ereigniszeit-Korrelationen und Verzögerungszeit-Verteilungsfunktionen auf Einzelzell-
ebene sind ein überzeugendes Werkzeug, um Zusammenhänge zwischen statistischen
Ereignissen in Signaltransduktionskaskaden und deren chronologische Abfolge zu
untersuchen. Insgesamt ermöglichen Ereigniszeit-Korrelationen auf Einzelzellebene
eine breit angelegte systembiologische Sicht auf zelluläre Signalwege und die Kinetik
der Signalübertragung.
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Abstract
The heterogeneity of cellular reactions to cell death inducers is enormous and there-
fore important to analyze. Endpoint measurements with averaged results of total cell
populations cannot resolve the heterogeneity in complex signaling networks. In this
work, methods for event-time correlations of fluorescence markers at the single-cell
level were established and applied in a nanotoxicity and a combinatorial chemother-
apy study (in vitro). The pairwise correlations of event-times, obtained from flu-
orescence time courses of individual cells, allow the determination of the temporal
sequence of apoptotic key events in signal cascades and to quantify the mode of
action and synergy of combinations of cell death inducing agents.
Fluorescence markers are an important tool to visualize biological events. In this
study, such markers were used for pairwise event-time correlations indicating apop-
totic changes in lysosomes, mitochondria (MOMP), oxidative stress level (OxBurst),
calcium release, caspase activity, phosphatidylserine flip, and plasma membrane per-
meabilization. Initially, the photochemistry, mode of action and functionality of
the markers for time-lapse measurements were investigated. The insights gained
were then implemented on automated live-cell imaging on single-cell arrays (LISCA).
LISCA is a scanning time-lapse technique for the recording of parallel image series
with hundreds of single-cell fluorescence signals. Specific features of single-cell time
traces can then be fitted with phenomenological functions to extract event-times.
Single-cell nanotoxicity studies can provide insights into interactions between nanopar-
ticles (NP) and cells. This study showed, by means of time correlations and delay-
time distribution functions, that the lysosomal pathway was triggered in human
lung cancer cells (A549) upon interaction with 58 nm amino-modified polystyrene
nanoparticles (PS-NH2). Furthermore, a secondary mitochondrial pathway was
shown for the first time to exist in parallel at a high concentration of NPs. In-
terestingly, this second pathway was not observed in the liver cancer cell line Huh7.
Chemosensitizers make it possible to reduce the dose of cytostatics, which cause
tremendous side effects and cytotoxicity. Therefore, the signaling pathways and ef-
fects of the novel sensitizer PS89 were investigated in a combinatorial chemotherapy
approach with the cytostatic agent etoposide (ETO). It was found that the sequence
of events in the apoptotic pathway was similar, irrespective of whether ETO and
PS89 were incubated with cells separately or simultaneously: MOMP and OxBurst
were induced almost coincidently, followed by the release of Ca2+ ions. In addition,
the synergy of the events was evaluated by comparison with a modelling of indepen-
dent events (Bliss), indicating synergistic effects by analyzing the plasma membrane
permeabilization.
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Abstract
In order to investigate the behavior of non-adherent cells in high-throughput, the
need for microstructured platforms for positioning individual cells, e.g. defined wells,
so-called microwells, becomes apparent. Therefore, various materials were inves-
tigated for their suitability as microwell materials. Two critical parameters were
identified: Low autofluorescence for a clear signal and high biocompatibility.
As a first feasibility study on PDMS microwells, the proliferation and apoptosis
of healthy stem cells and stem cells with myelodysplastic syndrome (MDS) were
investigated, providing information on the development of the disease. Preliminary
results show that the time to first division and the cell cycle duration were similar
for both cell types, while the apoptotic rate was slightly increased in MDS cells.
In summary, event-time correlations and single-cell delay-time distribution functions
are a powerful tool to investigate correlations between statistical events in signal
transduction cascades and the chronological sequence. Overall, event-time correla-
tions at the single-cell level provide a broadly applicable systems biology view of
cellular pathways and the kinetics of signal transmission.
xviii
Chapter 1
Introduction
Cum hoc ergo propter hoc.
With this, therefore because of this.
This well-known phrase from the field of philosophy describes the fallacy of spurious
causality. But correlation does not imply causation - Cum hoc non est propter
hoc. At a first glance, it seems likely that the correlation or the temporal and
local presence of two events (coincidence) are underlying causal dependency. But
causation is not proven neither with a correlation nor with coincidence (post hoc ergo
propter hoc). To prove causation, first, the relation between two events (cause-and-
effect-relationship) has to be determined (Figure 1.1). Is event A caused by Event
B? Or requires event A event B? Or are both events caused by another event x? In
principle, each case could be true, but has to be proven first to state causation.
A,B
A and B occur
coincidently
A          B
A causes B
B          A
B causes A
B          A, B          A        
A and B have no relation
x          A, B
Common cause x
causes A and B
coincidently
y          x, x‘,
x          …           A, x‘          …          B
Common cause y starts two chains
of cause and eect with potentially more terms,
which cause A and B coincidently
Figure 1.1: Relation between cause and correlation.
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Correlation (latin: correlatio, interdependence) is a statistical term for a relation be-
tween two or more events, objects, attributes, conditions or functions, which neither
implies causation nor is implied by it. Correlation is the connection or relationship
between two variables, while causation implies a cause-and-effect-relationship. In
short, a correlation only describes an existing relationship and causation clarifies
which event causes the other. Statistically, the measure for a linear correlation be-
tween two variables can be quantified with the correlation coefficient according to
Pearson or Bravais. The measured value can range from zero (no correlation) to one
(correlation is present). Further, it is distinguished between positive (e.g.: The more,
the better.) and negative correlations. The case of no correlation can be analyzed
with statistical tests such as the Null Hypothesis. Is the correlation between two
events assessed, causation can be attempted to be answered.
Also high-dimensional data in complex biological networks desire the investigation
of causal structures. In gene expression and proteomics data, correlation networks
are already frequently applied [1]. The field of system biology, where it is aimed
to be understood how the cellular organization determines behavior and interaction
as well as how the assembly of cell community is organized, is interested in linking
correlations with causality [2]. The correlative analysis of large cellular signaling
networks provides the power to test mechanistic hypothesis. Further, sufficient data,
in combination with causal models, intend to draw predictions [2]. But to prove
causation, well-designed experiments with as many as possible randomized factors
to exclude any interferences or side effects, are needed. However, in many cases this
is impossible due to infinite factors or experimental parameters or the impossibility
to change some factors. Further, such experiments are cost and time intensive as
well as complex to realize.
On the other hand, statistical analysis could help to draw directional relationships
out of the correlation data. For example, mediation analysis is a good theoretical
model to clarify the underlying mechanisms of relationship between an independent
variable and a dependent variable with the help of a so called hypothetical me-
diator variable [3]. Also here, the direct causation can not be proven, rather the
characteristic of the relationship between the two variables. In summary, a critical
experimental, theoretical and statistical verification has to be given to state causa-
tion between variables.
In this work, correlations between apoptosis events in signaling cascades were an-
alyzed. However, the correlations give a first insight into the complex network of
signaling, but no causal relationships between the events were drawn.
2
Single-Cell Event-Time Correlations
The underlying mechanisms and pathways leading to cell death can not be fully
unraveled by standard end-point bulk measurements [4, 5]. In bulk assays, where
the signal is averaged over the whole population of cells, the heterogeneity of the
cellular response remains hidden. But heterogeneity can be fundamental in some
biological processes [6]. The-cell-to-cell variability is assumed to be caused by noise or
stochasticity in gene expression (intrinsic noise) as well as by extrinsic noise (external
factors) [7]. Further, if the response of the cell population is not uniformly, the
average-based analysis masks potential sub-populations [8].
Moreover, mostly the readout is end-point and performed only at limited time points,
thus just giving a snapshot of the whole kinetics. But time-lapsed movies enable the
continuous monitoring of cells over hours to days to follow the whole dynamics of
the observed phenomena [9].
In this work, single-cell measurements facilitated the analysis of the heterogeneous
cell response to an apoptosis inducer and the identification of potential sub-populations.
Furthermore, time-lapse measurements were performed to follow the underlying dy-
namics in the course of apoptosis. Therefore, cells were seeded on microstructured
surfaces for a dynamic readout of single cells. Defined geometries of adhesive protein
areas, isolated by cell-repellent surroundings, were achieved by microscale plasma-
initiated protein patterning (µPIPP) [10]. The micropatterns provide standardized
boundary conditions for the extraction of single-cell time trajectories. Fully auto-
mated data acquisition allows the observation of hundreds of cells in parallel over
long periods of time with a high time resolution in up to four different fluorescence
channels. Furthermore, pair-wise event time correlations are a powerful tool to un-
ravel signaling cascades, e.g. in apoptosis. Therefore, different marker combinations
are measured in parallel per cell to resolve the chronological order of events within
one cell. The assessment of multiple events within one cell enable the disclosure of
potential correlations between the measured events. Accordingly, with dual correla-
tions of the events, the signaling cascade and its temporal context can be assembled.
The semi-automated fluorescence readout generates time traces of single cells. Ac-
cordingly, the so called event times are extracted from the time courses with maximum-
likelihood fitting. The detected event times are then correlated pair-wise via Princi-
pal Component and Cluster Analysis to unravel the temporal relationship within the
signaling transduction. These event-time correlations compose the signaling path-
ways in the induced apoptosis.
Apoptosis Exploiting for Cancer Therapy
Apoptosis, a form of programmed cell death, is necessary for the homeostasis of
cells in normal tissues to remove senescent, excessive or altered cells without causing
3
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inflammation [11]. Further, apoptosis was found to contribute to a high cell loss
in malignant tumors and promote tumor progression [12]. Thus, anticancer agents
were developed to induce apoptosis, but tremendous side effects and cytotoxicity in
chemotherapy are caused by the fact that cytostatics also trigger apoptosis in normal
tissue [12]. The precise manipulation of the cell death program would lead to less
toxic and mutagenic therapy than the present approaches.
Hence, in the 1960s, the development of combinatorial chemotherapy paved the way
to overcome the problems of cancer resistance and the detrimental side effects [13].
The idea is to provoke cell death with lower concentrations of cytostatics with the
support of so called chemosensitizer, which increase the vulnerability of cancer cells
towards apoptosis. The reduced concentration of anticancer agents increases the
chances of survival as well as the well-being of the patients. Further, the double-
sided offense of the agents with different target sides increase the probability of the
success potential for recovery and the absence of potential relapses.
Moreover, in the 1980s, signaling networks were found to be modified in cancer cells
and targeted therapy was a new promising approach in cancer research [13]. Signaling
cascades have a highly complex and pretentious nature. Thus it is challenging to
unravel the sequence of key players and the chronological order in signaling pathways.
But the identification of main check points allocates new potentially specific targets,
which could be addressed in cancer therapy. Further, the analysis of the crosstalk
between such main actors in signaling networks provides insight into sensitivity and
resistance for rational therapeutic intervention strategies [14].
In this study, on the one hand, the apoptosis signaling cascades of one type of
nanoparticles (PS-NH2) was examined, and on the other hand, a combinatorial
chemotherapy approach was investigated to understand the underlying cell death
pathways.
Overview of this work
In this work, the second chapter introduces the Fundamental Concepts and
Methods. Further, this study makes a contribution to the understanding of the un-
derlying mechanisms in apoptotic signaling pathways induced with PS-NH2 nanopar-
ticles, which is described in chapter 3, Event-Time Correlations in NP induced
Apoptosis. Correlations between key players in signaling pathways triggered by the
combinatorial approach of the cytostatic Etoposide and the chemosensitizer PS89 are
part of chapter 4, Correlation Analysis in Combinatorial Chemotherapy of
Etoposide and PS89. Autofluorescence and biocompatibility tests of different po-
tential microwell materials are described in the fifth chapter, Investigation of a 3D
Environment For Single-cell Applications. Further, an application of PDMS
microwells is delineated, namely a proliferation study of stem cells. Finally, the last
chapter six provides a short Conclusion and Outlook.
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Chapter 2
Fundamental Concepts and Methods
2.1 Single-cell Time-lapse Measurements
Since many years, biological bulk assays are widespread used to investigate the toxic-
ity of different materials. For example, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) test, a colorimetric assay to analyze the metabolic ac-
tivity in cells, is applied frequently. And since the metabolic activity correlates with
cell viability, it is often used as cytotoxicity assay. However, here we face the first
problem: is the signal due to many smaller cells, which metabolize less of the dye
than the average signal or stems the signal from few big cells, which have a higher
metabolism? Secondly, this average signal from bulk assays masks signals from sub-
populations completely. But the heterogeneity of the cells in response and timing
can be tremendous (Figure 2.1).
Bulk average value
a b
Bulk dynamics
Single-cell dynamics
time time
Figure 2.1: a) In bulk measurements the heterogeneity of the population is missed and potential
subpopulations are masked in an averaged signal. b) Bulk measurements can give misleading infor-
mation about dynamics of processes. Also end-point values, which are assembled to one presumed
dynamic can result in incorrect outcomes (red time course). Figure adapted from [15].
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The cell-to-cell variability is highly diverse and can have different origins. For ex-
ample, genetic and epigenetic differences, intrinsic noise, differences in cell cycle or
variations in reactions due to concentration differences were identified as potential
causes in cell response [16].
The need of single-cell assays was realized in the past [5, 9, 17, 18] and first nan-
otoxicity studies at the single-cell level were published utilizing different techniques
[17, 19–21]. But not only for nanotoxicity, also for stem cell research, the need for
single-cell arrays was found and successfully implemented [4, 8, 22]. Also, mathe-
matical models can support the understanding of signaling pathways [23, 24]. Nev-
ertheless, there is little knowledge about the heterogeneity in intracellular reactions
and further investigations have to be done.
To track single cells, they can be seeded in a low concentration on a cell-friendly sur-
face, where the cells can migrate freely. But this method requires a time-consuming,
laborious and often user intensive (manual) data analysis due to the movement of
the cells and the change in morphology. In this work, the microscale plasma-initiated
protein patterning (µPIPP) [10] facilitates an automated high-throughput readout
of single cells. Single-cell arrays provide uniform conditions for all cells by reduction
of external confounding factors and by exclusion of cell-to-cell-communication due
to the adequate distance to neighboring cells. Thus, a precise confinement of the
cells on the surface without distracting them, is crucial for tracking hundreds or
thousands of cells in parallel, possibly with different readout parameters. Another
common single-cell read-out technique, which is not surface-based, is flow cytome-
try, but the readout is end-point only [25, 26]. Time dependent measurements with
coarse grained time intervals are possible with flow cytometry, when samples are
prepared at different time points and sorted one after another. Besides to flow cy-
tometry, automated microscopy, laser scanning cytometry, capillary electrophoresis
or laser capture microdissection are recently used single-cell techniques. However,
they have all the disadvantage of low throughput and constrained applicability in
common [27].
On the other hand, time resolved measurements were performed in the past, for
example ECIS (Electric Cell-Substrate Impedance Sensing), where the impedance
as a function of time after addition of an external stimulus is measured. But also
here we have a bottleneck, namely that the signal is averaged over the whole mono-
layer. Endpoint assays give just a snapshot of dynamics, thus they are limited in
information. Even more, information is lost and just a piece of the whole picture is
given. Live cells observed in real time give much more information than end-point
readouts: not only the dynamics of cell fate decisions can be followed (e.g. varia-
tions in signaling, time interval of signal change, oscillating behavior etc), but also
the morphology of the cells as well as a quality control of the assay conditions can
be analyzed. For example, parameters such as patterning quality and stability over
time, indicated by migrating cells out of the adhesion sites, can be tracked. Further,
the time-lapsed images can be used to analyze how many and how often cells divided
6
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before cell death, which can give a hint of correlations between proliferation and cell
death decisions. Time-lapse experiments have the power to identify atypically be-
having cells and thus these cells can be excluded from the analysis, when they, for
example, migrate, divide or detach. Cells, which are dead from the beginning of the
experiment, can be excluded as well. This manual selection gives a high quality of
data and less false positive or false negative results.
However, some limitations still remain, which can be the bottleneck for performing
time-lapse measurements [5]. Although just a microscope, a camera, an incuba-
tion box with controlled temperature, CO2 and humidity and an automated stage is
needed as experimental setup, phototoxicity, photobleaching of the used fluorescence
markers and biocompatible environments can cause major problems.
Furthermore, data management, handling and processing gained a lot of attention in
the past years tagged with the buzzword ’big data’. In fact, such time-lapse measure-
ments over some days with hundreds of field of views can range to some Terabytes.
Furthermore, the extraction and the processing of information out of these huge data
sets causes problems. Despite the fact, that already some tracking software is on the
market [4, 28–31], the identification and continuous tracking of single cells, especially
suspension cells, can be challenging due to the fast movement of cells in solution. For
adherent cells, contour analysis would be advantageous to gain accurate and high
content information, which could include morphological changes during cell death,
for example [29]. However, since experimental conditions vary between the different
setups and projects, e.g. the contrast of the cells to the surface differs or no fluores-
cence is present, optimum cell recognition is still under investigation.
To counter act these issues, the advantages of single-cell and time-lapse measure-
ments were combined and continuous dynamics of single cells were recorded in this
study.
2.2 Apoptosis
How is cell death classified?
The Nomenclature Committee on Cell Death (NCCD) has classified major regulated
cell death (RCD) subroutines [32]. It is distinguished between mitochondrial perme-
ability transition-driven necrosis, necroptosis, ferroptosis, pyrroptosis, parthanatos,
entotic cell death, NETtotic cell death, lysosome-dependent cell death, autophagy-
dependent cell death, immunogenic cell death and intrinsic and extrinsic cell death
(Figure 2.2). In this work, the focus will be on the signaling pathways of apoptosis,
especially the intrinsic apoptosis, since the used apoptosis trigger are intrinsic ones.
A short outline for extrinsic pathways is given in Chapter 3.1.3.
7
Chapter 2 Fundamental Concepts and Methods
Fe²+RCD
Apoptosis Necrosis
Intrinsic Apoptosis
Extrinsic Apoptosis
Immunmogenic
cell death
Autophagy-dependent
cell death
Lysosomal-dependent
cell death
Neutrophil extracellular traps cell death
Entotic cell death
Parthanatos
Pyroptosis
Ferroptosis
Mitochondrial permeability transition pore
driven necrosis
Necroptosis
Figure 2.2: Overview of cell death types. Twelve different types of cell death are distinguished by
the Nomenclature Committee of Cell Death 2018. Figure adapted from [32].
How is apoptosis defined?
Following the recommendations of the NCCD 2018, cell death can be classified by
morphology [32]. One class is apoptosis, which is described as the following: ”... Type
I cell death or apoptosis, exhibiting cytoplasmic shrinkage, chromatin condensation
(pyknosis), nuclear fragmentation (karyorrhexis), and plasma membrane blebbing,
culminating with the formation of apparently intact small vesicles (commonly known
as apoptotic bodies) that are efficiently taken up by neighboring cells with phago-
cytotic activity and degraded within lysosomes; ...” [32] (Figure 2.3). Apoptosis
is programmed cell death (PCD), a particular form of RCD, and is therefore dis-
tinguished from necrosis, which is a form of traumatic cell death and induced by
external factors, thus a rather spontaneous cell death than a planned, programmed
and targeted cell death. Necrosis can be discerned from apoptosis easily by morpho-
logical changes, since necrotic cells increase in size until the cell membrane ruptures;
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no apoptotic bodies are formed. Further, necrosis is causing inflammation, which is
not the case for apoptosis.
Apoptosis
Normal cell
Shrinkage
Collapse of
nucleus and organelles
Membrane blebbing
Disintegration of organelles
Start membrane blebbing
No inflammation
Macrophage phagocyte apoptotic bodies
Figure 2.3: Process of apoptosis. In the first step the cell shrinks, also the nucleus and the
organelles. The organelles start to disintegrate and the membrane begins to bleb until the membrane
is completely blebbing and the organelles and the nucleus collapse. In the final stage, the apoptotic
bodies are engulfed by macrophages. Figure is adapted from [33].
When is a cell dead?
The process of dying is as long as reversible until the ’point-of-no-return’ turns
the process into irreversible. Executioner caspases, the loss of outer mitochondria
membrane potential, the flip of phosphatidylserine as well as the loss of plasma
membrane potential was discussed as such a point-of-no-return [34]. However, all
these suggestions were refuted in the past by different studies [35]. If no defined event
can be identified as such reversal point, the NCCD stated a cell as dead, if any of the
following criteria is given: (1) loss of plasma membrane potential, (2) the cell and
also the nucleus are completely fragmented and/or (3) the corpse or the fragments
were engulfed by neighboring cells [35]. Thus, dead cells have to be differentiated by
dying cells, which are undergoing various pathways during this process.
9
Chapter 2 Fundamental Concepts and Methods
2.3 Data Acquisition
2.3.1 Image Acquisition
For single-cell time-lapse measurements, microstructured slides were prepared as
published elsewhere [10, 36–38]. A detailed standard protocol can be found in the
Appendix A.2. In short, a PDMS 3D structured stamp is placed on a surface, which
is plasma initiated afterwards. A PLL-PEG solution is added to the hydrophilic
surface and is sucked underneath the stamp via capillary forces to gain non-adhesive,
passivated areas. After incubation, the stamp is removed and protein squares are
generated by the administration of a fibronectin solution on the sides, which were
blocked by the stamp before. The standardized conditions help to track hundreds
to thousands of single cells in parallel. Therefore, cells were seeded and after 6
h of cell adhesion the fluorescence markers as well as the apoptosis inducer were
added. An inverted TI Eclipse microscope (Nikon) was used to set around 200
fields of view per sample. With a 10 minute interval, phase-contrast images and a
maximum of three fluorescent images were acquired by a ClaraE CCD camera for
each field of view over a period of 24-30 h at 10x magnification. The slide was kept
at 37°C by an ibidi or an Okolab heating system. CO2 supply was provided or CO2
independent Leibovitz’ L15 medium was used. The fluorescence time traces were
obtained with fully automated data acquisition. Hence, the settings were scheduled
with the JOBS tool in the NIS Elements AR 5.02.00 64-bit software. The obtained
nd-files (proprietary Nikon format) were converted into TIFF files with a custom
macro. The nd-files are sorted by channels over time and positions, but the TIFF
files are then organized by position. So each TIFF file presents one position with all
channels over time.
The automated live-cell imaging on single-cell arrays (LISCA) is represented in Fig-
ure 2.4. The overview scan of the micropatterned cell array in the middle (black)
is zoomed in (on the left), where single cells on the pattern are shown. The fluo-
rescence of different markers in single cells are depicted underneath. The following
events or organelles are illustrated: the mitochondria (blue), lysosomes (cyan), the
flip of phosphatidylserine (red), nucleus (brown), caspase activation (yellow), and
OxBurst (purple). The scale bar represents 200 µm.
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CCD
Figure 2.4: Automated live-cell imaging on single-cell arrays (LISCA). Cells are seeded on a
micropatterned surface with 30x30 µm adhesion sites. A cell array is shown in the middle, which
is zoomed in to demonstrate the occupancy of the pattern by cells (on the left). Underneath,
different events or organelles, illustrated with fluorescence markers are shown: the mitochondria
(blue), lysosomes (cyan), the flip of phosphatidylserine (red), nucleus (brown), caspase activation
(yellow), and OxBurst (purple). The scale bar represents 200 µm. Adapted from [36], licensed
under a Creative Commons license [39].
2.3.2 Single-cell Fluorescence Readout
The single-cell fluorescence readout was performed with the custom ImageJ plugin
called Microwell Analysis, written by Christian Meggle, in ImageJ42. As a first step,
the time-lapse image stacks were used to determine the time traces of single cells by
defining a region of interest (ROI) grid corresponding to the fibronectin pattern in a
semi-automated manner. Empty, multiple or displaced occupied adhesion sites were
excluded from data analysis and sorted out by hand. Also doubling, migrating or
detaching cells were not taken into account. ROIs, which are crossed by cell frag-
ments, apoptotic bodies or nanoparticles were as well excluded, as this particles can
be clearly seen as a peak in the time courses, which is interfering with the fitting
routine. This manual, time and click intensive quality-control step is necessary to
ensure to only evaluate single occupied ROIs. Then, the ordinary background correc-
tion, which is included in the plugin, is applied to the image stacks. Afterwards, the
total fluorescence intensity is integrated for each ROI which is marked for analysis.
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2.4 Photochemistry and Mode of Action of
Fluorescence Markers
Since the discovery of fluorescence in 1904 by August Köhler and the development
of fluorescence markers in the 50s, fluorescent dyes became a frequently used tool to
observe and analyze cellular reactions, processes, activities and mechanisms [40].
In this work, we took a step forward and used pairwise marker combinations to gain
a deeper insight into signaling cascades in cells. Usually, only one marker is added
to the cell and several readouts are addressed with different markers, but in separate
experiments [41, 42]. Afterwards, the chronological order is composed together out
of these discrete experiments, which could be faulty, since the outcomes are not from
the same cell. Here, we add mostly two, in some cases even three markers to the
cells, addressing more than one target of interest. Therefore, this method provides
multiparametric data from one and the same cell, which enables the possibility to
draw direct relations between the signals, without the need of any assumptions. Of
course, the more markers are added to the cell, the more direct would be the detected
information. However, we realized that the viability of the cell and the tolerance of
the fluorescence spectra are limited to three markers.
With this single-cell time-lapse data, not only signaling cascades in their chrono-
logical order can be determined, but moreover, the probability in response can be
estimated. The high specificity and sensitivity of the markers as well as a good time
resolution provide high quality data, which allows drawing statements with high
precision and accuracy.
Several key events or checkpoints in the signaling cell death cascade were identified
in the past to play an essential role leading to survival or cell death [43–46]. De-
pending on the apoptotic trigger, a specific type of pathway, either extrinsically or
intrinsically, can be induced. Additionally, even within these pathways, the impor-
tant events show huge variety depending on the cell death inducer and the cell line
used [18].
Fluorescence markers are used as a tool to identify the involved events in the partic-
ular case and which events are essential for cell death. In the following chapter, the
photochemistry and the biological background of the fluorescence markers, which
were used to characterize the apoptotic behavior as well as the characteristic time
courses, are explained in-depth.
The applied concentrations of all fluorescence markers, the corresponding absorption
and emission wavelengths as well as the used exposure times for the markers can be
found in the Appendix A.4.
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2.4.1 Lysosomal Membrane Permeabilization - LysoTracker
In many investigated apoptosis signaling pathways, the first described apoptotic
event in the signaling cascade is the lysosomal membrane permeabilization (LMP).
The pH sensitive LysoTracker Deep Red (Thermo Fisher) is cell permeant and is
often used to illustrate LMP in vitro. It labels acidic organelles in live cells due to
the linkage of a weak base. It has an optimal excitation at 647 nm and an emission
maximum at 668 nm. The chemical structure is shown in Figure 2.5.
Figure 2.5: Chemical structure of the pH sensitive LysoTracker to stain acidic cell organelles.
For our setup, a low concentration of 75 nM was used, since it was staying in the me-
dia without any washing step for the whole measurement. In Figure 2.6, exemplary
single-cell time traces of the LysoTracker in A549 cells are shown. Apoptosis was
induced with 100 µg mL-1 PS-NH2 NPs. The time traces show an initial fluorescence
increase described by a parabolic function and a sigmoidal decrease of fluorescence
follows. The typical offset in intensity is labeled as tLMP and indicated with an arrow.
Details of the phenomenological fits and the definition of events times can be found
in the Chapter 2.5 and the Supplementary Information of Murschhauser et al. [36].
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Figure 2.6: Exemplary 30 h time traces of LysoTracker green recorded after apoptosis induction
with 100 µg mL-1 PS-NH2 nanoparticles in A549 cells are shown. The lysosomal breakdown is
indicated as tLMP and labeled with an arrow.
The fluorescence molecules of the LysoTracker accumulate inside acidic organelles
(lysosomes or late endosomes). In the acidic environment of these cellular organelles,
the acidotropic marker is protonated, which significantly increases the fluorescence.
Thus, in viable cells a bright fluorescence in the lysosomes is detected. Further, with
the addition of an apoptosis inducer, we see a decrease in fluorescence. The offset in
intensity is assumed to be correlated with the time point of LMP, thus the lysosomal
collapse or breakdown, and is labeled as tLMP.
2.4.2 Mitochondria Outer Membrane Permeabilization -
TMRM
One central event in various signaling cascades is the mitochondria outer mem-
brane permeabilization (MOMP), which is often referred as the point-of-no-return
for the cell in cell fate decisions [34]. A widespread used fluorescence marker to eluci-
date MOMP is the lypophilic cationic tetramethylrhodamine methyl ester (TMRM)
marker (Figure 2.7a).
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Figure 2.7: Tetramethylrhodamine (TMRM). a) Chemical structure of cationic TMRM. b) Accu-
mulation of the TMRM+ fluorescence marker within the negatively charged mitochondria matrix.
The maximum in the absorptions spectra is 552 nm and the emission maximum
is around 578 nm of the TMRM marker (Thermo Fisher Scientific). The lowest
possible concentration of 10 nM was used, to avoid side effects such as phototoxicity
and quenching effects, which were reported with a concentration from 50 nM on [47].
Active membranes in mitochondria of alive cells maintain a differential in electrical
potential between the inner and the outer side of the mitochondria membrane, the
so called membrane potential ∆ψM. Under physiological conditions, the ∆ψM is
between 120-180 mV and electronegative on the inter membrane side. TMRM is a
cell-permeate membrane-potential sensitive dye, thus often used for live imaging, and
is accumulating in functional negatively charged mitochondria (matrix) due to its
positive charge (Figure 2.7b) driven by the ∆ψM and following theNernst equation
[48]. An insignificant amount of TMRM is also accumulating in the inter membrane
space and the matrix spaces, but the volume of these spaces is negligible in relation
to the volume of the matrix (and the outside of the mitochondria, where also some
TMRM molecules stay) [48]. According to the Nernst equation, an increase of 61.5
mV in ∆ψM leads to a tenfold increase of monovalent cations in the matrix space
[49].
Membranepotential(mV ) = 61.5log10(ci/c0)
with ci as the concentration of cations inside the mitochondria and c0 the concen-
trations of cations outside. Thus, usually a 100-1000 fold higher concentration of
the TMRM marker can be found in the mitochondria (matrix) than in the cytosol
[34, 49]. Hence, it shows a bright fluorescence signal in healthy mitochondria and is
suitable for tracking the ∆ψM. It is assumed that the accumulation of the dye also
partly goes along with fluorescence quenching and a red shift, but the main part
remains unquenched [48, 50].
Single-cell time traces showed a fluorescence decrease due to loss of mitochondria
membrane potential, which was also previously described in [51]. MOMP is the re-
sult of the depolarisation of the mitochondria, whereby permeability transition pores
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are opened, which is e.g. the case in the initiation phase of apoptosis. Thus, anions
such as Cl-, are released and also the concentration of TMRM inside the mitochon-
dria (matrix) is decreasing. With the final MOMP, cytochrome c is released out of
the inter membrane space, which is between the inner and the outer membrane, and
triggers further apoptotic signaling [52].
In NP induced apoptosis, the TMRM intensity courses over time of single cells show
a plateau phase after an increase in the beginning, which indicates a constant level
of TMRM molecules accumulating in the mitochondrial matrix (Figure 2.8). The
breakdown of the fluorescence signal, which is stated as tMOMP, is assumed to go
hand in hand with the opening of transition pores and the loss of the membrane
potential and thus the release of the TMRM marker out of the mitochondria.
tMOMP
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Figure 2.8: Exemplary 30 h single-cell time traces of the TMRM marker for the illustration of
the mitochondria membrane permeabilization after apoptosis induction with 100 µg mL-1 PS-NH2
nanoparticles in A549 cells.
The same breakdown is seen for combinatorial chemotherapeutic (etoposide, ps89
and in combination of both) induced apoptosis, although at later time points (Figure
2.9). And, it is important to mention, the first characteristic phase is different to
the plateau phase in NP induced time traces. Here, we have a steep increase for the
accumulation of the marker in the mitochondria, followed by a decrease in intensity,
which can be more or less smooth. This drop in intensity is assumed to be correlated
with the promptness of the depolarisation and the accompanying opening of the inter
membrane pores of the mitochondria. The peak maximum, where the depolarisation
is assumed to begin is indicated with tDepolarisation. Further, the abrupt decrease of
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fluorescence at later time points indicates the collapse of mitochondria membrane
potential (tMOMP). Both features were seen also recently in mouse cortical neurons
after addition of a mitochondrial inhibitor [53]. The distinct peak, which is seen for
chemostatic treated cells, was not observed for NP treated cells. Further, the NP
induced apoptotic time traces are more noisy than in combinatorial chemotherapy
since NPs show autofluorescence.
tMOMP
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Figure 2.9: Exemplary 24 h time traces of the TMRM marker for mitochondria membrane perme-
abilization after apoptosis induction with the combination of 10 µM Etoposide and 25 µM PS89 in
A549 cells. The distinct peak maximum (tDepolarisation) and the subsequent decay at the beginning
of the time trace is assumed to correlate with the depolarisation of the mitochondria. The event
time of MOMP (tMOMP) is also indicated with an arrow.
2.4.3 Reactive Oxygen Species Indicating Cellular Stress -
CellROX
Reactive oxygen species (ROS) are important key players in many diverse apoptosis
signaling cascades [54]. The involvement in different apoptosis pathways is discussed
in Chapter 3.1. More general information about ROS as cellular stress indicator is
given in Chapter 3.5.
To monitor ROS production, several fluorescence dyes are used in literature. H2DCF-
DA, the diacetate (DA) form of H2DCF (2-7-dichlorodihydrofluorescein) is a cell-
permeable marker, which allows the intracellular accumulation of the non-fluorescent
H2DCF. If oxidized by non-specific ROS, the fluorescent product, 2-7-dichlorofluores-
cein (DCF), shows bright fluorescence. But this widely used marker should not be
used, due to it’s photo-oxidation and photo-bleaching. Additionally, this marker is
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also catalyzed by cytochrome c (which is released from mitochondria during apopto-
sis), and, even worse, creates ROS by itself [55]. Also the prominent dihydroethidium
(DHE) marker has several interferences, which are not suitable for multiplex time-
lapse experiments in single-cells [55].
Therefore, for this study, the CellROX ROS detection reagents from Molecular
Probes were chosen due to their photostability, ease use in complete growth media
and their broad variability (available in three different colors). Moreover, they are
suitable for multiplexing fluorescent probes, which is for example not possible with
oxidized DHE due to it’s broad emission spectra. For the multicolor compatibility
we used the CellROX green, the CellROX orange or the CellROX red dye, whichever
the other used markers were combined, with a final concentration of 100 nM. How-
ever, the chemical structure of the fluorogenic probes are corporate secret and the
exact mode of action is not revealed exactly. But, all three ROS detection agents
respond to hydrogen peroxide, peroxynitrite, nitric oxide, tert-butyl hydroperoxide
and hypochlorite anions and especially to hydroxyl radicals and superoxide anions.
CellROX reagents are weakly or non-fluorescent in a reduced state and show bright
fluorescence upon oxidation. The CellROX green reagent has an absorptions- and
emission maxima at 485 and 520 nm and is a DNA binding dye when oxidized, so
mostly localized in the nucleus and mitochondria. The CellROX Deep Red and the
CellROX orange reagents are localized in the cytoplasm and have absorptions- and
emission maxima at 644 nm and 665 nm or 545 and 565 nm.
All three reagents have the same characteristic phenomenological time course in
principal, dependent on the exposure and the cell line. Exemplary single-cell time
traces of CellROX after apoptosis induction with 10 µM ETO and 25 µM PS89
in A549 cells are shown in Figure 2.10. The increase of the fluorescence intensity,
thus the slope, is assumed to correlate with the amount of ROS, accordingly the
production rate of ROS and the stress level of the cell. After the increase, a sharp
drop in intensity is detected. The breakdown of the fluorescence is termed tOxBurst
and presumably correlates with the oxidative burst caused by the destruction of the
marker by an excess of produced radicals. The time courses are fitted with the same
phenomenological mathematical functions as the LysoTracker. From these fits, the
event times of the oxidative burst (tOxBurst) are extracted.
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Figure 2.10: Exemplary 24 h time traces of CellROX ROS detection agent in combinatorial
chemotherapy induced apoptosis. A549 cells were exposed to 10 µM etoposide and 25 µM ps89.
The typical time courses of the CellROX reagent for etoposide, PS89, the combina-
tion of both of them, STS and NP (Figure 2.11a) induced apoptosis in A549 cells
show the initial slope and the sharp drop in fluorescence as described above. But in
some cases, a very narrow peak in the beginning of the measurement after exposure
to NP is seen (Figure 2.11b). This early change in intensity illustrates a fast response
of the cells to the treatment. The higher susceptibility of the cells could be caused
by the cell passage (assumed for higher passages) or the quality of the NPs (less
agglomerates, thus faster engulfment).
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Figure 2.11: Exemplary time traces of CellROX ROS detection agent after exposure to 2 µM
staurosporine (a) and apoptosis induced with 100 µg mL-1 PS-NH2 nanoparticles (b), both in A549
cells. Most time traces of NP and STS induced have the characteristic course of the left graph, but
in some cases they show a fast-pasted response to the apoptosis trigger with a narrow peak (b).
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2.4.4 Calcium Release out of the Endoplasmatic Reticulum -
Calbryte
Calcium release is a result of endoplasmatic reticulum (ER) stress, and one of the
main trigger in combinatorial chemotherapy of etoposide and the sensitizer PS89
induced apoptosis signaling pathways [42].
Calcium markers are usually acetoxymethylester (AM), which are non-fluorescent,
but once hydrolyzed by (intracellular) esterases, they are converted into a activate
state. Upon binding calcium ions, the marker shows bright fluorescence [56].
Usually, the fluorescence markers are added in combination with the apoptosis in-
ducer at the same time and stay there for the whole experiment in a very low concen-
tration. However, this approach did not work for the calcium marker. In our case,
time-lapse measurements last for 24-30 h, which makes the use of FBS necessary to
avoid side effects like starving of the cells. But FBS contents also esterases, which
leads to cleavage of the fluorescence marker already outside of the cell, thus leading
to a broad and diffuse signal outside and inside of the cell. This makes an incuba-
tion step inevitably, and preferably under serum-free conditions. Thus, the impact
on the signal of FBS and the serum substitute Panexin NTA (PAN Biotech), which
has defined components and is suitable for adherent cells, was tested in different con-
centrations (10%, 5% and 1%; (v/v)). In summary, the signal at the beginning was
much better for NTA than for FBS, and the lower the NTA amount, the better was
the signal during the first hours. But for all conditions, the signal disappeared after
24 h. The first reason for this is, that also NTA contents some esterases. Secondly,
the widely used markers Cal-520 AM (AAT Bioquest) or Cal-590 AM (AAT Bio-
quest) show no retention inside the cells. The reason for the lacking retention could
be that some cell lines, presumably also A549 cells, express organic anion transporter
membrane proteins, which transport the marker from the inside to the outside of
the cell. The use of probenecid, which could prevent the leaking of the cell-loaded
dye out of the cells, should be avoided, since it has various effects on signaling path-
ways. Thus, the new Calbryte-520 and Calbryte-590 (AAT Bioquest) markers are
used, which are developed for higher retention once inside the cells. According to
the manufacturer, the indicator is a polar molecule in the active state and trapped
inside the cells thus unable to diffuse through the cell membrane. The best results
with a minimum but sufficient loading time, without affecting the cells too much,
were gained with an incubation of Calbryte-520 (1 µM) for 30 min in Hank’s Buffer
with 20 mM HEPES (HHBS). Note the low amount of HEPES, since HEPES in
higher concentrations was seen to induce cytotoxicity upon light exposure.
The single-wavelength calcium indicator used here, is only for the detection of relative
changes in the calcium concentration. The loading of the single cells can be different,
thus a quantitative analysis of the calcium level per cell would require a single-cell
calibration beforehand. The time courses of A549 cells after inducing apoptosis with
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etoposide or PS89 show mostly in the very beginning a decrease in intensity, which
is assumed to be bleached autofluorescence (Figure 2.12). Furthermore, very sharp
onsets in the fluorescence signal and a very sharp signal decrease is observed to be
characteristic for calcium time traces. The onset is correlated with the eﬄux of the
calcium ions out of the stressed ER into the cytosol (tCalcium Release) and binding to
the marker molecules, which are predominantly localized in the cytosol. The drop
in signal is rather not photobleaching as described in [57], but caused by the release
of the marker out of the cell due to PMP, as seen in the analysis of the raw data. In
literature, this typical peaks are called Ca2+ puffs or Ca2+ sparks [56, 58]. In some
cases, also very broad peaks, plateaus, double peaks or a smooth decrease of signal
are observed. In most traces, this does not affect the detection of the event times.
tCalcium release
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Figure 2.12: Exemplary 24 h time traces of Calbryte-520 after apoptosis induction with the
combination of 10 µM Etoposide and 25 µM PS89 in A549 cells. The time point of calcium release
out of the endoplasmatic reticulum (tCalcium Release) is indicated with an arrow.
2.4.5 Caspase-3/7 Activation - CellEvent Caspase Marker
Most of the apoptotic signaling cascades are caspase-dependent, also the PS-NH2
nanoparticle induced apoptosis pathways as described in Chapter 3.1.1.
Thus, to illustrate the activation of caspase-3 and -7, which is stated as the first event
in the late phase of apoptosis, the CellEvent green Caspase marker (Invitrogen) was
used. It was administered in a very low concentration (3%, (v/v)), since the marker
stays in the cell media during the whole measurement without any washing step.
The fluorogenic reagent is a nucleic acid binding dye with a four amino acid peptide
sequence (DEVD). The fluorophore is cell-permeant and non-fluorescent until the
DEVD binding side is cleaved by activated caspase-3 or caspase-7. Once the cleavage
is implemented, the dye binds to DNA and produces a bright fluorescence signal
(Figure 2.13).
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Figure 2.13: Mode of action of CellEvent green marker. The cell permeant DNA dye CellEvent
green is non-fluorescent as the conjugated DEVD amino acid peptide inhibits the binding to nucleic
acids. As soon as caspase-3 or capsase-7 are activated during apoptosis, the DEVD sequence is
cleaved and a bright fluorescence signal results from the binding to DNA.
Exemplary time courses of caspase-3/7 activation during PS-NH2 nanoparticle in-
duced apoptosis can be seen in Figure 2.14. There, the activation (cleavage of the
marker) can be seen as a sharp onset signal in the time courses (tCASP-3) and is
followed by a less abrupt decrease in fluorescence, caused by photobleaching. The
onset of fluorescence is assumed to be delayed due to the enzymatic reaction. The
fitting of the time traces for the late markers are described in Chapter 2.5.
tCASP-3
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Figure 2.14: Exemplary 24 h time traces of CellEvent green to illustrate the activation of caspases-
3 and-7 after apoptosis induction with 100 µg mL-1 PS-NH2 nanoparticles in A549 cells. The
activation of caspase-3 and -7 (tCASP-3) is indicated with an arrow.
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2.4.6 Phosphatidylserine Flip to the Outer Membrane -
pSIVA-IANBD
The second late event of PS-NH2 nanoparticle induced apoptosis, which was analyzed
in this study, is the phosphatidylserine (PhS) flip from the inner side of the plasma
membrane to the outer side of the membrane. The membrane lipid PhS is mainly
on the inner leaflet of the plasma membrane in viable cells, thus not accessible for
the cysteine pSIVA-IANBD fluorophore, which is non-fluorescent at this stage. As
soon as the cell is undergoing apoptosis, PhS is flipping to the outer leaflet and the
polarity sensitive fluorophore can bind to the lipid (Figure 2.15). The excitation
maximum of pSIVA is at 488 nm and the emission maximum at 530 nm. The pSIVA
marker was used in a concentration of 3% (v/v) without any further washing step.
Plasma 
Membrane
Live Cell Apoptotic Cell
Apoptosis
Homeostasis
Phosphatidylserine
pSIVA-IANBD
Fluorescent pSIVA-IANBD
Figure 2.15: Mode of action of the pSIVA-IANBD marker. In live cells, phosphatidylserine (pink)
is mostly on the inner leaflet of the plasma membrane. During apoptosis, the polar membrane lipid
flips to the outer leaflet of the membrane and the pSIVA-IANBD marker can bind, which is leading
to a bright fluorescence signal.
In single-cell time-lapse measurements, the translocation of the polar membrane
lipid PhS on the non-polar lipid environment and the subsequent binding of the
marker causes a sharp onset of fluorescence, indicated as tPhS-Flip (Figure 2.16). This
translocation is reversible. The fluorescence decreases after the sharp maximum due
to photobleaching.
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Figure 2.16: Exemplary 30 h time traces of pSIVA-IANBD showing the flip of the membrane lipid
phosphatidylserine from the inner leaflet of the plasma membrane to the outer leaflet (tPhS-Flip)
after apoptosis induction with 2 µM staurosporine in A549 cells.
2.4.7 Plasma Membrane Permeabilization -
Toto-3-/Propidium Iodide
The final stage of apoptosis includes the permeabilization of the plasma membrane.
In this phase, cell-impermeant dyes such as Toto-3 and Propidium Iodide can enter
the cell and bind or intercalate to the DNA (Figure 2.17).
Figure 2.17: Propidium Iodide (PI) and Toto-3 Iodide (Toto-3) are both intrinsically non-
fluorescent dyes, which are not cell-permeable. At the late phase of apoptosis, the plasma membrane
is permeabilized and the reporter molecules can enter the cell. There, a bright fluorescence signal
arises due to intercalation with DNA (PI) or external binding/bis-intercalation (Toto-3).
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Toto-3 iodide (Invitrogen), a carbocyanine dimer, has several modes of action: it can
externally bind, intercalate or bis-intercalate with either single-stranded or double-
stranded DNA [59]. It has its excitation maximum at 542 nm and the emission
maximum at 660 nm (Figure 2.18). Within this study, Toto-3 iodide was used with
in a concentration of 1 µM.
4 I-
Figure 2.18: Chemical structure of DNA binding marker Toto-3 iodide.
Propidium Iodide is intercalating between the bases of DNA with a stoichiometry
of 4-5 base pairs to one dye molecule. It also binds unspecifically to RNA. The
excitation spectra shows a maximum at 535 nm and the emission spectra at 617 nm.
Propidium Iodide (Imgenex) was used at a concentration of 1% (v/v). The chemical
structure of PI is shown in Figure 2.19.
Figure 2.19: Chemical structure of intercalating cell death marker Propidium Iodide.
Exemplary time courses of the PI marker of A549 cells after exposure of 100 µg mL-1
PS-NH2 nanoparticles show significant enhancement of fluorescence when reacting
with DNA after PMP (tPMP) and a slight and smooth decrease afterwards, which
can be related to photobleaching (Figure 2.20). These features are also characteristic
for Toto-3 Iodide.
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Figure 2.20: Exemplary 30 h time traces of Propidium Iodide to illustrate the plasma membrane
permeabilization (tPMP) after apoptosis induction with 100 µg mL-1 PS-NH2 nanoparticles in A549
cells. The event PMP is indicated with an arrow.
2.5 Data Analysis
2.5.1 Maximum-likelihood Fitting and Extraction of
Parameters
The single-cell time traces are saved as .csv files and are converted into .txt files
using an in-house written Matlab macro (Peter Röttgermann). Therefore, a meta
data excel file, which includes the experiment date, measured channels, used markers
and status (signal yes or no) information, is needed.
Maximum-likelihood Estimation
The event times were extracted with the help of the so called Phenomenological Event
Time Identification (PETI) analysis, which was custom written in Matlab by Daniel
Woschée. The maximum-likelihood method was utilized to fit phenomenological
functions to the fluorescence time traces to extract the event times of the fluorescent
markers. The marker-dependent model functions characterize the time courses of
the fluorescence markers. The markers were separated in two classes due to their
characteristic behavior, the early phase apoptosis and the late phase markers. For
both classes, the earliest time point of a change in the time course was chosen to be
extracted as event time.
The time courses of the markers for the early phase of apoptosis show an increase
in intensity which is described by a parabola (Figure 2.21). Further, a transition to
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a constant level via a more or less steep decrease is observed. The model function
fearly(t) to reflect the time courses is
fearly(t) = σ (t)(a const + s · a quad · (tvertex-t) 2)+(1- σ (t)) · b,
with the sigmoid function σ(t)
σ(t) = 1
1+e− γ (t step - 1)
where the first summand describes the parabola and the second the transition to
the constant level. The fit parameters aconst (constant ordinate offset), s (opening
of parabola), aquad (quadratic coefficient), tvertex (vertex of the parabola), b (final
saturation value), tstep (point of fluorescence breakdown) and γ (steepness) enable a
well fit of the functions to the measured time traces [60].
In the following, exemplary single time traces are shown for the LysoTracker (a),
the TMRM marker (b), the CellROX (c), and the Calbryte-520 marker (d) with the
final fits (red lines) to extract the event time (vertical black dashed line) respectively.
The dashed green line indicates the parabola and the green lines the asymptotes.
For best fits, the event times are extracted or the time traces were discarded, if no
event times could be identified. The noise is depicted as red dashed line.
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a b
c d
tLMP tMOMP
tOxBurst tCalcium release
Figure 2.21: Time traces of early markers (blue) (a) LysoTracker, (b) TMRM, (c) CellROX, and
(d) Calbryte-520 were fitted with mathematical functions. The indicated event times (vertical black
dashed line) were extracted with the help of mathematical functions such as a parabola (dashed
green line) and tangents (green lines). The final fit is shown as red line and the noise as a horizontal
red dashed line.
For the late markers CellEvent green, pSIVA-IANBD and the PI/Toto-3 Iodide, a
steep increase in intensity follows a constant level (Figure 2.22). A more or less steep
decrease, depending if the marker photobleaches or not, subsequents. The function
flate reconstructs the time traces
flate = A + B · σ (t) · (b + e γ (tstep-t)),
With
σ(t) = 1
1+e− α (t step - 1)
where α is the fit parameter steepness.
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Figure 2.22: Time traces of late markers (blue): a) CellEvent green Caspase marker b) pSIVA-
IANBD c) PI/Toto-3 Iodide were fitted with mathematical functions. Ascent tangents (green lines)
were used to extract the indicated event times (vertical black dashed line). In red, the final fit is
shown and the noise as a horizontal red dashed line.
The parameter event time, which is for the early markers tbreakdown and for the late
markers tonset, as well as the ROS rate (slope of the increase in CellROX time traces),
are then extracted from the fitted traces.
See further details in the Supplementary Information of Murschhauser et al. [36] or
[60].
2.5.2 Interactive Fitting
For the data of the combinatorial chemotherapy, described in Chapter 4, an inter-
active fitting routine was designed. The need for the development was seen as the
time traces of cells, which were treated with ETO, PS89 or the combination of both,
showed new features (discussed in Chapter 2.4), and more variations between the
traces within one marker were observed. Also the signal-to-noise ratio was slightly
worse than for the NP induced apoptosis time traces. To ensure high quality results,
which are guaranteed with accurate and precise extraction of the event times as well
as the prevention of false negative and false positive outcomes, an user interface was
operated to allow a manual correction for the fits. In short, since the so far developed
mathematical functions can not reference the actual time traces, a manual interac-
tion after the first rough fit is requested. Either, the event time can be directly
changed manually and accepted afterwards. Or, the fittings parameters, such as the
parabola or the exponential decay, can be adjusted as well as the fitting range of
the time course can be minimized to allow a more precise fit. After these changes,
the fitting routine is initialized again. The new fit can be accepted or changed once
more.
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2.5.3 Principal Component and Cluster Analysis
The plots with event or delay times were generated with custom written Matlab or
Python macros (Daniel Woschée). The distribution of event times are visualized in
one-dimensional histograms for each marker. The correlations between two measured
fluorescence markers are presented in two-dimensional scatter plots. The position of
the clusters were identified by mean shift clustering using a kernel density estimation.
The clusters were illustrated by ellipses with asymmetric major semi-axes in order
to consider anisotropic data scattering. The width and orientation of the clusters,
which are determined Principal Component Analysis (PCA), indicate the strength
of the correlations. The length of the major semi-axis shows the scattering of the
events. The longer the axis is, the larger is the variance in scattering. Further,
the minor semi-axis indicates the correlation of the events. Thus, the shorter this
axis, the stronger is the correlation between the two events. The orientation of the
ellipse and the major semi-axis in relation to the diagonal shows the time-dependence
of delay time. If the cluster, and thus the major axis is parallel to the diagonal,
no time dependence is detected, while the delay time increases or decreases with
time, if no parallelization is shown. To account the time delay between apoptotic
inducer administration and the start of the time-lapse, the time offset was added
to the time traces. More details of the determination of clusters and ellipses can
be found in the Supplementary Information of Murschhauser et al. [36]. All the
used macros for analyzing and plotting the data are available with the following
doi:10.5281/zenodo.1418465. For an overview, the workflow of data processing can
be seen in Figure 2.23.
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Data Acquisition - Nikon/Custom Macros
• Micropatterning
• Seeding cells and incubation for 6 h
• Addition of marker and inducer
• Determination of positions
• Image acquisition 24-30 h
• Data conversion
• Data transfer
Image Analysis – ImageJ with plugin Microwell Analysis
• Sorting of data in proper folder
• Semi-manuell grid determination
• Integration of fluorescence intensity in ROI
• Simple background correction
• Sorting out detaching, double/,multiple, floating cells etc
Results in .csv and .png
+ external Meta-Datafile (.xls)
File Conversion - MATLAB
TXT
Time Course Processing, MATLAB and Linux Cluster
Maximum-likelihood fitting routine
PDF and CSV
Data Visualization, MATLAB
• Histograms
• Scatter plots
• Cluster analysis
TIFF
Figure 2.23: The present status of the workflow of data acquisition and data analysis.
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Event-Time Correlations in NP induced
Apoptosis
3.1 State of the Art
Apoptotic signaling pathways are arbitrarily complex depending on the type, the
concentration and the exposure time of the apoptosis inducer, the used cell line and
experimental conditions (bulk or single-cell). Furthermore, especially the impact
of nanomaterials, such as nanoparticles, varies a lot. It depends on core material,
size, shape, coating, concentration, charge, stability in different solutions, method
of production, purification grade as well as the experimental conditions such as pH,
temperature and storage conditions. Particles in nanometer size gain new properties
due to the increased ratio of volume to surface area, which leads to higher surface en-
ergy, compared to bigger bulk particles. Therefore, a nanoscaled material is not only
more reactive, but also develops new chemical, magnetical, mechanical and optical
properties. These interesting features have raised the common interest tremendously
and the field of nanotechnology grew exponentially in production and application in
the 21st century [61–63]. Besides all the positive benefits of such nanomaterials, also
the risk and the impact on the environment and the human body have to be consid-
ered and characterized in a systematic and an exhaustive way. In the last decades
various studies have characterized the effect of the above-mentioned properties un-
der various conditions, see reviews [64–66]. Still, the underlying mechanisms and the
induced signaling pathways of many nanomaterials are poorly understood.
In the following, different pathways are described. First, the PS-NH2 nanoparticle
induced apoptotic pathway, which was the main focus in this study. Further, the
staurosporine (STS) triggered pathway, since STS was used as a positive control
to compare with the NP pathway. And lastly, an external apoptosis pathway, the
Fas-Ligand signaling cascade, is presented.
3.1.1 Signaling Pathways Induced by PS-NH2 Nanoparticles
The focus of this short literature overview will be on apoptosis signaling cascades
induced by PS-NH2 nanoparticles (58 nm). The physico-chemical properties of PS-
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NH2 nanoparticles are well characterized as well as their trigger of apoptosis in cell
culture [18, 41, 62, 67–71]. Thus, they were chosen as model particles to study the
apoptotic signaling pathways with time-lapse measurements at the single-cell level.
The A549 lung cancer cell line was selected, since it is frequently used in cytotoxicity
studies of nanomaterials to mimic inhalation scenarios.
Cationic PS-NH2 nanoparticles are known to induce cytotoxicity by apoptosis path-
ways [21, 41, 62, 67–70]. The toxicity is not due to the material per se, but due to
the coating with -NH2 groups. The effect was determined by comparison of different
coated and non-coated polystyrene particles [67].
In the initiation phase, the particle up-take occurs actively via energy-dependent en-
docytosis. Once inside the cell, the particles accumulate in the lysosomes [41, 70, 72–
74] (Figure 3.1). Inside the acidic lysosomes, some of the polycations get protonated
(high proton binding affinity), which leads to a pH increase (alkalization), the amount
of protons drops (buffering) and thus the cell is pumping actively protons inside the
lumen to compensate this loss [62, 70]. To preserve the electrochemical and osmotic
gradient, a subsequent water and ion (Cl-) flux inside the lysosomes is executed. The
consequential osmotic swelling of the lysosomes causes the final lysosomal breakdown.
During this lysosomal membrane breakdown (LMP), the membrane is first permeabi-
lized until it ruptures and the lysosomal content, e.g. cathepsin-D, is released. The
whole procedure is called the ”proton sponge theory” [75] and is well described in [66].
Further, in the PS-NH2 nanoparticles induced apoptosis signaling cascade the mito-
chondria are involved, observed in different cell lines [41, 62, 67, 69, 70]. Through the
activation of the mitochondria, mitochondrial reactive oxygen species (ROS) are re-
leased and/or due to the mitochondria outer membrane permeabilization (MOMP),
mitochondria content, e.g., cytochrome c, is streaming into the cytosol. Additional
ROS is produced due to MOMP and/or LMP and also substantially involved in the
downstream signaling [41, 69]. Wang et al. as well as Anguissola et al. proposed
the sequence of LMP-MOMP [67, 69]. Further, in a more detailed study Wang et
al. and also the group of Brunk, suggested the pathway LMP-MOMP-ROS [70, 76].
Furthermore, the group of Baumgartner et al. found additionally the event sequence
MOMP-ROS-LMP, suggesting two potential pathways [77]. In summary, all findings
come to terms that positive feedback loops, e.g., ROS-LMP-mitochondrial ROS-
LMP, can not be excluded and crosstalk between the key player is highly probable.
Thus, the involved key players are identified, but the timing of the events is still
unclear.
After the initiation phase of apoptosis, the execution phase of apoptosis is provoked.
In this final stage, caspases, especially caspase-9 through MOMP, as well as the
effector caspases 3 and 7 are activated [41, 62, 67, 69, 70]. Next, the membrane
lipid phosphatidylserine is flipping from the inside of the cell to the outer side of the
membrane (PhS-Flip) [21]. Finally, the plasma membrane is permeabilized (PMP)
and the cells are dying due to DNA damage [67].
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Note that the detailed signaling pathways described above are only valid for cationic
PS-NH2 nanoparticles with a size of around 58 nm, observed in different cell lines.
For other apoptosis inducers, various, more or less key players can be involved,
also in a different sequence. Furthermore, the described cascade is only valid when
the nanoparticles are added in combination with serum to the cells. In this case,
the serum proteins and different molecules form the protein corona on the surface
of the NP, the nanoparticles with this corona are endocytosed and accumulated
in the lysosomes [71]. There, the corona is degraded. In contrast, in serum-free
conditions the positive charge is not screened and thus leads within a short time
directly to plasma membrane permeabilization and without initiating the various
signaling pathways [69].
PS-NH₂ NPs with
protein corona
ROS
LMP
MOMP
?
PhS Flip
PMP
Caspase-3/7
Caspase-9
endocytosis
swelling
PS-NH₂ NPs
without protein corona
Figure 3.1: Overview of the apoptosis signaling cascade induced by 58 nm sized cationic amino-
modified polystyrene (PS-NH2) nanoparticles (NPs) coated with media proteins. ROS= reactive
oxygen species; LMP=lysosomal membrane permeabilization, MOMP= mitochondria outer mem-
brane permeabilization; PhS-Flip= Flip of phosphatidylserine from the inner side of the plasma
membrane to the outer membrane side; PMP= plasma membrane permeabilization.
35
Chapter 3 Event-Time Correlations in NP induced Apoptosis
3.1.2 Staurosporine Induced Cell Death Pathways
Since many years, the bacterial alkaloid staurosporine (STS) is known for inducing
cell death and is frequently used in apoptosis studies as a model inducer for analyzing
signaling pathways [78–82]. Therefore, the broad-spectrum protein kinase inhibitor
STS is used as a positive control for cell death in this study. Further, it is suited best
as a positive control, since the pathways of STS induced apoptosis are very similar
to the ones described above for PS-NH2 nanoparticles. In the following paragraph,
the known STS signaling cascades from literature are described in short.
In the early phase of apoptosis, the first point of action are the lysosomes. Johansson
et al. showed in human foreskin fibroblasts that the inhibition of cathepsin D, which
is released from ruptured lysosomes, also inhibits the release of cytochrome c [80].
Cytochrome c is usually set free out of the mitochondria, when the mitochondria
outer membrane is permeabilized. Subsequently, a reduced caspase activity and
thus a delayed cell death was detected in response to the inhibition [80]. Hence, in
summary, the pathway is roughly the same as for NPs: LMP-MOMP-CASP-PMP.
Also ROS and the calcium release seem to play a role in staurosporine-induced
apoptosis [79]. Additionally, as a stage in between, the formation of the so called
apoptosome was found to be an important step. When ATP binds to cytochrome
c, the assembly of the apoptosome is realized with the composition of pro-caspase-9
and the apoptosis protein-activating factor-1 (Apaf-1) [80]. This formation of the
apoptosome was not reported for PS-NH2 NP induced apoptosis yet. Manns et al.
also found an apoptosome independent pathway [78]. By the apoptosome, caspase-3
is activated via pro-caspase-3 and caspase-9. Also caspase-independent pathways
were found for STS [80, 81].
3.1.3 Comparison to an External Apoptosis Trigger: the
Fas-Ligand
Besides the intrinsic mitochondrial ROS induced apoptosis, also an extrinsic path-
way, mediated by death receptors, exists. The binding of a ligand to the recep-
tor initiates protein-protein interactions in the cell membrane and initiator-caspases
are activated. The so called tumor necrosis factor (TNF) receptor superfamily of
cytokines includes the death receptor activating ligands TNFα, the TNF-related
apoptosis-inducing ligand (TRAIL) as well as the Fas-Ligand (FasL) [83, 84]. The
FasL is expressed among others on tumor epithelium and can be membrane bound
(mFasL, apoptotic) or soluble (sFasL), which has no apoptotic effects [85]. The Fas
receptor is one of the major known receptors, also prominent as cluster of differen-
tiation 95 (CD95) or apoptosis antigen 1 (APO-1). The Fas receptor is a 36 kDa
transmembrane receptor [86], which is a pre-associated homotrimer [87]. Due to the
binding of the Fas-Ligand, the receptor trimerizes via cross-linked disulfide bind-
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ings. An overview of the FasL induced signaling pathways is shown in Figure 3.2.
The clustering of FasL and the receptor is necessary for the receptors stabilization
and activation [88]. Minutes after binding of the Fas-Ligand to the receptor, the
Fas-Associated protein with Death Domain (FADD) and procaspase-8 are activated
and the formation of Fas/FADD/caspase-8, the so called death-inducing signaling
complex (DISC), is initiated [89]. If additional FADD and caspase-8 are recruited,
resulting from the accumulation of released endosomal DISC in the cytosol, type
I of the FasL induced apoptosis pathway is triggered [90–92] (Figure 3.2, left). In
this pathway, caspase-3 is directly activated and the chromosomal DNA is degraded,
which leads to apoptosis [93, 94]. However, with less activated caspase-8 and FADD,
thus a low level of DISC formation, the caspase-3 activation is only possible with an
amplification of caspase-8 through a loop in the mitochondria [92, 95, 96] (Figure
3.2, right). This alternative is the so called mitochondria dependent pathway type
II, where the cleavage of Bid leads to the proapoptotic activation of the mitochon-
dria and thus the release of cytochrome C. The apoptosome is formed and thereon
caspase-9 triggers the executioner caspase-3 leading to apoptosis [92].
FasLigand + Fas-Receptor
Formation of FADD
Trimerization of Receptor
Activation of Pro-Caspase-8
Formation of Caspase-8
Release of Cytochrome C
Formation of DISC with FasL, FADD and Casp-8/Casp-10Endocytosis of DISC
Caspase-3
Apoptosis via degradation of chromosomal DNA
Cleavage of Bid
Proapoptotic activity of mitochondria
Apoptosome
Caspase-9
Type I
High level of DISC formation
Type II
Low level of DISC formation
Figure 3.2: Overview of the pathways type I and type II in the Fas-Ligand (FasL) induced apop-
tosis. The assembly of the FasL in the Fas receptor is leading to the trimerization of the receptor
and the Fas-associated Protein with Death Domain (FADD) is formed. Pro-caspase-8 is activated
and subsequently is Caspase-8. The FasL, FADD and Caspase-8 and also Caspase-10 result in the
Death Inducing Signaling Complex (DISC). With high levels of DISC formation, the type I pathway
is triggered, where the Caspase-3 is directly activated, which finally is leading to cell death via the
degradation of chromosomal DNA (left). The type II pathway is induced with low levels of DISC
formation and via the activity of the mitochondria and the release of cytochrome c, the caspase-9
is triggered via the apoptosome and the cell is undergoing apoptosis (right).
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3.2 Nanotoxicity Screening
Nanotechnology was identified as a key enabling technology of the 21st century [97].
The use of nanomaterials has the great potential to support challenges in health
care and energy deficiencies. Nevertheless, the widespread use of nanomaterials in
consumer products, such as cosmetics, food, medical applications, clothes and house-
hold products, points out that toxicological research and health risk assessment is
inevitable, to analyze the impact on the environment and the human body. Risk
assessment is a difficult task, since the impact of nanomaterial varies tremendously,
depending on material, size, shape etc. . Also the method of choice and the cell line
have consequences on the outcomes. To obtain insight in the various effects of manu-
factured nanomaterials (MNMs), a large-scale study was performed by two institutes
(Karlsruhe Institute of Technology (KIT) and European Commission Joint Research
Centre (JRC)), three universities (LMU Munich, University College Dublin and the
University of Birmingham) as well as one industrial partner (Promethean Particles)
[18]. This study was realized within the European Commission’s 7th Framework
Programme project NanoMILE.
The aim of the project was to get an overall inside view of different MNMs with dif-
ferent surface characteristics in various cell types (liver, lung, colon and the immune
system). The experiments were performed with different techniques, mainly high-
throughput/-content (HT/C) methods. Different end-points were examined such as
cell count, mitochondrial membrane potential, lysosomal acidification, steatosis, cell
membrane permeability and apoptotic cell death. The data was standardized using
the Signal to Noise Ratio (SNR) to compare the results across the laboratories. The
SNR is defined as the determined value subtracted by the mean of the background,
and divided by the background standard deviation [18]. No additional information
for significance is needed, since the SNR is providing it indirectly. All results can be
read in Hansjosten et al. [18], in the following paragraph the results of experiments,
done by LMU (P. Röttgermann and A. Murschhauser) are summarized.
14 soluble MNM were tested, ranging from SiO2, TiO2, CeO2, ZnO and Ag with var-
ious coatings. PS-NH2 (100 µg mL-1) MNM was used as a positive control, whereas
pure medium was taken as negative control. The concentrations exposed to A549
cells, seeded on microstructured surfaces (see the protocol in the Appendix A.2), were
1, 2, 3.9, 7.8, 15.6, 31.2, 62.5 and 125 µg mL-1. These final concentrations correlate
with surface area doses of 0.3, 0.6, 1.2, 2.4, 4.9, 9.8, 19.5 and 39.1 µg/cm2. Nanopar-
ticle solutions were prepared following standard operation procedures (SOPs) when
not delivered already in solution. The fetal bovine serum (FBS) used for this study
was centrally purchased as one lot (Gibco, Life Technologies, Darmstadt, Germany,
Cat. Number 10270-106, LOT-Number 41G1931 K). The end-points chosen by LMU
were cell death, imaged with the nuclear stain PI (2%, (v/v)) and Hoechst 33342
(25 nM), as well as cell viability, which was illustrated with the caspase-3/7 marker
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CellEvent green (3%, (v/v)). The cells were exposed to the nanoparticles diluted
in DMEM together with the fluorescence markers for 24 h, at 37°C. Phase contrast
and fluorescence images (DAPI, PI and GFP) were taken after incubation. the data
analysis was performed using the in-house written ImageJ plugin Microwell Analysis,
as described in Chapter 2.3.2, as well as custom MATLAB codes (P. Röttgermann)
to analyze the SNR. In our case, the SNR was calculated as the following:
SNR =
Xc −NCc
SDNC
where Xc is the average of the number of viable cells (X) for the concentration c,
evaluated indirectly with the PI stain in different experiments, for each MNM and
each concentration, NCc is the average of dead cells in the negative controls (NC),
SDc the Standard Deviation (SD) of dead cells in the negative controls. The aver-
age number of viable cells was calculated by subtracting the ratio of dead cells (PI
positive) and the total number of cells from one. The Null Hypothesis implies that
no effect of the MNM compared to the negative control is detected. The threshold
-2 would hint a downwards effect and +2 an upwards effect. The value 2 is retrieved
from the hypothesis that the means of two normal distributed variables can be as-
sumed to be equal, if the variables are received from different number of experiments
and unknown, but similar variance [18]. The effect has to be observed for at least
two subsequent concentrations to be significant.
In summary, we could observe that single A549 cells (LMU results, Figure 3.3, right
column) were more sensitive than monolayer A549 cells (KIT/JRC/UCD, Figure 3.3,
left column) in all conditions. Silica particles and also the CeO2 particles, except
for one outlier, had no toxic effects, neither in monolayer nor at the single-cell level,
as indicated in green in the heat map. TiO2 particles seem to be more toxic to
single cells than to bulk cells, since the color code for bulk cells is green while for the
single cells, especially the highest concentration of the hydrophobic and hydrophilic
nanoparticles, the color is changing to red (toxic). Whereas ZnO particles only seem
to be toxic to bulk cells in the two highest concentrations, single cells are dying after
a treatment with the four highest concentrations. Furthermore, the toxicity of silver
nanoparticles is increasing dose-dependently for bulk measurements, while for single
cells silver nanoparticles were toxic in all concentrations. These outcomes clearly
state that single-cell measurements have to be considered for future nanotoxicity
studies, since the sensitivity of the cells is much higher at the single-cell level than
in confluent monolayers.
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Figure 3.3: Heat map of Manufactured Nanomaterial (MNM) induced cell death readouts in
monolayer and single cells. Monolayer cells (left column) and single cells (right column) were
exposed to different MNM as indicated for 24 h in DMEM and 10% FBS (v/v) with the range of
concentrations from 1 to 125 µg mL-1. Dead cells were evaluated by the Propidium Iodide stain,
indicating plasma membrane permeabilization, and the total number of cells with Hoechst 33342.
The number of viable cells was calculated by subtracting the ratio of dead cells and the total number
of cells from one. The Signal-to-Noise-Ratio (SNR) is calculated by subtracting the dead cells of
the negative controls from the number of viable cells and normalizing the difference by the standard
deviation of the negative controls. The SNRs are illustrated as heat map, where the color code is
ranging from dark green (more viable cells than the negative control) to red (decrease of viability).
Reprinted from Supplementary Information of [18] with permission from Springer Nature.
3.3 Correlations in the Initiation Phase: LMP,
MOMP and ROS
The need of further detailed investigation of nanoparticle impact on the single-cell
level was shown in the preceding broadly based study as well as described in Chapter
2.1. Single cells are more sensitive to nanomaterials than cells in bulk measurements.
Thus, single-cell time-lapse measurements with the model PS-NH2 nanoparticles
were performed in A549 as well as in Huh7.
The following chapter is based on the publication Murschhauser et al. [36].
Hereafter, the distribution of event (offset) times of the three early markers (Lyso-
Tracker, CellROX and TMRM), measured in A549 cells after apoptosis induction
with 25 and 100 µg mL-1 PS-NH2 nanoparticles or 2 µM STS, were analyzed (Fig-
ure 3.4). A549 cells were seeded onto micropatterned surfaces (see protocol in the
Appendix A.2) and automated live-cell imaging on single-cell arrays (LISCA) was
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performed to obtain single-cell time traces. The event times were extracted with
the maximum-likelihood routine and only cells were included, which showed both
marker signals. The data from up to 600 cells per marker are pooled from different
marker combinations. Approximated log-normal distributions are indicated with a
black line in each plot. By comparison of the NP exposures, a dose-dependent timing
of the events is observed. The maxima for the lower concentration of NPs (25 µg
mL-1 NPs, brighter colored distributions), namely 11-13 h, are shifted towards later
time-points than the ones for the higher concentration (100 µg mL-1 NPs, darker
colors), which are observed between 5-9 h. The time and dose-dependent cytotoxic-
ity of amino-modified nanoparticles is in good agreement with literature [21, 62, 67].
The event time distributions of staurosporine treated cells show a timing in between
the two NP concentrations, namely between 8-10 h. To exclude the suspicion of
side effects caused by the fluorescence markers, negative controls, where only media
and the markers without apoptosis trigger were added to the cells, were performed.
Experiments, which showed more than 20% double positive cells, were excluded from
analysis. Also the dependency of marker-combinations was examined, and found to
be present in some combinations, causing slight shifts (see data in Supplementary
Material of Murschhauser et al. [36]). Furthermore, the day-to-day variance was
evaluated by comparing identical marker combinations measured on different days.
The scattering of the events was justifiable (Supplementary Material Murschhauser
et al. [36]). In the Supplementary Material all the statistics of the histograms and
the following plots can be found as well [36].
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Figure 3.4: Event time distributions of early markers in A549 cells over 30 h. Cells were exposed
to 25 µg mL-1 (brighter colors) and 100 µg mL-1 PS-NH2 nanoparticles (darker colors, a) or 2 µM
STS (b) and the event times are illustrated for the fluorescence markers LysoTracker, Tetramethyl-
rhodamine (TMRM), CellROX green. Each graph consists of a set of pooled experiments with
different marker combinations. Only cells with both marker signals are shown (n). Log-normal dis-
tributions are fitted to the distributions (black line). Adapted from [36], licensed under a Creative
Commons license [39].
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Nevertheless, the aim to clarify the sequence of events during NP induced apoptosis
could not be accomplished with the histograms, since the broadness of the distri-
bution width is too large compared to the shifts of the maxima for the different
markers.
Thus, to unravel the order of events, pairwise correlations of the events (1) and (2) of
one marker combination were investigated, instead of averaged event times. There-
fore, tevent (1) was plotted against tevent (2) in scatter plots for the three different
exposures 25 and 100 µg mL-1 PS-NH2 nanoparticles (Figure 3.5a, d, g and 3.5b, e,
h) and 2 µM STS, respectively (Figure 3.5c, f, i). The different marker combinations
were plotted per row for each treatment. The scatter plots are divided in two halves,
to identify the chronological order of events. For example, if the single-cell data
points are in average above the diagonal, event (2) follows event (1). If the average
of event time points are directly on the diagonal, the events happen simultaneously.
Event clusters are identified by mean-shift clustering. The ellipses shown are gained
with Principal Component Analysis (PCA) and illustrate the centers and widths of
event time distributions. The length of the semi-axes of the ellipses, rising from the
center of the ellipse and oriented along the two components respectively, visualize
the mean square displacement of events. The PCA is a powerful tool to unravel the
average timing of events, thus the order and the delay time between two correlated
events (see more details in Chapter 2.5.3).
For PS-NH2 NP induced apoptosis, the lysosomal pathway LMP-MOMP-OxBurst
was identified in both NP concentrations. The outcomes suggest that the lysosomal
breakdown is triggering the permeabilization of the outer mitochondria membrane
and the following increase in ROS level. Also here, the higher NP dose shows a higher
impact and the event times shift to earlier timing. Furthermore, for the higher NP
dose, a bimodal behavior could be observed, indicated by data points underneath the
diagonal. In summary, the event time points of all marker correlations hint the exis-
tence of a second pathway, in fact a mitochondrial pathway. The sequence of events
is MOMP-OxBurst-LMP, showing that with the breakdown of the mitochondrial po-
tential the cellular stress level is increasing, indicated by the oxidative breakdown,
followed by the lysosomal leakage. For the staurosporine induced apoptosis, similar
scatter plots to the ones of the high NP dose are obtained. Also here, both pathways,
the lysosomal signaling cascade as well as the mitochondria triggered pathway, are
shown in the two-dimensional marker correlations.
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Figure 3.5: Two-dimensional scatter plots of event times obtained by pairwise-marker correlations
measured in A549 cells. Pairwise correlations of event times tevent (1) and tevent (2) of fluorescence
markers are shown in each scatter plot. Apoptosis was induced with the treatment of cells to
25 µg mL-1 nanoparticles (left), 100 µg mL-1 nanoparticles (middle) or STS (right). MOMP was
correlated with LMP (a, b, c) as well as with OxBurst (d, e, f). Moreover, LMP and OxBurst were
correlated with each other (g, h, i). n is the number of depicted cells. Adapted from [36], licensed
under a Creative Commons license [39].
The A549 cell line was used as a lung cancer model system, which is often used
in cytotoxic studies to investigate the inhalation pathways. Additionally, NPs are
uptaken by the intestine and accumulate in the liver [18]. Thus, the Huh7 human
hepatocarcinoma cell line was a suitable second model system to for comparison.
Interestingly, also in the liver cancer cells the dominant pathway with the mitochon-
dria as key player was seen, even though with longer delay times than examined for
A549 cells (Figure 3.6). Furthermore, the dose-dependent shift to earlier time points
for the higher NP dose, which was observed in A549 cells, could be reproduced with
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Huh7 cells. However, the second pathway, observed for the high dose in A549 cells,
was not evident for Huh7 cells.
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Figure 3.6: Pairwise marker correlations of single-cell event times in Huh7 cells. Scatter plots were
obtained by correlation of tevent (1) and tevent (2) of one marker combination respectively. Namely,
MOMP was combined with LMP (a, b), and OxBurst (c, d) as well as LMP was correlated with
OxBurst (e, f). Huh7 cells were exposed to 25 µg mL-1 nanoparticles (left column) or 100 µg mL-1
nanoparticles (right column). n indicates the number of cell shown. Adapted from [36], licensed
under a Creative Commons license [39].
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Figure 3.7 summarizes the findings of 58 nm PS-NH2 NP induced apoptosis in A549
cells in one scheme. The nanoparticles trigger cell death via the lysosomal pathway,
which is in good agreement with literature [41, 62, 69]. The breakup of the lysosomes
triggers the permeabilization of the mitochondria and the ROS level is increasing.
This sequence of events was detected and is indicated as LMP-MOMP-OxBurst in
the scheme. Additional to the mitochondria triggered pathway, which was observed
for both the low (25 µg mL-1) and the high concentration of NPs (100 µg mL-1), an
additional mitochondrial cascade was observed, which seems to be directly activated
via the mitochondria. This branch pathway was observed for the high concentration
of nanoparticles (100 µg mL-1), as well as for staurosporine. The MOMP-OxBurst-
LMP pathway (right side of Figure 3.7) is in good agreement with the findings of
Baumgartner et al., who suggest also the presence of two signaling pathways [77].
But only the powerful tool of pairwise marker correlations of single-cells achieved
with time-lapse measurements have the capability to unravel such bimodal behavior
directly and in parallel. However, it should be kept in mind that the event correla-
tions do not imply causal relations between the correlated events.
Finally, both pathways lead to cell death, indicated by the plasma membrane per-
meabilization (PMP), via activation of caspases-3 and -7 and the consequent flip of
phosphatidylserine from the inner to the outer leaflet of the plasma membrane (see
following Chapter 3.4).
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Figure 3.7: Schematic model of lysosomal and mitochondrial pathways in NP induced apoptosis
in A549 cells. On the left hand the lysosomal pathway is indicated, which is triggered by the
addition of 25 µg mL-1 and 100 µg mL-1 amino-modified polystyrene (PS-NH2) nanoparticles. The
nanoparticle are uptaken and accumulate in the lysosomes, thus leading to swelling and lysosomal
rupture. Lysosomal content is released, resulting in MOMP and oxidative Burst (OxBurst). A
critical threshold in ROS production is influencing MOMP, but not LMP (blue framed rhombus).
Furthermore, for the higher concentration of nanoparticles, a second, mitochondria provoked signal-
ing cascade is observed. OxBurst is following MOMP and leads to LMP. Both pathways, analyzed
in detail in the initiation phase, drive the cell to cell death, indicated by the plasma membrane per-
meabilization (PMP), via activation of caspase-3 and -7 and via the flip of phosphatidylserine from
the inner to the outer side of the plasma membrane (PhS-Flip, execution phase). The delay times
between the measured events are indicated as ∆t. Adapted from [36], licensed under a Creative
Commons license [39].
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3.4 The Execution Phase: Caspases, PhS-Flip and
Final Cell Death
The execution phase is the second phase in apoptosis, following the initiation phase.
After the lysosomal breakdown, the cathepsin D release followed by the mitochon-
drial collapse and a significant increase in ROS level, taking place in the first stage of
programmed cell death, executioner caspases, namely caspase-3 and 7 are activated.
The activation leads to the flip of phosphatidylserine from the inner to the outer
leaflet of the plasma membrane. Finally, the plasma membrane is permeabilized and
the cell death programme is completed. But, also in this phase, the chronological
order and the timing in between the events is still not fully understood.
Therefore, late marker combinations were analyzed. Firstly, the distributions of
event times in late marker combinations were investigated (Figure 3.8). A549 cells
were exposed to 25 µg mL-1 nanoparticles (Figure 3.8a, bright colored distributions)
or 100 µg mL-1 nanoparticles (Figure 3.8a, darker colors) and 2 µM staurosporine
(Figure 3.8b). The data was pooled from different marker combinations measured
in different experiments. The number of cells is given by n and only cells with both
marker signals are shown.
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Figure 3.8: Distribution of event times for late markers Caspase-3, pSIVA-IANBD and Toto-3
Iodide or Propidium Iodide after apoptosis induction with 25 µg mL-1 nanoparticles (a, bright
colors), 100 µg mL-1 nanoparticles (a, darker colors) or 2 µM STS (b) in A549 cells. The num-
ber of cells is indicated with n, which is gained from different experiments and different marker
combinations. Only double positive cells are shown. Adapted from [36], licensed under a Creative
Commons license [39].
As seen for the early marker combinations, the timing of the event times, thus the
maxima of distributions shifted to earlier time points for the high dose of NP in
comparison to the low dose of NP. In numbers, the maxima for the low NP dose
are between 16-21 h and for the high dose between 8-9 h. Furthermore, also here,
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as seen for the early marker combinations, the STS induced apoptosis shows event
times in between the two NP concentrations (13-15 h).
To examine the sequence and timing of events in the execution phase of NP induced
apoptosis, different marker combinations were tested. First of all, the correlation
of the oxidative burst (OxBurst), indicating preceding intracellular stress, and the
final event, the plasma membrane permeabilization (PMP), which is accompanied
with cell death, was investigated. As expected, PMP is following OxBurst (Figure
3.9). Further, the events for the higher dose (Figure 3.9b) are evidently earlier than
for the lower dose (Figure 3.9a) and STS (Figure 3.9c). Moreover, the events for
the 100 µg mL-1 nanoparticles point out a higher correlation, indicated by a more
narrow ellipse, than the other two exposures.
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Figure 3.9: Two-dimensional scatter plots of event times for OxBurst and PMP correlations. A549
cells were treated with 25 µg mL-1 nanoparticles (a), 100 µg mL-1 nanoparticles (b) or 2 µM STS
(c). Adapted from the Supplementary Information of [36], licensed under a Creative Commons
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Finally, it was recognized that the noise in the scatter plots is mainly descending
from events of the apoptosis initiation phase. This was proven when comparing cor-
relations between an early with a late marker as well as the comparison between two
late marker combinations (Figure 3.10). The first combination (Figure 3.10a) shows
more distributed data points, thus more scattering, whereas combinations between
late markers yield more narrow correlations (Figure 3.10b). This is indicating that
the noise of the heterogeneous signals has its origin in the early phase of apoptosis.
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3.5 Correlation between Reactive Oxygen Species
and LMP or MOMP
What are ROS?
ROS can be superoxide anions (O2°-), hydroxyl radicals (HO°), peroxyl (RO2°),
alkoxyl (RO°), nitroxyl radicals (NO°) or other non radical oxygen derived radicals,
such as hydrogen peroxide (H2O2), organic hydroperoxides (ROOH) or hypochlorous
acid (HOCl) [83].
Reactive oxygen species (ROS) are necessary in the cell as redox messengers in in-
tracellular signaling and cellular regulation. ROS is known to be mainly generated
in mitochondria due to incomplete reduction of oxygen during oxidative phospho-
rylation during ATP production. Defects in mitochondrial function e.g., inefficient
oxidative phosphorylation and MOMP can direct increased ROS levels [98]. As soon
as ROS are not only byproducts of cellular oxidative metabolism, but produced in
higher concentrations due to cellular stress, the redox functions are not maintain-
able and unregulated signaling, cytotoxicity, DNA damage and apoptosis can occur
[61]. Further, ROS seem to be particularly involved in degenerative diseases such as
arthritis, Alzheimer’s disease, diabetes, Parkinson’s disease and cancer [61]. Thus,
one the one hand, ROS can be beneficial for the cell and essential for survival, but
on the other hand also fatal. Furthermore, ROS can induce cancer, then again ROS
can also be introduced as cancer therapy in the sense that ROS can trigger apopto-
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sis in cancer cells. Thus, ROS plays in both, cancer and apoptosis, a role. In this
study, the aim was to understand the down-stream signaling connected with ROS
in apoptosis signaling cascades. Especially the strong evidence for a link between
ROS and LMP as well as the relation between ROS and MOMP was scope of this
investigation.
What is the source and the cause of ROS?
The main source of ROS is the mitochondria, which is at the same time also target of
ROS [54]. Also the endoplasmatic reticulum is an important source of ROS [99]. ROS
can arise from lipid peroxidation, increasing activity of enzymes, such as NADPH
oxidase, xanthine oxidase, myeloperoxidase and flavoprotein oxidases, but also from
transient metals, hemoglobin, riboflavin, catechol amines and particularly from the
electron transport chain in the mitochondria [100].
In general, any external trigger, which is causing cellular stress, can increase the
ROS level. Chemotherapy, radiation, inflammatory cells and also nanomaterials can
induce apoptotic concentrations of ROS. In this study, the impact of nanoparticles,
namely amino-modified polystyrene (PS-NH2) nanoparticles were investigated.
ROS in non physiological concentrations was shown to cause the permeabilization of
lysosomes as well as the breakdown of mitochondria [43, 101]. Thus, in our study,
not only the event time of ROS was extracted from the single-cell time traces, but
also the increase in CellROX intensity. The slope of the curve, examined with the
maximum-likelihood fitting routine, is assumed to represent the production of ROS,
thus the ROS rate. For the analysis whether the ROS rate correlates with MOMP or
LMP, the production of ROS was plotted against the event times of MOMP (Figure
3.11a-c) and LMP (Figure 3.11d-f). A549 cells were treated with 25 µg mL-1 58
nm PS-NH2 nanoparticles (Figure 3.11a and d), 100 µg mL-1 PS-NH2 nanoparticles
(Figure 3.11b and e) and 2 µM staurosporine (Figure 3.11c and f). In the case
of the correlation of ROS with MOMP, a critical threshold of ROS presumably
exists, which is inducing MOMP. Thus, when the rate of ROS is higher than this
threshold, MOMP supposedly occurs earlier (Figure 3.11a-c), indicated with Pearson
Correlation Coefficient (PCC) values of -0.18, -0.26 and -0.17, respectively. This
inverse correlation was not observed when ROS was correlated with LMP (Figure
3.11d-f). In this case, very low PCC values were evaluated. Details on the PCC are
explained in the Supplementary Information of Murschhauser et al. [36].
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3.6 Cathepsin Inhibition with Pepstatin A
The involvement of lysosomes in apoptosis was already discussed in detail in Chap-
ter 3.1. In short, after addition of an apoptotic stimuli, e.g. staurosporine, the
lysosomes are permeabilized (LMP), which leads to the release of cathepsin D into
the cytoplasm, where further down-stream signaling is activated. Various signaling
pathways can then be mediated via caspases or the release of pro-apoptotic factors
like the protein cytochrome c from the mitochondria (after MOMP) into the cytosol.
Mitochondrial ROS is leading to a positive feedback loop, triggering again LMP
[43, 76, 102, 103]. In this chapter, the effect of cathepsin D is discussed, since it
seems to play a crucial role in the apoptotic signaling cascade. Especially, its inhi-
bition is interesting, and we investigated the question whether the following events
in the pathway can be blocked without influencing the signaling cascade itself.
Cathepsin D belongs to the class of proteases, enzymes which hydrolyze peptide
bonds, and is the only aspartic protease in the lysosomes [104]. The term ’cathepsin’
stands for ’lysosomal proteolytic enzyme’ [105] and cathepsins are the largest group
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of proteolytic enzymes in the lysosomes. Pepstatin A is shown to inhibit [105, 106]
or delay apoptosis [70, 107]. In the latter study, PS-NH2 NP induced apoptosis was
delayed, but the inhibition could not protect the cells from damage, suggesting that
the activation of caspase-3/7 was not affected. The authors suggest that cathepsin
D does not play a major role in caspase-dependent apoptosis. But, that is in con-
tradiction with literature [43, 77, 80, 105]. More likely, pepstatin A may not have
inhibited the release of cathepsin D completely, even though they used a relatively
high concentration (50 µM) and a long incubation time (16 h), or alternative sig-
naling pathways were leading to apoptosis. Since cathepsin D is also involved in
ROS dependent apoptosis [102, 103, 108, 109], the events MOMP, LMP as well as
OxBurst were measured in all possible combinations (LMP-MOMP, MOMP-OxBurst
and LMP-OxBurst). Apoptosis was induced with 2 µM staurosporine, since cathep-
sin D release was detected as event in STS triggered cell death and is well known in
literature [80, 110, 111]. The concentration used by Wang et al. was relatively high
(50 µM) and the incubation time quite long (16 h) [70]. These experimental settings
might have been too invasive, thus potentially triggering side effects or initiating
other signaling. Thus, a lower concentration of 1 µM pepstatin A was chosen and
the A549 cells were only incubated with pepstatin A for 2 h before the addition of
STS, presenting non-invasive conditions to avoid impacts on the complex signaling
cascade or on the sensitive events. In these conditions, no evident effects of inhibition
were recognized (Figure 3.12).
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Figure 3.12: Correlations of single-cell events for A549 cells, triggered with 2 µM staurosporine
and incubated for 1 h with pepstatin-A (1 µM), which forms 1:1 complexes with Cathepsin-D
(blue) and without Pepstatin-A (magenta). Three different marker combinations were measured:
LMP-MOMP (a), MOMP-OxBurst (b) and LMP-OxBurst (c).
The center of the clusters of pairwise marker combinations for cells treated with or
without pepstatin A were not clearly distinguishable from each other in timing, nei-
ther in the marker combination of LMP-MOMP (Figure 3.12a) or MOMP-OxBurst
(Figure 3.12b), nor for LMP-OxBurst (Figure 3.12c). The events for cells, which
were inhibited with pepstatin A, were expected to be delayed in timing or even to be
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blocked. Further, no increase in the number of double positive cells is evident; the
number of cells exposed to the inhibitor were expected to be lower, if the inhibition
would have been successful.
For further measurements, a longer incubation time as well as a higher concentra-
tion of pepstatin A is recommended, but still in a non invasive regime. Then, even
more attention has to be payed to side effects, which could be followed with different
controls, e.g. for morphology, doubling time, migration and detachment from the
substrate.
3.7 Comparison with an External Cell Death
Inducer: the Fas-Ligand
The analysis of the effects of FasL at the single-cell level in a dynamic manner is still
under-researched and rarely shown before. Most of the bulk measurements are eval-
uated with single microscopy images or with end-point readouts. Thus, the temporal
context of FasL cascades has been little studied so far. A greater understanding of
the underlying processes and pathways can potentially overcome the resistance and
increase the tumor cell response by addressing events more specifically. Brunk et al.
found that also lysosomes are involved in FasL induced apoptosis [112]. It was also
discovered that cathepsin D, which is released from leaking lysosomes, seems to play
an essential role [113]. Further, the number of intact lysosomes depends on the time
of exposure to anti-Fas antibody indicating that apoptosis is caused via lysosomal
breakdown [110]. Moreover, Bojic et al. analyzed amongst others the events MOMP
and LMP after induction with 200 ng mL-1 anti-Fas antibody (in combination with
1 µg/mL chlorhexidine) in an end-point readout setup (flow cytometry) [114]. They
found that the number of intact mitochondria decreased after 3 h and a considerable
amount of damaged mitochondria was detected after 11 h. More than 30% destabi-
lized lysosomes were seen 15 h after apoptosis induction. These results suggest that
MOMP as well as LMP is involved in FasL induced apoptosis, even though at very
late time points, suggesting the pathway type II. The Annexin cell viability stain
showed double positive cells 15-18 h after apoptosis induction in very low numbers
[114].
In our experiments, the A549 cell line was resistant to the TRAIL ligand, but not
to the FasL, thus being a suited cell line as model system. Our results for single
A549 cells after induction of apoptosis with 200 ng mL-1 FasL measured in time-lapse
experiments, show also the event sequence of MOMP-LMP, although at even later
time points (Figure 3.13a). Most of the cells show both signals after 22-23 h (center
of the clusters with standard deviation: MOMP: 22.52±1.29 h, LMP: 23.83±1.18 h)
with a time delay of 1.31±1.75 h. Note, that the statistic of 18 cells is low and allows
only rough estimations. Further, the PhS-Flip is following MOMP (Figure 3.13b),
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which is in agreement with Bojic et al. [114], even though at later time points. The
shift to later time points could be due to the addition of chlorhexidine in the study
of Bojic et al. [114]. In our case, most of the events are detected between 25 h
(24.77±0.87 h) and 27 h (27.06±0.81 h), thus with a time delay of 2.29±1.19 h. For
reliable statements more cells need to be analyzed.
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Figure 3.13: Pairwise fluorescence marker correlations of event times in single A549 cells. Two-
dimensional representation of event times tevent (1) and tevent (2) of correlated markers induced by
exposure of 200 ng mL-1 Fas-Ligand to cells. The center of the ellipses for LMP-MOMP are located
at earlier time points (a) than for the correlation between MOMP and pSIVA-IANBD (b). n is the
number of double positive cells plotted.
Overall, also our results hint for the pathway type II, since MOMP is involved and
the timing of the events is quite late, which could emphasize that more processes are
included, which is more time elaborative. Also the broad scattering of the events,
seen in both marker correlations, could give indication for type II. It is noteworthy
that the amount of cells, which are double positive comparing to the total amount
of cells measured is quite low (max. 20%). The reason for this could be that many
cells are detaching during the experiment and have to be sorted out, even when they
showed apoptosis before detachment, since the decrease in intensity of the MOMP
signal cannot be distinguished by the decrease in intensity caused by detachment.
This is creating a slight bias, which could not be avoided in this case. A lower
concentration of FasL (100 ng mL-1) did not show significant apoptosis. Also a con-
centration of 500 ng mL-1 FasL was tested to increase the number of apoptotic cells
but the detachment of cells was even worse. Thus, 200 ng mL-1 was chosen as a
reasonable compromise. The FasL apoptosis induction is a surface phenomenon and
the first steps, the ligand to receptor binding and receptor trimerization, take place
on the cell membrane, which could explain the increased detachment, compared to
STS or NP triggered apoptosis.
In future, the statistic could be improved with more experiments using a higher
concentration of the FasL. Therefore, 3D environments could counter act the de-
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tachment of the cells (Chapter 5). Further, more marker correlations, which would
support a deeper insight into the signaling cascades. Especially, the involvement of
caspases and cellular stress (ROS) are of interest.
3.8 The Delay Time Distribution Function
So far, we investigated pair-wise event-time correlations, which allow to distinguish
between signaling cascades. In this chapter, deeper analysis of the event correlations
in the early phase of apoptosis in A549 cells, induced with 25 µg mL-1 58 nm PS-
NH2 nanoparticles, is provided. This chapter is based on a manuscript of Daniel
Woschèe, Alexandra Murschhauser, Helmut H. Strey, Joachim O. Rädler, ’Modeling
signaling cascades based on single-cell event-time correlations’, which is currently in
preparation.
We discovered that the low concentration of amino-modified polystyrene nanoparticle
triggers only the lysosomal signaling cascade, for which the three combinations of
early markers were measured: LMP–MOMP, MOMP–OxBurst and LMP-OxBurst.
The delay times between subsequent events were estimated for hundreds of single
cells, namely A549 cells (Figure 3.14a) and Huh7 cells (Figure 3.14b). As signaling
cascades in cells are chains of stochastic events, we assumed gamma-distributed delay
times for the partial event chains (LMP–MOMP, MOMP–OxBurst). Visually, we
can draw the relation between the events as connection series:
A
PAB(t)−→ B PBC(t)−→ C
where P is the probability, event A is LMP, B is MOMP and C is OxBurst in this
case. The gamma functions can be convolved and the sum of the delay times of
A→B and B→C correlates with the delay times of A→C and can be calculated with
the following equation:
PAC =
∫
PAB(τ)PBC(t− τ)dτ
In this case, the distribution of the total event chain (LMP-OxBurst) was shown to
correspond to the convolution of the events of the partial chains (LMP–MOMP and
MOMP–OxBurst) (Figure 3.14). The estimated gamma distributions are illustrated
as blue lines on the histograms of the measured time delays. The parameters of the
gamma distributions, κ for the number of processes and θ for the decay rate, as well
as the number n of cells is indicated in each plot. The mean time delays µ = κ θ
of the path between LMP and MOMP and the path between MOMP and OxBurst
sum up to the mean time delay of the path between LMP and OxBurst. The fits
show that the measured data are described best by this model when the path between
LMP and OxBurst involves two intermediate processes (for A549) or six subprocesses
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(for Huh7), each having a duration around 7 or 16 h, respectively. However, visual
inspection shows that the gamma distribution is merely a rough approximation to the
data. The assumption that the intermediate processes are exponentially distributed
might not suit the data perfectly, especially since the statistics for Huh7 cells is
quite low. More likely, it might be a distribution with its maximum after a certain
lag time. Hence, the number of intermediate processes indicated by κ is rather a
nominal number representing a model parameter than the real number of biological
processes.
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Figure 3.14: Gamma distributions for the early events LMP, OxBurst and MOMP measured in
A549 (a) and Huh7 (b) cells after apoptosis induction with 25 µg mL-1 58 nm PS-NH2 nanoparticles.
The measured delay times (in h) are plotted as orange histograms for the combinations LMP and
MOMP, MOMP and OxBurst and LMP and OxBurst and are fitted by gamma distributions (blue
lines). The estimated parameters κ and θ of the gamma distributions, n as the number of single
cells and the calculated mean values of the gamma distributions, are indicated. The mean time
delays of the two subpaths (first and second row) sum up to their concatenations (third row).
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Chapter 4
Correlation Analysis in Combinatorial
Chemotherapy of Etoposide and PS89
4.1 State of the Art
The following results are summarized in the manuscript Murschhauser A., Woschée
D., Braig S., Angelika M. Vollmar, Rädler J. O., Targeting the ER-Mitochondria
Interface Sensitizes the Leukemia Cells towards Cytostatics, which is currently in
preparation.
Topoisomerase II Inhibitor Etoposide
The chemical structure of the anti-neoplastic reagent (neoplasm, abnormal growth
of tissue) Etoposide (ETO), an epipodophyllotoxin (extracted from the root of the
indian podophyllum plant), which inhibits the enzyme topoisomerase II (TOP2), is
shown in Figure 4.1.
Figure 4.1: The chemical structure of the anti-neoplastic agent Etoposide, which is inhibiting the
topoisomerase II.
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TOP2 is a DNA unwinding enzyme, and essential for DNA replication, transcription,
chromosomal segregation and DNA recombination [115]. The mode of action to
inhibit TOP2 can be executed in two different ways: on the one hand, the activity
of TOP2 can be inhibited directly, which is done by the so called TOP2 catalytic
inhibitors, and on the other hand there are the TOP2 poisons, which include ETO,
forming covalent complexes of TOP2 and DNA [116] (Figure 4.2).
Apoptosis
TOP2  
Etoposide
DNA/Top2
complex
Inhibition of
DNA re-ligation
DNA
Figure 4.2: Mode of action of the chemotherapy agent etoposide. Topoisomerase II (TOP2, pink)
is an enzyme which unwinds the double stranded DNA. By the addition of Etoposide (purple), a
covalent complex of DNA and TOP2 is formed, which inhibits TOP2. Further, the re-ligation is
inhibited and DNA breaks lead to apoptotic cell death.
ETO belongs to the non-intercalating TOP2 poisons. After 12 years of clinical trials,
ETO was approved by the Food and Drug Administration (FDA) in 1983. ETO can
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be applied for lung cancer, lymphoma, germ cell tumors, soft tissue sarcomas, ovarian
cancer, breast, melanoma and renal cancer either via transfusion (intravenous) or
oral, which is then a long-term administration with no need for hospitalization. It
was found that an application for 2 h over 5 days is more effective than a continuous
application for 24 h, even when the same dose was administered at the end [115].
Thus, the timing of administration is important, since TOP2 is only expressed in cells
during selected mitotic cell cycle phases. Standard applications are lung, testicular
and melanoma cancer. It was found that etoposide phosphate is less toxic and shows
less variability than ETO [115].
Unfortunately, tumor cells develop resistance through alterations or mutations in
winding sites of TOP2. Further, slowly growing tumors have less TOP2 due to
lower proliferation rates, which makes the therapy with ETO less effective. Also the
side effects are tremendous. Healthy cells have not the same uncontrolled growth
as cancer cells, but still they divide and thus provide targets for chemotherapy. For
example, secondary malignancies and cardiotoxicity are recognized as side effect of
ETO. Thus, ETO was frequently used for apoptosis studies in the past [117] and
is still an interesting chemotherapeutic model substance, especially to analyze it
in a combinatorial chemotherapy approach to overcome the resistance and the side
effects.
Network Pharmacology
The ’one-drug one target’ therapy revolutionized medicine as single-target drugs
offer tremendous effects by triggering one specific check point [118]. However, this
monotherapy concept is not applicable for complex diseases such as cancer or patholo-
gies with multiple targets or pathways. Further, deficient efficacy and resistance of
cells to chemostatic agents are common reasons for relapse and high mortality rates
for some cancer types [118]. Thus, the approach of combinatorial chemotherapy, a
promising concept to improve efficacy and to overcome resistance as well as side ef-
fects and toxicity of anti-neoplastic agents, was established in the 1960s [13]. Novel
multi-target mechanisms, in which multiple targets are affected simultaneously, are
more effective than single-target drugs - the biological system is seldom able to react
to two or more agents with different target sides synchronously. Thus, the efficacy
is increased on the one hand, and on the other hand less resistance to the drugs can
be developed. To address these two issues, specific drug design has to be considered
thoroughly. Network pharmacology, which includes systems biology, network anal-
ysis, connectivity, pleiotropy and redundancy, is a powerful strategy for innovative
drug discovery by understanding the kinetic and biological characteristics of the drug
[119]. Several drug combinations were shown to be more than additive (synergistic)
[120]. In summary, to tackle specific diseases by addressing local targets, the whole
underlying cellular network, conditioned by the genome, proteome, the environment
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and the pathophenome, has to be understood. Barabasi et al. reflect the paradigm
of network medicine appropriately: ’Think globally, act locally’ [121].
The Chemosensitizer PS89
As explained above, one main problem of cancer therapy is the resistance of cancer
cells and the side effects. To overcome this resistance in the case of ETO, a new T8
compound class was developed to increase the vulnerability of cancer cells [122]. For
the survival of cancer cells, a balanced homeostasis in the endoplasmic reticulum
(ER), which is guaranteed by ER chaperons (assistant proteins for non-covalent
folding/unfolding of proteins), is essential. One of such chaperons is the protein
disulfide isomerase (PDI), responsible for the reliable folding of proteins in the ER.
If the folding is not processed completely, the cell undergoes cell death. Thus, PDI is
the perfect target to sensitize cancer cells towards apoptosis. The study highlighted
that the PDI inhibition mechanism of the T8 derivatives is based on binding in close
proximity of the catalytic center of PDI. The reversible PDI inhibitor T8 family
showed dose-dependent increase of apoptosis in leukemia and breast cancer cells in
combination with sub-toxic concentrations of ETO. The mode of action was observed
to be synergistic and the long-term survival of leukemia cells was suppressed. As the
protein synthesis in cancer cells is significantly higher than for healthy cells, non-
cancerous cells did not respond to this chemotherapy approach [122]. Within these
T8 compounds of PS83-PS89, PS89 (Figure 4.3) showed to be the most sensitizing
activity and was thus chosen for further biological and mechanistic investigations
[42].
Figure 4.3: The chemical structure of the chemosensitizer PS89.
Signal Transduction induced by Etoposide and the Sensitizer PS89
The pharmacological profile of the combinatorial chemotherapy of the cytostatic
ETO and the chemosensitizer PS89 at the ER-mitochondrial interface was estab-
lished by the group of Prof. Angelika Vollmar (Pharmaceutical Biology) [42].
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In short, the apoptotic machinery is initiated by the cleavage of the B-cell receptor
associated protein 31 (BAP31), a key communicator in this network of cell death,
into p20BAP21. Subsequently, caspase-8 is activated and ER stress is triggered as a
consequence. Further, calcium ions are released from the ER in high levels. Accord-
ingly, in the phase of ER-mitochondrial crosstalk, the pro-apoptotic proteins Bak
and Bax form oligomeric pore complexes, which lead to the permeabilization of the
outer membrane of the mitochondria (MOMP). The breakdown of the mitochondria
is accompanied with the release of cytochrome c out of the inter-membrane space.
As a result of MOMP, also the level of reactive oxygen species (ROS) increases and
again triggers ER-stress and the release of calcium ions out of the ER. With the
elevated rate of ROS, the feedback loop of signals in the pathway, triggered by ETO
and PS89, is presumably closed.
This target network analysis was revealed with single-cell techniques such as flow
cytometry, fluorescence-activated cell sorting (FACS) as well as confocal microscopy
accompanied with immunostaining. These powerful tools give a good understand-
ing of key events in the signaling network. However, these methods are limited
to end-point readouts, giving just information about selected time points. To fol-
low the whole dynamics of the underlying processes during cell death, for example
the evolution of MOMP via opening inter-membrane pores, depolarisation and final
breakdown of mitochondria, time-lapse measurements enable the possibility to fol-
low the whole kinetics within the signaling cascades. Furthermore, pair-wise marker
correlations pave the way for the analysis of relationships between different events
within one and the same cell. In this study, single-cell time-lapse measurements were
performed to unravel more details about the effects and timing in signaling cascades
of ETO and PS89 as well as pathways triggered by the combination of both, with
the focus on the early events MOMP, oxidative burst/increase in ROS level and the
endoplasmic release of calcium ions (Figure 4.4). Additionally, triple combinations
of markers were realized to give hints about the correlations between the mentioned
early events and the final stage of cell death, namely the permeabilization of the
plasma membrane.
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Apoptosis
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Figure 4.4: Illustration of the hypothetic pathway induced by Etoposide (ETO) and PS89. The
combination of ETO and PS89 triggers the endoplasmic reticulum (ER) and a calcium release
evolves. This endoplasmic stress leads to the permeabilization of the outer membrane of mitochon-
dria (MOMP). MOMP induces further the increase of the reactive oxygen species (ROS) level and
the oxidative burst (OxBurst). The oxygen radicals again provoke ER stress and the feedback loop
is likely closed. Finally, the signaling cascade terminates in apoptosis.
4.2 PS89, a Potential Effect Enhancer of
Etoposide
4.2.1 Analysis of the Signaling Cascade
High-Throughput Microscopy Method for the Assessment of Single-Cell
Time Traces
This project was realized in collaboration with the group of Prof. Vollmar, who
analyzed the PS89 target network recently [42]. The aim is now to follow up with
these findings and set the focus on the three early events of calcium release, mito-
chondria membrane permeabilization (MOMP) and ROS levels. The calcium release
out of the stressed endoplasmic reticulum was detected with the calcium indicator
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Calbryte-520, MOMP via the mitochondrial membrane potential dye TMRM and
the reactive oxygen species (ROS) levels were tracked with the oxidative stress agent
CellROX orange. More details about the photochemistry and characteristic fluores-
cence time courses of the staining reagents are given in Chapter 2.4. For this study,
A549 lung cancer cells were chosen as model cell line, since ETO is also applied
in lung cancer therapy as described above. For the high-throughput assessment of
single-cell time traces microstructured arrays were used, which were fabricated with
the established technique Microscale Plasma-Initiated Protein Patterning (µPIPP),
described in Chapter 2.3.1.
Sequence and Timing of Events in Etoposide and PS89 Induced Apoptosis
at the Single-Cell Level
In the work of Koczian et al. the key players in the combinatorial chemotherapy
of the chemosensitizer PS89 and the cytostatic ETO were analyzed [42]. The effect
enhancement of the chemosensitizer PS89 and time-dependent dose effects were ex-
amined with the end point readouts of the cytosolic calcium level, the dissipation
of mitochondria and the intracellular ROS level. However, this work was performed
with end-point assays in separate experiments. It is therefore interesting to follow
the whole dynamics of the underlying processes during the termination of the sig-
naling cascade and set the order of events with the help of time-lapse measurements.
So far, the sequence of the key players was adopted from literature and no relations
between the key players have been established. Thus, the time-correlations between
the events were investigated in this study, to follow the time intervals in which the
processes take place.
The temporal evolution of single-cell event times was assessed. In Figure 4.5, the
distributions of event times were plotted per exposure. The order of the three mark-
ers per column was set by the maxima of the distributions. The maxima, shown
with its standard deviation, are gained by fitting a log-normal distribution to the
distribution of event times. Note that only the event times of cells are plotted which
showed both signals (n) and the data is pooled from different marker combinations.
Both, the single PS89 and the ETO exposure, as well as the treatment with the
combination of PS89 and ETO showed the sequence of OxBurst, MOMP and cal-
cium release, wherein the maxima of OxBurst and MOMP event time distributions
are very close. Hence, the histograms indicate that the calcium release out of the
ER is a result of the increase in ROS level and the subsequent depolarisation and
permeabilization of the outer mitochondrial membrane. Due to the similarity of
the log-normal distribution maxima of the OxBurst and the MOMP events, a close
relation of the mitochondrial breakdown and the oxidative burst is evident.
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Figure 4.5: Histograms of event time distributions. A549 cells were exposed to Etoposide, PS89
and the combination of both Event time distributions are shown for OxBurst, MOMP and the
calcium release respectively. The maximum of the log-normal distribution is indicated as tmax with
its standard deviation. n is the number of shown cells.
However, the average event times are not sufficient enough to determine the exact
sequence of events. The relative shifts in the maxima of the event time distributions
are too small in comparison to the width of the distributions. Additionally, the
log-normal distributions fitted to the event times seem not to reflect the actual
distributions. Especially in the case of PS89, where the statistics is quite low due to
the marginal cytotoxicity effect of PS89, which causes less double positive cells, the
log-normal fits deviate from the event time histograms.
Thus, two-pair correlations of different markers were used to unravel the order of
events. In Figure 4.6, a 3x3 scatter plot matrix of event time correlations is shown.
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Figure 4.6: Two-dimensional scatter plots of pairwise marker correlation of event times tevent
(1) and tevent (2). Apoptosis was triggered with 10 µM ETO (left column), 25 µM PS89 (middle
column) or the combination of both (right column). MOMP was correlated with OxBurst (a, b,
c) as well as with Ca2+ release (d, e, f). Moreover, MOMP and Ca2+ release were correlated with
each other (g, h, i). n is the number of shown cells.
The exposures, namely Etoposide 10 µM (Figure 4.6a, d, g), PS89 25 µm (Figure
4.6b, e, h) and the combination exposure of both (Figure 4.6c, f, i) are illustrated
per column, whereas the different event time correlations MOMP-OxBurst, OxBurst-
Ca2+ release and OxBurst-Ca2+ release are depicted per row. In each scatter plot,
the event times of the first marker (tevent(1)) are plotted against the event times
of the second marker (tevent(2)). Every single data point depicts a single cell that
showed both events. In this case, the events of the x-axes are the ones labeled in the
legend at first (e.g. MOMP in the first row), and the events of the y-axis are the
second one of the legend (e.g. OxBurst for the first row). The diagonal is illustrated
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as a measure of the location of the ellipses. The positions of the clusters, which have
been determined by mean shift clustering using an Epanechnikov kernel density,
provides the desirable insight into the order of events. The width and orientation,
which have been determined by Principal Component Analysis (PCA, see details in
Chapter 2.5), indicate the strength of the correlation.
Our data shows that in the case of the MOMP-OxBurst correlations, almost all data
point are positioned on the diagonal, which means a coincidence of these events.
Further, all clusters of the scatter plots of MOMP-Ca2+ release and OxBurst-Ca2+
release correlations are located above the diagonal. This means that the second event
(tevent(2)) follows the first event (tevent(1)).
In summary, our results of the two pair-correlation of events show the sequence of
MOMP-OxBurst-Ca2+ release (Figure 4.7), whereas MOMP and OxBurst are
correlated so closely that one can assume that these two events occur almost at the
same time. These outcomes are in good agreement with the results of Koczian et
al., who assumed the same order of events [42]. In addition, they proposed that the
Ca2+ release triggers MOMP, whereas we did not see the cluster of events for Ca2+
release-MOMP. So far, no conclusive reason for the absence of the cluster is found.
Figure 4.7: Signaling cascade induced by ETO and PS89 as well as for the combination of both
was found to be MOMP - oxidative Burst - calcium release in A549 cells.
Further, a significant effect enhancement of ETO triggered by the chemosensitizer
PS89 was detected for the different end-point readouts in Koczian et al. [42]. In
detail, the combination of ETO and the chemosensitizer PS89 induces significantly
higher cytosolic Ca2+ concentrations in Jurkat cells, illustrated by increased Cal-520
fluorescence, than for the ETO or PS89 single exposure. Further, when analyzing
the mitochondrial damage, a PS89 mediated amplification in mitochondrial apopto-
sis was recorded in combi treated cells in comparison to the single ETO exposure.
Moreover, the intracellular ROS level, the third apoptosis indicator analyzed there,
was increased with the combinatorial treatment and even higher levels were gained
after 48 h. The outcomes of the PS89 single treatment were comparable to the neg-
ative control in all three readouts.
Accordingly, our results are shown in Table 4.1. The percentage of cells with double
positive signals for the combinations MOMP-OxBurst, MOMP-Ca2+ release and
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OxBurst-Ca2+ release in all three exposures (ETO, PS89 and Combi) was analyzed.
In agreement with Koczian et al. [42], the effect of the PS89 single treatment is
negligible low (max. 12%) and comparable to the negative controls (between 1%
and 6% in different marker combinations). Further, we see a slight increase in effect
with the combination treatment (9%, 1%, 5%) in comparison to the ETO single
treatment, which indicates the chemosensitizing effect of PS89. Similarly, the flow
cytometry results show a minor increase of cytosolic calcium level and ROS level after
24 incubation by the additional administration of PS89 with ETO. The doubling of
dissipated mitochondria from 10% to over 20% could not be observed directly, due
to the fact that we only analyze cells with both the MOMP and the OxBurst or the
Ca2+ release signal. Furthermore, the different cell line (Jurkat vs A549) can cause
slight differences.
Marker Combi/Exposure ETO PS89 Combi
MOMP-OxBurst 32% 3% 41%
MOMP-Ca2+ release 30% 5% 31%
OxBurst-Ca2+ release 30% 12% 35%
Table 4.1: Analysis of PS89 Effect Enhancement. The percentage of cells with double positive
fluorescence signal is shown for each exposure and the three marker combinations MOMP-OxBurst,
OxBurst-Ca2+ release and OxBurst-Ca2+ release.
Besides the combi effect, also a time-dependent effect was recognized by flow cytom-
etry and the calcium level increased especially after 48 h compared to 24 h. Also
the number of cells with dissipated membrane potential was almost as triple as high
after 48 h of incubation than for the 24 h incubation. Additionally, the intracellular
ROS level was observed to be elevated for ETO after 48 h exposure compared to 24
h [42].
In contrast, the single-cell event time correlations provide a more differentiated out-
put (Table 4.2). The centers of the clusters, which are shown as crosses in the ellipses
of the scatter plots in Figure 4.6, depict the average timing of the event times (shown
with its standard deviation). In comparison, the centers of the first as well as of the
second cluster of ETO and combi treated cells are similar, whereas the centers of the
event times of PS89 exposed cells are shifted to later time points, which is in agree-
ment with the fact that PS89 alone is not harmful to the cells (see Table 4.1., low
percentage of double positive cells). The center of the event times for the correlation
between MOMP-OxBurst in PS89 treated cells is not available (n.a.), as the event
times are scattered along the whole diagonal and only low statistics are available.
Furthermore, the delay times between the two correlated markers are examined (last
column, (∆t in hours)). For the correlation between MOMP-OxBurst, very short
delay times (< 1 h) were calculated for both ETO and combi treated cells. This
quantification supports the narrow ellipses of event times directly on the diagonal
of the scatter plots and the assumption that MOMP and the oxidative burst are
closely related and occur almost coincidently. Accordingly the fact that the centers
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of the makers for ETO and combi treated cells are similar, also the delay times
are comparable. Also the fact that the delay times for the correlations MOMP-
Ca2+ release and OxBurst-Ca2+ release are very close to each other (for ETO) and
analogical (for the combi), is another strong argument for the coincidence of MOMP
and OxBurst.
ETO 10 µM Center of 1st M. [h] Center of 2nd Marker [h] ∆ t [h]
MOMP-OxBurst 13.86±0.35 14.10±0.35 0.24±0.49
MOMP-Ca2+ release 11.11±0.38 14.58±0.35 3.47±0.52
OxBurst-Ca2+ release 11.50±0.30 14.97±0.28 3.47±0.41
PS89 25 µM Center of 1st M. [h] Center of 2nd Marker [h] ∆ t [h]
MOMP-OxBurst n.a. n.a. n.a.
MOMP-Ca2+ release 16.32±40.96 18.62±0.90 2.3±1.32
OxBurst-Ca2+ release 16.52±0.63 20.57±0.53 4.05±0.82
Combi Center of 1st M. [h] Center of 2nd Marker [h] ∆ t [h]
MOMP-OxBurst 13.12±0.39 13.25±0.39 0.13±0.55
MOMP-Ca2+ release 11.85±0.42 15.77±0.39 3.92±0.57
OxBurst-Ca2+ release 11.86±0.34 15.45±0.33 3.59±0.47
Table 4.2: Analysis of PS89 time-dependent effect enhancement. The centers of the first and
the second marker (M.) with standard deviation in hours are tabulated for ETO, PS89 and the
combination of both (Combi) for the three marker combinations MOMP-OxBurst, MOMP-Ca2+
release and OxBurst-Ca2+ release. The delay times with the standard deviation in hours between
the two centers are depicted in the last column (∆t). n.a. = not available.
Depolarisation Lag Time of Mitochondria
The mitochondrial membrane permeabilization due to the opening of inter mem-
brane pores is a consequence of mitochondrial depolarisation. As described in Chap-
ter 2.4.2, a peak was observed for the time traces of ETO, PS89 and the combination
of both. The maximum of the peak was set as the time point of the beginning of
the depolarisation, which is assumed to be described in the subsequent decay of flu-
orescent intensity. As additional information, the time delay between the maximum
of the peak (tDepolarisation) and the breakdown in intensity (tMOMP) was analyzed to
examine the lag time of depolarisation.
In Figure 4.8, the histograms of the depolarisation lag time are shown for the three
exposures ETO (Figure 4.8a), PS89 (Figure 4.8b) and the combinatorial therapy of
both (Figure 4.8c). As expected, the highest mean lag time of depolarisation was
recorded for the chemosensitizer PS89 (Mean = 11.5±6.9 h), since also no major
effects of single PS89 treatment were detected in the correlation analysis. Further,
cells treated with ETO show mostly a lag time between 0-12 hours with a mean
lag time of 8.3±5.7 h, while the mean lag time for cells exposed to the combination
treatment is shifted to later time points (Mean = 10.0±5.9 h).
The reduction in lag time of depolarization, thus decreasing the time between the
beginning of depolarisation and final mitochondrial breakdown, would lead to earlier
cell death and could help to increase the efficacy of drug treatment.
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Figure 4.8: Lag time of depolarisation analysis. The distributions of time delays between the ac-
tivation of depolarisation (tDepolarisation) and mitochondria membrane permeabilization and break-
down (tMOMP) is shown in the histograms for ETO (a), PS89 (b) and the combination of both
(c).
4.2.2 Quantitative Noise Analysis of Heterogeneity in Cell
Response
Noise in biological context describes the variability in data when experiments are
reproduced or a background signal interferes with the desired signal [123]. However,
in biological systems random noise can be beneficial, since it leads to an increase
in signal transmission and is thus a ’noise benefit’. An intermediate noise magni-
tude provides an optimal performance. This phenomenon is defined as stochastic
resonance [123]. Further, noise is essential for mutation and evolution to ensure in-
dividuality of cells [124]. Moreover, cell fate decisions and population heterogeneity
are noise-driven processes. Nevertheless, Rao et al. stated that also heterogeneous
processes need order in a certain way; if a cell fate decision is done, the down-stream
signaling is strictly regulated [124]. But how the order emerges from disorder re-
mains still a triggering question.
Non-genetic heterogeneity in cell response can have two causes, the intrinsic and the
extrinsic noise [16, 125]. The intrinsic noise is caused by molecular fluctuations and
can be modeled with stochastic methods [124, 125]. Intrinsic noise can be moderated
by negative and integral feedback loops, gene dosage, parallel cascades and regula-
tory checkpoints ensuring the completeness of the separate steps before proceeding
with the signaling pathways [124]. Extrinsic noise can arise from external factors
[125] and is intracellular uniform but shows varieties between cells [7].
Apoptosis shows often cell-to-cell-heterogeneity and heterogeneity in response. Single-
cell measurements enable to follow noise directly and are key to analyze heteroge-
neous responses [126]. Thus, to guarantee a high quality of the single-cell data from
which reliable statements can be drawn, a careful data analysis as well as thor-
ough noise analysis (cell-to-cell-variability) is essential. Despite the very clear order
of events, which was revealed with the definite clusters of correlated events in the
scatter plot analysis, the data gives more information. Not only the signals which
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were shown are interesting, also one can challenge the data why some cells did not
response. In particular, during data analysis it was recognized that a considerable
percentage of cells did not show any signal or only the one or the other signal. Thus,
the following questions popped up: How many cells showed just the one or the other
signal? Is there a mechanism or a scheme behind these signal patterns why only the
one or the other marker is shown? Can we find a biological reason for this? In the
following, these questions were attempted to answer with the single-cell data.
The analysis of the heterogeneous response of the cells revealed that in average
around 50% of the cells treated with ETO in single and combi treatment showed no
signal at all. These results are in good agreement with the outcomes of Koczian et
al., who showed for three different cell lines an increase of the apoptosis rate up to
40-50% by the combination of different chemotherapeutics with PS89 [42]. The PS89
single treated cells evinced in average 82% no signal, which was expected, since the
chemosensitizer should have no effect, comparable to the negative control [42].
In Figure 4.9, an exemplary pie chart of heterogeneous response is depicted. The cells
were treated with the combination therapy and the events MOMP and OxBurst were
correlated. Almost half of the cells show no signals (gray), while only a small portion
of cells is present, which showed only the one or the other marker. Additionally,
around 3% show the order OxBurst-MOMP, but almost 40% (38.6%) shows the
preferential sequence MOMP-OxBurst. The cells with the sequence OxBurst-MOMP
are assumed to be detected falsely in the analysis.
Figure 4.9: Exemplary pie chart of the division in cellular response in the MOMP-OxBurst cor-
relation, measured in A549 cells after treatment with 10 µM ETO and 25 µM PS89.
To evaluate the reason for the high no-signal response, single-cell traces were screened
thoroughly. Heterogeneity and ambiguity were recognized in the fluorescence traces
and limit the possible accuracy of the fitting routine used before. Thus, the MOMP
and OxBurst data is fitted with the interactive fitting (see Chapter 2.5.2). Hence,
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an higher quality and accuracy of the event time determination is given and false
positive or false negative event times negligible. But still, the data is challenging
to analyze. In fact, there may be several reasons for the ’low’ susceptibility of the
cells to the combinatorial chemotherapy. First, the cells can be resistant to a certain
extent, and thus show no apoptotic signaling [127]. Second, the observation period
of 24 h could be too short, since a evident increase in response was recorded after 48
h in the case of Jurkat cells [42]. For a closer assessment of this parameter, further
experiments for over 48 h should be performed. Moreover, the responsiveness to
an apoptotic inducer varies from cell line to cell line. Further, the concentrations
of the markers are low due to the fact that the marker are in the medium for the
whole experiment, but still in a sufficient range. Thus, the missing signals should
not be caused by lacking fluorescence marker molecules. Additionally, the effect of
ETO was found to be highly dose and time schedule dependent [128]. In accordance
to this, the low concentration of etoposide could be the reason for the moderate
response value, but on the one hand, the concentration of chemostatics should be
kept as low as possible due to the side effects in the patient. And on the other hand
higher concentrations of ETO favor the detachment of the cells off the microstruc-
tured surface. A lower concentration of ETO was tested (2.5 µM, data not shown)
and with the now used concentration of 10 µM already an increase in detachment of
cells was recognized. With a further increase in concentration even more cells would
come off presumably.
In conclusion, the three questions asked before can be answered with the following
achievements: The number of cells with double or only single response could be
quantified and analyzed in detail, which is not possible with end-point bulk mea-
surements. The percentage of cells, which show only the one or the other marker is
not higher than 30% in all conditions. Interestingly, the number of cells, which show
no signal is in the same range for ETO as well as for Combi treated cells, which was
expected to differ from each other (a higher impact of the combination was assumed).
The biological reason for this behavior could be the low concentration of ETO (10
µM) and an interplay with potential resistance of the A549 lung cancer cell line.
For further experiments, the most promising approach to increase the percentage of
cells, which response to the combination of ETO and PS89, would be to increase the
time of administration up to 48 h.
In addition to this, the data was scrutinized more precisely in terms of differences
in single and double signals given by the cells for the the first analysis of the effect
enhancement of PS89 (Chapter 4.2.1) and the calculation of the Bliss level (next
Chapter 4.2.4). In Figure 4.10, one exemplary distribution is shown for the marker
combination OxBurst-Ca2+ release. The A549 cells were treated with the chemosen-
sitizer PS89 and the event times per marker were plotted. The upper panel shows
the OxBurst events and the bottom panel the ones for the Ca2+ release. The bins
in orange show cells, which demonstrated both signals, the blue bins illustrate cells
with only the OxBurst events and the green columns depict cells with only the Ca2+
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release signal. By comparison of the upper and the bottom panel it is observable
that for the OxBurst event it makes no significant difference if the cells showed both
signals or only one signal. However, for the Ca2+ release, the gap in response is
significant between double and single responses. While the distribution of only Ca2+
release events shows most events between 0-5 hours, the cells which showed both
events are shifted to later time points (around 20 h).
Due to this differences in response, the more restrict criteria was chosen that only
double positive cells were taken for the effect analysis as well as for the determination
of the Bliss level.
n = 95 (13%)
n = 124 (17%)
Ca2+ release
OxBurst
Only Ca2+ release
Figure 4.10: Exemplary distribution of event times for the combination OxBurst-Calcium release
in PS89 treated cells. While the OxBurst marker (CellROX) shows negligible differences in response
between cells with only the OxBurst signal and cells with both signals, the Calcium indicator
(Calbryte-520) shows significant differences in single and double response. While the distribution
of both signals is shifted to later time points (around 20 h), the calcium events only show most
events at earlier time points (0-10 h).
4.2.3 The Distribution Function of Delay Times
Next to the distribution of event times, the distribution of the delay times between
the events was analyzed. It is assumed that the signaling cascade is a chain of
stochastic events and the events are happening consecutively and independent, thus
we can fit the distributions of delay times with gamma functions. The distribution
of the total event chain is the convolution of the partial chain events. More details
can be found in Chapter 3.8.
In Figure 4.11, the distribution of delay times (orange) is shown with the fitted
gamma distributions (blue lines) for ETO, PS89 and the combination of both (per
column). The marker combinations MOMP-OxBurst, OxBurst-Ca2+ release and
MOMP-Ca2+ release are illustrated per row.
A strong correlation between MOMP and OxBurst has been discovered. In all three
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exposures, MOMP and OxBurst happen nearly simultaneously, MOMP leading for
only a few minutes (median≈ 0.2 hours). However, the median of delay times for
OxBurst-Ca2+ release is slightly higher in each exposure than the median for MOMP-
Ca2+ release. This was not expected since the sum of delay times between MOMP-
OxBurst and OxBurst-Ca2+ release should be the delay time of MOMP-Ca2+ release
or even higher than the sum. As explanation, the ambiguity of the time traces can
cause inconsistency during the interactive fitting. In detail, the fluorescence traces of
different markers have been analyzed independently. If the event time of one marker
was ambiguous, the earliest event time was chosen. However, this determination
might cause shifts in timing, if the event time could not be detected correctly. Even if
the interactive fitting increased the accuracy and quality of the event time detection
tremendously, especially the OxBurst time traces remain challenging to analyze.
Probably Machine Learning is a good approach to tackle this problem, which is
discussed in the Outlook Chapter 6.2.
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Figure 4.11: Gamma fits to distributions of delay time evolution in Etoposide, PS89 and combi-
nation treated A549 cells. The measured orange histograms show the distribution of time delays
(in h) for the combinations MOMP-OxBurst, OxBurst-Ca2+ release and MOMP-Ca2+ release. The
blue lines depict the gamma distribution fits. The estimated parameters k and θ of the gamma
distributions, n as the number of single cells and the calculated mean values of the gamma distri-
butions are indicated. In this case, the mean time delays of the two sub-pathways (first and second
row) do not sum up to their concatenations (third row).
4.2.4 Quantitative Evaluation of Synergistic Effects of PS89
Chemosensitizers such as PS89 are developed to increase the effect of the cytostatic,
which is given in combination with the chemosensitizer. In best case, the effect of
the combination is higher than only the sum of both (additive effect). If the effect
is more than additive, a so called synergy is given for the two combined drugs.
This statistic (in)dependence test for the description of two drugs, which have dif-
ferent target sites and different mechanisms of action, was described first by C. I.
Bliss in 1939 [129]. Accordingly, the combined effect P12 of independent drugs in
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a specific effective concentration with effects P1 and P2 can be calculated with the
following equation:
P 12 =
P 1+2
P 1 + P 2 − P 1P 2
where P1+2 is the measured effect of the combination. Is P12 more than one, the
combined effect of the two agents is synergistic. When P12 is one, the variables are
independent and the effect is additive. The two combined drugs are antagonists, if
P12 is less than one.
In our work, the percentage of double positive cells (of total cells) for the marker
combinations MOMP-OxBurst, OxBurst-Ca2+ release and MOMP-Ca2+ release were
tested for synergy. While the combination of ETO and PS89 in the correlations of
OxBurst-Ca2+ release and MOMP-Ca2+ release indicate no synergistic effects (0.93
and 0.91), synergy was presumably detected for the MOMP-OxBurst correlation (1.2
> 1). When testing the synergy for a late marker combination, OxBurst-PMP, a
synergistic effect might be determined (1.7). Note that the outcomes of the Bliss
independence test can vary depending on the readout parameter. The group of Prof.
Vollmar found synergistic effects in the combination therapy for the readouts ROS
level, cytosolic calcium level and dissipated mitochondria membrane potential. The
cell death assay where the PMP is detected as indicator for apoptosis showed synergy
for the combination treatment, as our results did.
Next to the Bliss level calculated with the percentage of double positive cells, a
dynamic Bliss level was analyzed. Therefore, a kernel density of the event time dis-
tributions was compared to a dynamic Bliss level. The Bliss level was calculated for
each time point separately. In Figure 4.12, the event time distributions (histograms)
for the three events MOMP, OxBurst and Ca2+ release are plotted with the ker-
nel density (black line) and the Bliss independence level (black dashed line) for the
combination. By comparison of these two fits, no synergy was evident.
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Figure 4.12: Dynamic Bliss Analysis of the events MOMP, OxBurst and Ca2+ release for ETO,
PS89 and combi treated A549 cells. The event times were pooled from the correlations MOMP-
OxBurst, OxBurst-Ca2+ release and MOMP-Ca2+ release. By comparison of the kernel density
(black line) and the Bliss level (black dashed line), no obvious synergistic effects were indicated.
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Further, the last event in the apoptosis signaling cascade, the plasma membrane
permeabilization (PMP) was analyzed. In Figure 4.13, the kernel density distribution
(black line) and the Bliss level of the event time distributions (black dashed line) for
PMP are shown. For the combination, a slight shift of the calculated Bliss level to
later time points in comparison to the kernel density is recognized. This shift could
indicate a synergistic effect of the chemosensitizer PS89 in combination with ETO.
In summary, we could analyze the Bliss independence in a quantitative as well as in
a dynamic way for better understanding of the drug synergy between ETo and PS89.
The data indicates synergistic effects in some marker correlations. The assessment
of the effect dependence of two drugs was shown to hinge on the analyzed event.
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Figure 4.13: Dynamic Bliss Analysis of the plasma membrane permeabilization (PMP) for ETO,
PS89 and combi treated A549 cells. The PMP event times were received from PMP-OxBurst
correlations. The Bliss level (black dashed line) shows a shift to later time points than the measured
kernel density (black line), indicating presumably synergy.
4.2.5 Triple Marker Correlations
So far, linear signaling pathways were investigated with the help of pairwise marker
combinations. Therefore, two markers were added to the cell and the order of two
events can be determined. Further, with the examination of different double corre-
lations the whole cascade of the correlated events can be composed. However, for
the estimation of crosstalk or a network of signals, the parallel tracking of more than
two markers is essential. If one could analyze three or more markers per cell at the
same time, more information about the fate decisions, the cell has to made during
apoptosis, could be gained. Moreover, multiple correlations could finally lead to in-
formation about causation. If, for example, three markers are measured and the cell
shows one signal only with the one but not with the other signal beforehand, this
could mean that the following signal is induced by the one signal. For instance, one
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could image the following hypothetical example: the cell is not dying, thus showing
no plasma membrane permeabilization (PMP) and the oxidative burst is occurring,
but not the calcium release. But if the cell shows both signals, the oxidative burst
and the calcium release, the cell is dying (positive PMP signal). Thus, cell death
is a result of the combination of the calcium release and the oxidative burst. Such
indication about causation, thus information beyond correlations, would further help
for specific targeting key players in the cell death signaling cascade. Mostly, not only
one key event is responsible for the final cell death, but the interaction between the
apoptosis actors.
Therefore, three markers were added to A549 cells to investigate the network signal-
ing. In addition to the marker combinations already measured before, the cell death
indicator Toto-3 Iodide was supplemented. All other experimental conditions were
kept as for the measurements before. The negative controls (markers only, no apop-
tosis inducer), which were performed in each experiment, were as low as for double
correlations (between 0-4%) and also cell morphology was not different. Thus, nega-
tive effects or influence due to an overload of fluorescence markers can be excluded.
All three markers were used in such low concentrations that they are not harmful to
the cells, even when they were kept in the media for the whole measurement without
a washing step.
Interestingly, the main section of cells showed no signal at all. For the ETO treated
cell in average 54%, for PS89 exposed cells 80%, and for the cells treated with the
combination of both in average 56% showed no signal. In all three triple marker com-
binations (MOMP-OxBurst-PMP, OxBurst-Ca2+ release-PMP and MOMP-Ca2+ release-
PMP) the rest of the cells show a broad and almost even distribution with only one or
two of three signals. In the same range the cells show all three signals, thus a very low
amount (5-16%). The low percentage of triple signals and the high amount of cells
with no signal can be due to resistance of the A549 cells and the low concentration
of ETO, as discussed for the double marker correlations.
Moreover, the A549 cells show only for the MOMP-OxBurst-PMP correlation a
higher percentage of triple signals for the combination treatment than for ETO
alone (Figure 4.14a). For the other two correlations (OxBurst-Ca2+ release-PMP
and MOMP-Ca2+ release-PMP), the effect for the combination exposure of ETO
and PS89 was lower than for ETO only (Figure 4.14b and c). Further investigations
would be necessary to clarify the cause of the depressed effect in the combination.
76
4.3 Discussion and Outlook
0%
5%
10%
15%
20%
Control ETO PS89 Combination
OxBurst-Calcium-PMP
0%
5%
10%
15%
20%
Control ETO PS89 Combination
MOMP-Calcium-PMPa b c
0%
5%
10%
15%
20%
Control ETO PS89 Combination
MOMP-OxBurst-PMP
Pe
rc
en
ta
ge
o
f
to
ta
l #
 o
f
ce
lls
Figure 4.14: Analysis of triple combinations. Double positive cells plotted per exposure: negative
control, Etoposide (ETO), PS89 and the combination of both.
This first attempt of triple correlations was technically performed successfully, since
some cells did show all three signals. However, further investigations with different
marker combinations have to be carried out to gain more insight about the signaling
network. For example, triple correlations with a higher ETO concentration over a
longer period (e.g. 48 h) could be measured to examine whether the low percentage
of triple signals is limited due to the measurement interval of 24 h or the low con-
centration of ETO. Further, another late marker, such as pSIVA-IANBD, could be
used to examine which events or event combinations are leading to cell death.
4.3 Discussion and Outlook
In summary, our results of the two pair-correlations of events showed the sequence of
MOMP-OxBurst-Ca2+, which is in good agreement with the findings of Koczian
et al. [42] as well as literature: the connection between Ca2+ levels, mitochondria
and ROS during apoptosis was reported frequently [45, 130–133]. For example,
Rizzuto and co-authors described that waves of mitochondrial Ca2+ control cell fate
[134]. Further, they report that apoptosis might be triggered by non-physiological
concentrations of intracellular Ca2+ by opening the permeability transition pores of
the highly transport regulated inner membrane of mitochondria (see Figure 2.6).
Calcium was reported to be the messenger of the crosstalk between the ER and
the mitochondria [135]. Further, ROS may induce unbalanced redox and triggers
the unfolded protein response (UPR) [136], supporting our result of the correlation
between ROS and Ca2+ release, which is an indirect consequence of UPR and ER
stress.
The order of events published in Koczian et al. were assumed on the base of litera-
ture, but the actual sequence of events could not be determined with the endpoint
readouts of the different approaches (e.g flow cytometry) [42]. With single-cell time-
lapse measurements, we succeeded to determine the definite order of events and
record the delay times between the events. However, the increase in effect enhance-
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ment was not as evident as for Koczian et al. [42], which could be due to the pair-wise
readout.
In future, the time dependent effects arising after 24 h seen in Jurkat cells, could
be assessed with 48 h time-lapse measurements to analyze whether the steep effect
increase also shows up after 48 h in the single-cell setup.
Also, the events leading compulsorily to cell death are intriguing to study. Triple
correlations between events could help to understand direct relationships, in the
direction of causational relations. Thus, triple measurements with a different end-
point marker than Toto-3 Iodide, e.g. pSIVA-IANBD, could help to gain further
insight in the signaling networks. Consequently, the specification of key players,
which are directly responsible for the absolute induction of apoptosis pathways as
well as the establishment of cause-and-effect-relationships are providing new target
sides and possibilities for innovative chemotherapeutic approaches.
Furthermore, the analysis of functional correlations could improve the investigation
of the dependency of the events. Then, the Bliss level could be calculated from more
quantitative valuables. So far, the Bliss level was examined with the percentage of
double positive cells or the dynamic course of the event times probability.
In future, the Area Under the Curve (AUC) of a calcium marker time courses as
well as the slope of the OxBurst time traces could be correlated with the event times
of MOMP, OxBurst and Ca2+ release, respectively. The AUC could give a hint on
the amount of the released calcium out of the stressed endoplasmic reticulum and
would be a more quantitative parameter than the event time of Ca2+ release. Note,
that for a quantitative analysis, a ratiometric (dual-wavelength) fluorescence marker
has to be used rather than the single-wavelength calcium indicator Calbryte-520.
The marker used in this study is only suitable for the detection of relative calcium
concentration changes, not for a quantitative analysis.
Further, the slope of the fluorescence intensity in the OxBurst time traces, which
correlates presumably with the ROS rate, could be analyzed. Both parameters are
probably more suitable for the calculation of the quantitative Bliss level than the
percentage of double positive cells.
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Chapter 5
Investigation of a 3D Environment For
Single-cell Applications
5.1 State of the Art
In times of personalized medicine and personalized health care the importance of
high-throughput methods and platforms, where hundreds to thousands of cells can
be observed in parallel to test different combinations of drugs or administration time
intervals with a low volume of test sample, is significantly increasing. Especially for
stem cell research, where the access or availability of samples is strongly limited,
the miniaturization and dense packaging of test arrays, so called microwells, is an
urgent need. Furthermore, the observation of a high number of single-cells in par-
allel has gained more interest in the last decade, since the heterogeneity in cellular
response and the presence of sub-populations was recognized. So both, cell-based
and single-cell chip research grew in the last years, indicated by sextubled number of
publications within 6 years (2002-2008, [27]). Therefore, high statistics, gained with
such arrays, are inevitable for reliable and reproducible results. Some researchers
had set the number of 10 000 cells, which have to be observed for credible statements
and up to 1000 cells for the development of general single-cell arrays [27]. Further,
a dense packed and miniaturized array has the advantage of automated analysis. In
consequence, in 2006 the term Lab-on-a-chip, the idea of a small lab on a chip with
all needed instrumentation’s for the whole workflow, was established by the group
of Manz [137]. Meanwhile, a own field of research with it’s own journal, named also
Lab-on-a-chip, with thousands of applications, not only biological implementations,
has developed.
Various assays can be performed on such cell-based arrays: culturing, adhesion,
migration, electroporation, separation, protein-localization, live cell imaging, drug
screening, sorting, patterning, trapping, transfection, lysis etc [27]. Microwells, one
can say the successful miniaturization of standard microwell plates, can be designed
for single cells in a size of roughly double the cell size (30-50 µm to 100 µm), to
observe for example cell fate, proliferation, drug response, cytotoxicity etc. Or,
the microwells are in the range of a few hundreds of µm (200-500 µm) to host more
than one cell, to study for example cell-to-cell communication or spheroid formation.
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Microwells can be used for adherent cells, but especially for non-adherent cells, the
local confinement is beneficial for observing and tracking single cells, since otherwise
they diffuse out of the field of view during the experiment. Additionally, no further
coating or surface treatment is required, which is essential for most adherent cell lines.
Next to the size, also the height of the microwell walls has to be considered. When
cells are observed over days, a sufficient supply with media has to be guaranteed.
Thus, higher walls for more volume or a volume of media, which covers all wells
above, has to be considered. Note, that the exchange of media with the above
basin is not fully guaranteed with the combination of very high walls and narrow
wells. Furthermore, depending on the size of the microwells, the seeding density is
determining the occupancy of all wells. Additionally, the seeding density depends on
the intention of single or multiple occupancy per single well. Cells are usually seeded
in solution, and after some incubation time, where the cells can settle down to the
bottom of the wells by gravity, the wells are washed to remove extensive cells, which
have not sedimented, and probably another seeding step is performed to adjust the
number of cells. Technically, an overall occupancy of around 70% would be desirable,
to make the data analysis be worth it. In fact, studies have shown that the single
occupancy of microwells follows a Poisson distribution and only around 30-40% of
the microwells are occupied with a single cell [138].
Furthermore, it is a note worth to say that not all cell lines are suitable for the
use of microwells. In the course of this work, the human T cell leukemia Jurkat
cell line was tested, which would have been the perfect model system for the com-
binatorial chemotherapy project with Etoposide and the sensitizer PS89 (Chapter
4). But, even though several materials, sizes and coatings were tested, the non-
adherent Jurkat cells were all dead at the end of the experiments, the latest after 48
h of incubation with only media in microwells. In short, Jurkats were incubated in
PEG-DA microwells (35 and 50 µm length) or PEG-DA trenches (120 µm length), a
setup, which has already been used for other studies [139–141] with (microwells) and
without fibronectin (FN) coating (trenches and microwells). Fibronectin, an adhe-
sive extracellular matrix protein, should in principle increase the biocompability to
the surface. Furthermore, in-house made liquid glass microwells (with and without
FN coating) were checked for cell survival. In addition, Jurkat cells were seeded in
in-house made PDMS microwells (35x35 and 50x50 µm squares), which were also
coated with FN or not. In summary, nine different conditions were measured with
the help of time-lapse experiments for at least 24 h and mostly with the CellROX
marker green, indicating cellular stress and the PI marker, which illustrates cell death
by plasma membrane permeabilization. The intracellular stress signal was in most
of the experiments visible (or rather the breakdown in intensity showing oxidative
burst) and the PI signal was evident in most cases at the end of the experiment.
In the best case only 11% of cells were dead after 48 h, but not in a reproducible
manner. The results show that neither the material, nor the size were the cause of
cytotoxicity. Also the coating with FN could not avoid cell death. Further, the access
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and supply with media and nutrients was guaranteed, due to testing the structures in
different sizes and setups such as dishes or 8-well slides. In the end, we came to the
conclusion, that this type of cell line is not suitable for a confinement in microwells.
The cause of cell death could be microinjuries, induced by hitting the walls during
stage movement, mechanical stress through the confinement itself (both necrotic cell
death) or chemical secretion of stress or cell death signals, which are additionally ac-
cumulating in the confined environment (apoptosis). No correlation between single
occupied or multiple occupied wells could be observed, both conditions were leading
to cell death. One could explain these outcomes of limited viability of single Jurkat
cells in a microwell with the fact that Jurkat cells have the tendency to aggregate
in healthy cell cultures (see pictures in the Appendix of standard protocols A.1). If
neighboring cells are missing in single occupied wells or the neighbor cells are too
far away in bigger microwells, the formation of groups is hindered and the viability
decreases, which finally could lead to cell death.
In the past, the first tested materials for such arrays were glass, silicon and silicon-
based materials, due to the origin of semi-conductor industry of such chips [27],
but due to the better transparency and lower expenses, polymers have gained more
widespread application [142, 143]. Polyethylenglycol (PEG), poly(methylmethacry-
late) (PMMA), polyurethane (PU), polystyrene (PS) or photo resists such as SU-8,
are used amongst others. But the most common polymer is polydimethylsiloxane
(PDMS) [27]. It addresses all the requirements as a microwell material for a fast,
easy, inexpensive and feasible fabrication of microwell arrays, thus accessible even for
standard equipped laboratories [144, 145]. PDMS can be sterilized, it is temperature
resistant in the range of cell experiments as well as suitable for microscopy, due to
optical transparency [27, 146–148]. One can even microscope directly through a
certain height of PDMS layer. Further, it can be bonded to microscopy slides or
microscopy foils and is gas permeable [149, 150].
But most important, PDMS exhibits a low autofluorescence [151] and a high biocom-
patibility [152]. To which extent this is valid, also in comparison to other microwell
materials, will be described in detail in the following chapter. Seven different mate-
rials were tested for autofluorescence, the nature emission of light, and biocompati-
bility, in this case defined as the tolerability of biological organisms (cells) with the
tested material. At the end of this chapter, a summary of conclusions and an outlook
concerning the tested materials and properties is given. Further, an application of
PDMS microwells, namely a proliferation study of stem cells, is described in detail.
For a start, the individual materials are introduced in short.
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Polycarbonate
Polycarbonate (PC) was found 1898 by Alfred Einhorn and is a synthetic thermo-
plastic polymer, namely a polyester of the carbonic acid ([ROCOO]n). In most poly-
carbonates, bisphenol A (BPA) is the dihydroxy component and reacts in a surface
condensation with phosgen. PC is relatively expensive in comparison to other poly-
mers due to its extraordinary properties such as dimension stability, transparency,
scratch-resistance, high hardness and stiffness, impact strength and chemical resis-
tance to many mineral acids and aqueous solutions of oxidizing agents or neutral
salts. In combination with polyurethan it can be turned even into an UV resistant
material. Polycarbonates are amorph and show high biocompatibility. Many appli-
cations in industry are on the market: spectacle lenses, optical lenses, windows for
airplanes and police cars, CDs, DVDs, LEGO, solar panels and medical disposables.
Here, a polycarbonate foil was tested (300MICRONS GmbH), which contained mi-
crowells of 300 µm in diameter and 300 µm depth. Since the microwell foils were
produced by hot-embossing, the pore sizes can range from nm to µm following the
information of the manufacturer. Brightfield images of the foil were taken with a 10x
objective and 50 ms exposure time (Figure 5.1). The pores were identified as exclu-
sion criterion for the use in single-cell measurements. The pores are in the size range
of suspension cells and thus the identification and tracking of single cells would be
impossible due to the indistinguishability to the pores. Despite the perfect size of the
microwells, the easy use and low autofluorescence (Chapter 5.2), the polycarbonate
foils were excluded as single-cell assay platform.
Figure 5.1: Brightfield image with 10x magnification of a polycarbonate foil with microwells of 300
µm diameter and 300 µm depth, fabricated by hot-embossing. Pores are visible due to production
processes in hot-embossing.
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Polyethylenglycol diacrylate (PEG-DA)
Polyethylenglycol diacrylate (PEG-DA) or polyethylenglycol dimethacrylate (PEG-
DMA) are two polymers, which were used in our chair already for different single-cell
3D applications. On the one hand, we used the material for so called microtrenches
to follow the cell division and apoptosis of a whole family [140] and on the other
hand, as microwells for progenitor cell division [141]. The structures were produced
using soft lithography [144], namely the technique of micromolding in capillaries
(MIMIC) [153]. More details about the material and the platform can be found in
[154, 155]. In the past, the material was mainly used for label-free applications, but
in this study, the focus was on fluorescence purposes such as signaling cascades and
thus the material was again analyzed for autofluorescence (see results Chapter 5.2).
Furthermore, another idea was to spin-coat PEG-DA on a silane-treated glass slide
and expose it to UV via a mask to create structures (photolithography). This less
manual and less time consuming approach was promising, since also there the bio-
compatible, well-known PEG-DA could be used in principle in combination with glass
surfaces, which is well compatible for microscopy and further surface modifications.
This approach was published several times by the group of Revzin et al. [156–160].
However, we were not able to reproduce their so called hydrogel microstructures even
when using the same molecular weight (MW) of PEG-DA (575, the PEG-DA with
MW of 258 is not too viscous), similar photoinitiator and silanes for silanization of
the glass substrates. Further, different spinning speeds and times were tested, but
none of the different parameter and setup changes could improve the adhesion of
the polymer onto the surface, not to mention the height of the PEG-DA layer. So
in the end, no proper coating thickness could be gained for the exposure to UV to
cross-link the polymer via free-radical polymerization. In principle, after the UV ex-
posure, the non treated areas, which were covered by the mask, can be dissolved in
DI water after the development. But the descriptions given in the papers of Revzin
et al. [156–160] were quite contradictory and ambiguous. The spinning speeds and
times were quite different among the papers or not indicated at all, silanes used for
silanization and the silanization process itself were varying. Lastly, the heights of
the structures as well as the exposures times were just described in ranges, not with
precise values. In summary, if this approach should be further developed, PEG-DA
with a significant higher molecular weight (e.g. 4000), which is very costly, should
be used.
Indexed-matched fluoroacrylate polymer MY-134
The fluoroacrylate polymer MY-134 is an patented and undisclosed elastomer (MY
Polymer, Israel), since it has the unique property of a refractive index (1.34), which
is matching the refractive index of cell culture medium (n = 1.338) [161]. This would
be advantageous for the data acquisition and analysis of time-lapse measurements
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for adherent as well as for non-adherent cells, since the microwells itself would not
distract the tracking algorithm, which is for example the case with PEG-DA struc-
tures, which are causing fringes. The commercially available polymer can be cured
under UV and is biocompatible, but only under some circumstances. Namely, the
polymer has to be cured under argon atmosphere for 15-20 min, further under pure
oxygen for 15 min to bleach the photoinitiator and afterwards the photoinitiator has
to be removed by incubation in pure ethanol for 4-6 days. Only with this procedure
the biocompatibility is given, otherwise it is a cytotoxic material. No information
concerning the autofluorescence is provided by the manufacturer, but material fluo-
rescence can be decreased by UV exposure in pure oxygen for 15 min [161].
Another alternative could be the MY-133 MC, which is also patented and undis-
closed, fabricated by MY Polymer. But this amorph polymer is not acrylate based
but a polyurethane prepolymer with an isocyanate term and designed to cure with
ambient water (moisture-curing). Also this MY polymer has an interesting refractive
index, in fact close to the one of water in a cured state (n = 1.33). Cell based applica-
tions are not published so far, but one for a calibration slide for the characterization
of the TIRF excitation field [162]. Following the manufacturer instructions, 200 µm
layers can be cured in 20-60 min under ambient conditions and have to be baked for
1 h at 80-100 °C. Ambient conditions depend on the thickness of the layers, thick
layers take longer curing while high humidity accelerate the curing.
SU-8
SU-8 (glycidyl ether of bisphenol A (BPA)) is a negative photoresist epoxy novolack
with exceptional properties such as thermal and chemical resistance to many sol-
vents. Further, excellent mechanical, physical and optical properties are the reasons
that SU-8 is a frequently used material in the semi-conductor industry and is often
used in microfabrication techniques (microchips, microfluidics etc) due to the ability
to form structures with high aspect ratio. However, the high autofluorescence [163],
the highly hydrophobic surface [163] as well as the low surface energy was experi-
enced as a major problem. Especially for biological applications, such as cell-based
assays, the lacking adhesion of cells to the surface poses a problem. Further, the
antimony salts, which are present in the material as photo acid generator, and their
potential toxicity are still under debate [164]. The antimony levels could be reduced
by an increased UV exposure and additional baking time or baking steps [165]. In
general, the biocompability of SU-8 structures and their applicability in biomedical
implementations or use in vivo is questionable [166]. For example, the results of a
broad-scale devised study to evaluate the biocompatibility in vitro and in vivo must
be questioned, since only the leachates were analyzed with the help of an end-point
bulk assay (MTT assay) [165]. Thus, the studied 9L rat glioma cells were never
in direct contact to the SU-8 structures and the used biological assay just provides
an averaged signal, not considering sub-populations or heterogeneity in cellular re-
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sponse. Further, the dynamics were peculated, which could be a crucial point in
biomedical applications, which are potentially exposed for long times to the body.
Morover, it is questionable, whether the examined muted immune response in mice
is acceptable and especially whether the recommendation as an implant material is
justified. Also the study of Stangegaard et al. shows double-edged outcomes [167].
On the one hand, the chemical surface procedure (HNO3-CAN) increases the growth
rate and morphology of cells in comparison to untreated structures, but on the other
hand, around 200 genes show differences in gene expression profiling. One reason for
the ambiguous biocompatibility could be the component bisphenol A (BPA), which
is also educt in polycarbonate production (see above). Depending on the involved
processes and the final concentration in the end polymer, BPA could be more or
less toxic. But as such, BPA was shown to be toxic for flora [168], fauna [169] and
humans [170].
However, SU-8 arrays were seemingly successful applied to investigate stem cell fates
[171], which is in general a difficult and sensitive task. Overall, it was shown that
the biocompability of SU-8 structures can be enhanced with surface treatment. For
example, oxygen plasma treatment, which is shown to be stable over weeks [172],
enhanced cell proliferation in comparison to untreated SU-8 surfaces [164]. Further,
coating with PEG can increase the biofunctionality [173].
Prototype Resist from Microresist Technology
The prototype resist from Microresist Technology GmbH is a photocurable polymer,
which is not commercially available yet and was tested as prototype. It can be used
for molding techniques (MIMIC) and NanoImprint Lithography (NIL). Thus, the
material is comparable to PEG-DA in principle, only that the quality is reproducible
(photoinitiator has not to be mixed manually), it is more viscous, thus suitable for
spin-coating (which is not possible with low MW PEG-DA) and the curing has
to be performed without O2, thus under inert gas atmosphere. It is clarified as
biocompatible resist, as all components are biocompatible. The resist has the ISO
10993 certificate for biocompatibility of medical devices classification; therefore, the
supernatant, which was exposed to the resist, has not to be harmful to the cells to
receive this commendation. The autofluorescence is quite low, comparable to ibidi
foils (data not shown, measured by C. Leu).
Liquid Glass
Glass is ubiquitous in our everyday lives and also in industry as well as in science
a widely used material due to its excellent properties such as optical transparency,
thermal and chemical resistance, inertness and biocompatibility. However, the clas-
sical techniques to structure glass are hazardous (due to the necessity of HF), time-
consuming and expensive or rather impossible for most laboratories due to the need
85
Chapter 5 Investigation of a 3D Environment For Single-cell Applications
of clean room facilities. Thus, glass is not suitable for rapid prototyping or for
example stereolithography or 3D printing. Also the fabrication of microfluidics re-
mains challenging since multilayer components are needed and the bonding between
glass layers is problematic [174]. Thus, polymers have turned out to be the golden
standard.
However, two commercially available glass structures, which where fabricated by
etching, were tested for comparison. On the one hand, etched glass wafers (Schott)
from QUALCOMM with lines of 60 µm depth (which were not homogeneously
etched) and a total thickness of 300 µm were tested for almost 24 h with the CellROX
green marker (indicating cellular stress) and the PI marker (cell death marker). In
short, the results of the first test done by E. Chatzopoulou the MOLM-13 cells seem
to survive, but are stressed (high signal from CellROX green).
On the other hand, the Licarda CC 384 well MicroplateTM made out of high-quality
glass bottom with 150 spherical subwells per microwell (etched into the glass surface)
was tested. The microwells were 3.2 mm in diameter and the subwell diameter was
200 µm with a depth of 100 µm. The thickness of the etched glass in total remained
unclear in the manufacturer instructions. MOLM-13 were seeded after the tedious
removal of air bubbles in two different seeding densities and twice replicates per den-
sity. Both densities were tested with or without fluorescence marker (CellROX and
PI). A time-lapse of 24 h showed that in all conditions apoptosis started after 24 h,
and after 50 h all cells were dead. The reason for cell death could be the roughness
of the glass surface. Furthermore, the autofluorescence in the GFP and DAPI region
was not negligible. The increased autofluorescence in the DAPI channel was also
observed by E. Chatzopoulou for the etched glass wafer.
Recently the group of Bastian Rapp from Karlsruhe Institute of Technology (KIT)
established a sintering method from photocurable components to form the so called
Liquid Glass [174]. The liquid photocurable amorphous silica nanocomposite over-
comes the three main drawbacks of microstructuring of glass: since the prepolymer
can be structured at room temperature using PDMS molds, the disadvantages of the
isotropic properties of the usually applied etching process are passed over. Secondly,
the manufacture was turned into a replication process. Finally, the bonding on sur-
faces of the structures is not a problem anymore, since the photocured composite is
a polymer. A thermal binding and sintering process step is following, which is con-
verting the cured polymer into glass, and comparable to fused silica glass concerning
physical and chemical properties [174]. The complete protocol for the fabrication
of Liquid Glass structures can be read in [174]. In general, it has to be mentioned
that the group of Rapp creates mostly bigger structures of some cm or more simple
designs. Also in the follow up paper from 2017, the shown examples, which were
printed with stereolithography 3D printers, are rather big or simple in design when
microscaled [175]. However, when reproducing this technique in our laboratories and
adapting the process to our needs (microwells in the range of 30-50 µm and 30 µm
depth), we faced some serious issues. In the following, the work mainly done by C.
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Leu and P. Altpeter is described.
As a first approach, the Micro Molding in Capillaries (MIMIC) technique [153],
which was used with PEG-DA and PEG-DMA in the past [140, 141], was tested
with the nanocomposite. However, the viscosity of the polymer is too high, air is
entrapped during the process and the wetting is insufficient. Next, the Solvent As-
sisted Microcontact Molding (SAMIM) [144] method showed also some drawbacks.
When squeezing the PDMS mold onto the polymer, a residual layer on the bot-
tom is present and as the material is pressed to the edges, an edge bead is created.
Further, in the next step of sintering, thermal stress is created and the structures
bend clearly, delaminate or even break. The most promising attempt, was the micro
Transfer Molding (µTM) technique [144], where the polymer is casted on a PDMS
mold and excess material is removed. This sandwich is flipped onto a substrate,
thereafter the PDMS mold can be removed. After curing, the Liquid Glass poly-
mer is as a structure on the substrate. This approach shows only a thin layer of
remaining material on the bottom, less entrapped air and thermal stress, as well as
only small edge beads. Also the stress related effects are reduced and in total, the
method shows a higher reproducibility than the other two approaches. But still,
only small areas with certain designs can be produced due to the thermal stress and
the bending of the structures, if they are too large or too thin. Entrapped air leads
to the break of the structures during molding. Further, the manufacture of Liquid
Glass is not as time efficient and low cost as expected, even when the structures are
re-used, since the process takes full two days with a existing design and 5 days for
a new design (fabrication of a new Si-master included). In summary, the properties
of the material speak for themselves (high transparency, low autofluorescence), but
further development would be necessary for structured surfaces in microscopy slide
size and small microwell designs.
Polydimethylsiloxane (PDMS)
Poly(dimethylsiloxane) (PDMS) is an elastomeric organosilicon and has the chemical
formula CH3[Si(CH3)2O]nSi(CH3)3, where n is the number of monomers. In general,
the base and the curing agent react with cross-linking via hydrosilation. In our
lab, PDMS from Sylgard 184 (Dow Corning) is used. Dimethylsiloxane oligomers
with vinyl-terminated end groups function as the base and a hexachloro platinum
catalysator catalyses the reaction. Dimethylvinylated and trimethylated silica acts
as a filler and the curing agent has a cross-linking agent (dimethyl methylhydrogen
siloxane) and the inhibitor tetramethyl tetravinyl cyclotetrasiloxan [152]. A Si-C
bond is formed from the vinyl and silicon hydride groups via hydrosilation to cross-
link the polymer [152]. PDMS has a high temperature resistance (due to high bond
energy of Si-O backbone), a low surface energy due to the high mobility of the Si-O
chain, is chemically stable and optically transparent [176]. Only its hydrophobic
nature can be disadvantageous in some cases, but it can be made more hydrophilic
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via oxygen plasma activation. Due to its excellent properties, it is widely used in
science, industry and our daily lives e.g. in medicine as surfactant and anti-foaming
agent, in cosmetics as well as in food. Especially the research areas of microfluidics
and softlithographie were pushed by George M. Whitesides, and PDMS was exten-
sively used [142–148, 152, 153]. The viscoelastic polymer is also gas permeable, thus
also suitable for many biological studies [145]. Still, the compatibility of PDMS with
cells is discussed ambiguous in literature, it may depended on the cell line and each
approach has to be tested separately [150]. Further, the material can be spin-coated
due to its viscosity (depending on the number of monomers). Also the autofluores-
cence was shown to be very low and comparable to the one of glass [151]. PDMS
presents the perfect material for rapid prototyping [148] and is accessible to every
standard laboratory as structures can be produced in a fast and in-expensive way in
almost unlimited designs.
5.2 Quantitative Analysis of Autofluorescence of
Microwell Materials
Autofluorescence, the natural emission of light, is common in biological substances,
for example in amino acids due to the aromatic ring system like tryptophan, tyrosin
and phenylalanin [177]. Also other biological molecules such as riboflavin, melanin,
collagen, chlorophyll or nicotinamide adenine dinucleotide phosphate (NADPH) can
be excited with UV or deep UV [177]. This property can be useful, since specimen or
organisms can be analyzed without further fluorescent dyes. Chloroplasts, daphnia
or chlorella, for example, can be excited under the microscope without labeling
[178]. But otherwise, e.g. the autofluorescence of polymers, can be obstructive for
some experimental setups. In most readouts the desired target is illustrated with
the help of fluorescent molecules or dyes. Especially for single-cell measurements,
were each cell is observed separately and the signal is not averaged over the whole
population, the intensity can be quite low. Further, often only low concentrations of
fluorescent markers are used to avoid phototoxicity or the dyes are quite expensive
(e.g. labelled antibodys) and thus only applied in nM concentrations. Moreover,
if the target molecule is only present in limited quantities, which is for example
the case of secreted cytokines per cell (fM), a low background signal is important.
Unfortunately, many polymers, which are used for microfluidics or microstructures,
such as parylene, polyimid and polyester show a non negligible autofluorescence
[179]. But for such sensitive measurements, as mentioned above, a good signal-to-
noise ratio is essential for a accurate, high quality readout. Thus, the right choice of
material when designing a new setup, is crucially.
Therefore, we measured the autofluorescence of seven different materials, which are
potential candidates for the development of microwells to observe cells at the single
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cell level or in groups. The materials were all measured with the same background
(in ibidi glass dishes) on the same microscope (Nikon) with 50% lamp intensity
and 200 ms exposure time. The materials were measured with a quadband filter
with the following channels: DAPI (exc: BP 392 nm, bandwidth 23 nm, emi: 432
nm, bandwidth 40 nm), GFP (exc: BP 474 nm, bandwidth 27 nm, emi: 515 nm,
bandwidth 35 nm), PI (exc: BP 554 nm, bandwidth 23 nm, emi: 595 nm, bandwidth
35 nm) and Cy5 (exc: BP 625 nm, bandwidth 18 nm, emi: 730 nm, bandwidth
140). Even when some materials were tested before, the independent control if the
materials are suitable for the specific needs we have, is important. And also when
these outcomes are just rough estimates, as they are not calibrated to the thickness of
the structures respectively, a first valuation is key to further develop only microwells
with materials which completely fulfill the set requirements.
In summary, PDMS (both in-house made and the commercial ones from Microsur-
faces Ltd.), Liquid Glass and the polycarbonate foil show a relative low autofluo-
rescence as expected, thus are conceivable microwell materials (Figure 5.2). How-
ever, the polycarbonate foil was excluded due to the pores as discussed before. The
index-matched polymer MY-134, SU-8 [180] and PEG-DA show a significant aut-
ofluorescence as assumed from our experience (PEG-DA) and literature (SU-8), thus
not applicable for fluorescence measurements. The reason for the autofluorescence
of MY-134 could be the missing inert atmosphere during the first and the missing
pure oxygen during the second curing step. A potential approach to decrease the
autofluorescence of SU-8 and PEG-DA could be to increase the baking and/or curing
times and/or steps. In the case of PEG-DA, the purification of the monomer and
photo-bleaching the structures could be helpful [181].
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Figure 5.2: Autofluorescence of seven different potential microwell materials. A hot-embossed
polycarbonate foil (300 µm depth, from 300MICRONS, orange), in-house made Liquid glass struc-
tures (various depths, red), PDMS wells in micromesh foils (80 µm depth, Microsurfaces Ltd.,
pink), in-house-made PDMS microwells (60 µm depth, purple), in-house micromolded PEG-DA
microwells (30 µm depth, green), in-house SU-8 microwells (40 µm depth, dark blue) and molded
and UV cured MY-134 wells (300 µm depth, blue) were analyzed. Autofluorescence was measured
in four different channels (DAPI, GFP, PI and Cy5) on a Nikon Ti eclipse microscope with 200
ms exposure time and 50% of light intensity and plotted as grey values. Structures were placed on
glass bottom ibidi dishes for a standard background.
5.3 Analysis of Biocompability of Microwell
Materials
Another important parameter, which should be considered during the development
of microwells next to autofluorescence, is biocompatibility (compatibility with biolog-
ical systems). In general, biocompability of the material is given by the components
itself. If all components are biocompatible, the whole composition should be also
harmless to cells. On the other hand, the overall biocompatibility of the material can
be increased in some cases. For example, the biocompability of SU-8 should increase
with curing or another baking step; incomplete curing therefore, can lead to harmful
properties [165]. Or, in case of the indexed-matched elastomer MY-134, the curing
has to be processed under argon atmosphere for 20 min to cure the polymer com-
pletely, another 15 min under pure oxygen are necessary to bleach the photoinitiator
and within a last step, the structures have to be incubated for 4-6 days in ethanol to
ensure that biotoxic components are diluted. Of this complex and time-consuming
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protocol with its several steps is not followed completely, biocompability is not given
and apoptosis occurs within 5 h [161]. If missing biocompability is the only param-
eter, which is the reason not to use the material, several steps could be done to
increase biocompability: ultra-violet irradiation, plasma deposition, more washing
steps or incubation steps in harmless buffers to wash out toxic remains or coating
the surface of the final structures with proteins such as fibronectin. In the following,
the test results of different materials for the fabrication of single-cell or multi-cell
microwells are described as well as further process steps, which were performed to
increase biocompability, if not given by the material itself. The polycarbonate foil
was not tested with cells, due to the pores in the material (Chapter 5.1). The differ-
entiation between suspension cells and the pores would not be possible. PEG-DA
was already shown as a excellent material for single-cell time-lapse measurements, if
no fluorescence readout was needed [140, 141]. Since the technical possibilities for
the complete curing of MY-134 under inert atmosphere and thereafter under pure
oxygen are not given yet, the biocompatibility tests with MY-134 are deferred. The
SU-8 resist was not tested for biocompatibility, since the results of the autofluores-
cence tests were unambiguous. The autofluorescence is too high and the material is
not suitable for fluorescence microscopy experiments. Further, the new Microresist
Technology resist was tested in our group with adherent and non-adherent cells.
Microwells made with the prototype resist with a diameter of 60 µm were incubated
with three different cell lines (A549, Huh7, MDA-MB-231) for 24 h. After the incu-
bation cells did not adhere to the substrate, but were not dead yet (negative trypan
blue staining). So far, no final conclusion can be made about the applicability for our
needs. But, FN coating should be tested to increase the attachment of the cells to
the material to test further the viability. Next, the non-adherent MOLM-13 cell line
was tested with 30 µm microwells, made out of the prototype resist, for two days.
Unfortunately, almost all cells were dead after incubation. Also here, further coating
should help to increase the viability of the cells and thus the biocompatibility of the
prototype resist. The biocompatibility of Liquid Glass structures (50 µm wells)
was tested by A. Reiser with Huh7 cells for 24 h without any further coating after
the UV sterilization. The cells proliferate on the substrate, in the wells as well as
between the wells. A specific passivation would be necessary to avoid the adhesion
on the bridges between the wells. Therefore, the technique from the group of Smith
et al. could be tested [182]. Further, Smith developed with the group of Maniura-
Weber a protocol for the surface functionalization of microwells with the help of
micro contact printing of FN and the specific passivation with Pluronic F127 [183].
Moreover, Viasnoff and co-workers recently established a highly advanced method
to coat even the walls of the microwells with a different substance than the bottom
of the wells and passivate the runways additionally [184]. For suspension cells, a
48 h time-lapse from E. Chatzopoulou showed that MOLM-13 cells, treated with
CellROX and PI markers only, are dead after the two days of incubation in Liquid
Glass microwells. Here, a coating with FN would help to increase the viability of the
cells potentially.
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PDMS was found to be a excellent material or single-cell studies. First tests with
MOLM-13 cells showed perfect results with high viability of the cells after 48 h. It
is noteworthy to say that only the sterilization with UV or gas is successful. The
sterilization with ethanol is not useful, since the absorbed ethanol will diffuse out
during the measurement and cause cell death. Due to the positive results of the
pre-tests, PDMS was the material of choice and PDMS microwells were fabricated
with the help of a molding cast to analyze stem cell proliferation over seven days.
The whole manufacture process, design of the structures as well as the study itself
are described in Chapter 5.5 in detail.
5.4 Summary and Outlook
To summarize the knowledge gained from experiments and literature, the tested ma-
terials, fabrication techniques, setups/manufacturers, advantages and disadvantages
as well as final conclusions per material, were tabulated (Figure 5.3). Moreover, the
table includes three more materials: cyclo olefin polymers (COP) and cyclo olefin-
copolymer (COC) as well as MY-134 MC. The cyclic olefin polymers are promising
since they are low in autofluorescence (data not shown, measured by C. Leu), are easy
to manufacture, e.g. with etching or hot embossing and have an high biocompati-
bility. In fact, both materials were already excessively used for single-cell time-lapse
measurements, since COC (Topas) was previously and COP (Zeonor) is nowadays
the material of ibidi foils. First tests with microwell fabrication were made, but fur-
ther development is needed. MY-133 MC was already mentioned in the context with
MY-134 as an alternative material since it can be cured conveniently with ambient
humidity and can be structured with already established micro molding technique.
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5.5 Application: Time-resolved Proliferation Study
of MDS Stem Cells
5.5.1 State of the Art
Hematopoietic Stem Cells (HSC)
Throughout our whole life, the blood system is responsible to continuously provide
the body with blood cells, since mature blood cells have a short life time. Approxi-
mately one trillion (1012) cells are developed in human adult bone marrow, making
blood the most regenerative tissue [185]. This establishment and maintenance is
based on self-renewing hematopoietic stem cells (HSC), which are present in small
quantities (1 per 105) in the bone marrow [186, 187] and the division in progenitor
cells. These two features are possible due to asymmetric cell division (approx. 10%),
which depends on intrinsic as well as extrinsic factors; it has been suggested that
stem cell differentiation is a stochastic process [188]. Despite the fact that they di-
vide not frequently, it is believed that the whole pool of HSCs is turning over every
few weeks [189]. Furthermore, it was found that HSCs can switch between dormancy,
where the activity is preserved, and self-renewal during the homeostasis and repair
modes [189]. In the 1960s, the multilineage differentiation of HSCs was discovered
and around 20 years later, the classical hierarchical roadmap with the HSCs on the
apex, was established (Figure 5.4, Discrete Differentiation) [186, 187, 190, 191]. In
this model, the mononuclear HSCs form either more HSCs (self-renewal) or com-
mitted progenitors, such as lymphocytes or common myeoloid progenitors (CMP).
Out of these CMPs, which are large blast cells, megakaryocyte-erythroid progenitors
(MEPs) or granulocyte-macrophage progenitors (GMPs) can be developed. CLPs
are the progenitors of T and B lymphocytes, MEPs of erythrocytes and megakary-
ocyte platelets and GMPS are the progenitors of maturing cells such as neutrophils,
eosinophils, basophil mast cells, dendritic cells, kupffer or langhans cells as well as
monocyte macrophages (see a complete overview in [186]). This tree-like branched
model has step-wise processes with distinct states (multipotent, oligopotent and
unipotent) and considers HCS to be homogenous [191].
In contrast, during the last decades, a continuous differentiation process has gained
growing acceptance (Figure 5.4, Continuous Differentiation) [191, 192]. The differ-
entiation during early human hematopoiesis is not defined by discrete intermediate
progenitor stages and branched tree-like decisions in this model, but by a cellular
continuum. Velten et al. proposed the existence of so called low-primed undiffer-
entiated (CLOUD)-HSPCs as transitory stages [192]. From these CLOUD-HSPCs,
distinct, but independent lineages are developed within the continuous flow of dif-
ferentiation. The lineages emerge earlier than thought and deepen gradually forced
by fate mediators and gene expression.
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With increasing methodologies, the ability to unravel the self-generation of HSCs as
well as the generation of lineage-committed progeny is growing. Moreover, the het-
erogeneity of stem cells was recognized, whereas it was believed before that HSCs are
homogenous [191]. Further, it was found that HCS maybe cannot progeny unlimited
and produce progenitors and thus are not equal with embryonic stem cells [186].
Despite the fact that blood is probably the most investigated developmental system
due to seminal mouse experiments [185], still many open questions are arising. For
example, whether the intermediate progenitors are present in the continuous model
or if the fate of lineage-biased HSCs is predetermined [191]. However, new methods
such as novel functional assays, omics-based techniques, non-invasive lineage tracing
and single-cell time-lapse measurements will further support in vivo experiments and
promote the understanding of hematopoiesis.
Discrete Differentiation Continuous Differentiation
Megacaryocytes Erythrocytes Myelocytes Lymphocytes Megacaryocytes Erythrocytes Myelocytes Lymphocytes
Stem cells
Progenitor cells
Maturing cells
Figure 5.4: Two HSC Differentiation Models in Comparison. The Discrete Differentiation model
illustrates step-wise hematopoiesis with distinct states (multipotent, oligopotent and unipotent) in a
tree-like hierarchy from stem cells to progenitors over to maturing cells. In contrast, the Continuous
Differentiation model in early hematopoiesis is based on a continuous flow of differentiation and
lineage trajectories evolve independent of each other. Figure adapted from [191].
Myelodysplastic Syndrome (MDS)
The characteristic of the Myelodysplastic Syndrome (MDS) is a clonal stem cell dis-
order with active, but ineffective hematopoiesis [193]. MDS patients are grouped in
high-risk (median survival of 6 years) and low-risk patients with a median survival
of 6 months [194]. MDS can lead to cytopenia (reduction in number of mature blood
cells) or acute myeloid leukemia (AML). The syndrome was divided in 5 subclasses
by morphology in 1982 by the French-American-British (FAB), which was recently
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reconsidered by the World Health Organization (WHO) into 8 subclasses [194]. If
MDS evolves after the exposure to a mutagen such as toxic materials or after ther-
apy of another disease, it is called secondary MDS [194]. Especially older people
between 60 and 75 are diagnosed with MDS with a incidence of 15-50 per 100,000
humans per year (for >70 year old humans) with balanced sex distribution [194].
Clinical indications are fatigue, exertional dyspnea (shortness of breath), anemia,
thrombocytopenia, leukopenia, granulocytopenia etc during the further progress in
MDS.
Distinction to Acute Myeloid Leukemia (AML)
MDS may not only be the early phase of AML, and should not be considered as
preleukemia anymore [195]. There are biological and clinical differences between the
two diseases, whenever they show similarities, e.g. similar survival using the same
therapy. But in contrast with AML, most MDS patients show increased programmed
cell death, e.g. apoptosis and proliferation in vitro and in vivo [193, 195], presumably
for compensation of the two progresses with each other. Most patients with MDS
do not evolve AML until death. So far, the FAB classification distinguishes between
MDS and AML by the number of fibroblasts. Patients who have less than 30% blasts
are classified with MDS and the ones with more than 30% blasts are diagnosed with
AML [195]. This is a rather arbitrary classification. Also the new classification by
the WHO is better, but not optimal (AML diagnosis if more than 20% blasts are
present)[195]. Albitrar at el. proposed that biological parameters, such as apoptosis
and proliferation rate or differentiation, would provide a more distinct, precise and
appropriate classification than the one based on the number of blasts [195]. Span and
co-workers have taken up this idea and suggested low-risk MDS, identified by high
proliferation, shorter cell doubling times and high apoptosis rates, whereas high-risk
MDS shows the opposite trends [193].
Therapeutic Approach
The cure of MDS is uncommon, also since the usual enhanced age of the patients is
the bottleneck. Allogeneic bone marrow transplantation is the only curative treat-
ment, which is unfortunately not possible for elderly patients (>60 years). However,
the life quality of the patients can be increased with curative approaches, e.g. ery-
throcyte treatment against anemia. Further, it has to be distinguished between
low-risk patients and high-risk patients, who need aggressive chemotherapy and/or
stem cell transplantation [195]. Also here, the age and the healthy fitness of the
patients is limiting the therapeutic possibilities. Moreover, next to allogeneic bone
marrow transplantation, which implies high toxicity, the autologous transplantation
is an alternative (higher survival rates). Furthermore, hematopoetic growth fac-
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tors, demethylating agents, immunosuppressive agents or more toxic substances, e.g.
arsenic trioxide, can be applied [195].
5.5.2 Single-Cell Time-lapse Setup
PDMS Microwell Fabrication
The first step to investigate the proliferation of stem cells with single-cell time-lapse
measurements was the preparation of the PDMS microwells. The microwells have
a diameter and a depth of 300 µm to host single to few cells per well (Figure 5.5).
This size provides enough space for the cells to divide for 7 days and ensures that the
cells still can be tracked in single-cell resolution. The depth of the well ensures that
the cells can not escape due to stage movement. Furthermore, a wall was designed
around the 30 microwells to block thermal convection from the wells in the dish and
to prevent great movement of the cells. The less movement of the cells, the easier the
tracking and identification of the cells will be during data analysis. A dish was chosen
as experimental format to provide sufficient supply of media during the one week
measurement (3 mL). The whole protocol for the PDMS microwell fabrication can
be looked up in the Appendix A.3. In short, PDMS was pored on a polyoxymethylen
(POM, ibidi) casting mold, after removing bubbles from the PDMS mixture (10:1
monomer:cross-linker solution) and covered with a smooth foil to guarantee proper
adhesion of the structures to the glass bottom of the dishes later on. Further, the so
covered mold was placed between two metal plates, which was then fixed with two
clamps for curing. This sandwich construct was cured overnight at room temperature
and afterwards in the oven at 50 °C for another overnight. The clamps were then
released and the foil removed to peel the PDMS microwells out of the mold. For
sterilization, the structures were either exposed to UV for 10 min or gas sterilized
(external company, DMB Apparatebau GmbH). The UV sterilization causes some
changes to the PDMS surface (methyl groups are hydrolyzed and created hydroxyl
groups are quite reactive, a SiO2 is formed), but no difference to the gas sterilization
was observed.
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r = 150 µm
h = ~300 µm
Figure 5.5: Photographic and schematic illustration of in-house made PDMS microwells. PDMS
structure with 30 microwells and a surrounding wall to avoid convection streams is formed out of a
polyoxymethylen mold and is placed in a glass bottom ibidi dish for measurements (photograph on
the left). Microwells have a spacing of 500 µm to each other (zoom in on the right) and a diameter
and depth of 300 µm.
HSC preparation
HSC cells were prepared by Michele Kyncl from the group of Dr. Katharina Götze,
Klinkium rechts der Isar, III. Med. Klinik, TU Munich. The samples were taken
from iliac crest surgery of anonymous donors with MDS diagnosis, which were tested
negative for hepatitis B and C as well as for the HI virus (S1 classification). The
cells, which were termed in the following ’healthy cells’ have its origin from healthy
bone marrow donors.
In detail, MDS samples were obtained by the cytological aspiration of bone mar-
row from the iliac crest region. Samples were diluted with PBS and mononuclear
cells were isolated by gradient separation. The cell suspension was centrifuged and
mononuclear cells were collected from the interphase. After centrifugation, cell pel-
lets were mixed with freeze medium and frozen at -80°C. For long term storage,
healthy and MDS samples were stored in a N2 biotank.
On the day of the experiment, the patient and donor samples were thawed and im-
mediately placed into media. Reducing dead cells, density gradient separation was
performed. Mononuclear cells were centrifuged, washed with PBS and after another
centrifugation step mixed with CellTraceTM Violet stain (a proliferation dye) in PBS
and incubated in a water bath. The reaction was stopped by adding ice-cold medium
containing HBSS, heat-inactivated FCS, HEPES, and Pen/Strep. After incubating
on ice, the suspension was centrifuged and antibody staining was performed. Cells
were first incubated with biotin-coupled antibodies, including anti-CD4, anti-CD8a
, anti-CD1, anti-CD19, and anti-CD235a. The mixture was incubated on ice in the
dark and then centrifuged. Pellets were resuspended with fluorescence-coupled an-
tibody mix. After incubating on ice in the dark, medium was added and the cell
suspension was centrifuged. Pellets were resuspended in medium containing propid-
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ium iodide and filtered. Lin-CD45dim CD34+ CD38- CD45RA-CD90+ cells were
sorted with 4 lasers. Cells were collected in serum free medium.
Assessment of Single-Cell Arrays
As a next step, the sterilized PDMS microwells were incubated with 3 mL medium
at 37 °C before seeding to get rid of bigger bubbles. Remaining smaller bubbles
were removed with energetic up and down pipetting of the media. The structures
have to be free from bubbles, since they hinder the seeded cells to settle down and
disturb the tracking of the cells later during data analysis. Afterwards, the cells were
directly seeded into the microwells with gentle handling. The seeding density varies
from well to well, but it was taken care that not too many cells are in each well
to guarantee a single-cell readout. The cells were incubated for 10 min to let them
settle down by gravity. The density was checked and another seeding step followed
if necessary to adapt the occupation of the wells to its optimum (2-3 cells per well).
Image acquisition
Time-lapse measurements were performed with a Nikon Ti eclipse microscope and
an Okolab incubation box at 37°C and 10% CO2 (final app. 5%). The stage was
slowed down to reduce shaky movements of the cells, which would distract the cell
tracking. The 7 day measurement protocol was divided in 24 h intervals of image
acquisition, which are connected in series, to stabilize the software and the computer
system (big data sets of min. 1.8 TB). Bright field images were acquired every 4-5
minutes, to do justice to the motility of the cells, with an exposure time of 5 ms.
Usually, two healthy samples and two MDS samples were imaged in parallel per
measurement, thus 120 field of views (wells) were set in total. Images were taken
with a 20x objective and -5-10 µm out of focus, since the cells are then brighter and
the contrast to the well bottom is higher. A high signal-to-noise ratio increases the
ease and feasibility of the user to identify and track the cells.
Identification and Tracking of Single Cells
The following data analysis was performed in collaboration with the group of Dr.
Carsten Marr from Helmholtz Zentrum München, Institute of Computational Biol-
ogy.
For the identification and tracking of the HSC and the healthy cells, the software
tool The Tracking Tool (tTt) was used [30]. This tool enables the manual tracking of
single cells in long-term experiments with high accuracy. Even when the data shows
uneven illumination or differences in brightness between wells or images within one
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well a robust analysis should be guaranteed. Large data sets can be analyzed with-
out expert knowledge and an user-friendly interface allows for manual inspection to
ensure the validity and quality of the data.
As a fist step, the microscopy data is converted from proprietary Nikon format (.nd)
to TIFF files, to open the data in tTt and qTfy (will be needed later on). The image
stacks are examined manually to select those cells, which should be tracked and a
identity (ID) is given. This ID is controlled over time, if the track is not lost or
changed by accident. The track will be lost only, when the cell dies. In our case, all
cells were tracked to quantify how many cells divided or died in total. Further, qTfy,
a software for the quantification of cellular and molecular properties, is needed to
assemble the lineage trees for each single cell. This non-automated single-cell anal-
ysis ensures a high accuracy and quality of the data for conclusive lineage threes to
analyze the proliferation of stem cells as well as apoptosis and possibly even motility.
5.5.3 Results and Discussion
Also here, the advantages of time-lapse measurements are obviously, since the con-
tinuous observation of cell division, cell shape, motility, real-time tracking of cell
cycle times and size changes of stem cells is possible. However, due to the limited
access to the rare and costly stem cell samples as well as data analysis challenges
[5, 30], time-lapse studies were performed in the past [4, 22, 29, 141, 196, 197], but
not standard yet.
In Figure 5.6, the distributions of the time to first division (tdiv) of healthy cells
in comparison to MDS cells, are shown. The violin plots show the kernel density
distribution (grey) to estimate the distribution of tdiv as well as statistical values
such as the 50% quantile (bold red line) and the 25% and 75% quantiles (red lines)
above and underneath the 50% quantile. The left graph shows 51 healthy cells and
the right plot depicts 30 MDS cells; since the statistic is not vast, the following
statements are preliminary and conditionally. The median of tdiv for healthy cells
is 57.33±21.10 h, which is slightly longer than for MDS cells (48.50±18.71 h). But
due to the overlap of the standard deviations of the medians, the difference is not
significant. Further, the 25% and 75% quantiles are broader distributed and shifted
to later time points (25% quantile: 48.67 h, 75% quantile: 71.17 h) than for MDS
cells. Here, the 25% quantile is closer to the median (45.08 h) than the upper 75%
quantile (59.33 h). In summary, the values of tdiv for both cell samples are similar,
while the violin shapes of the kernel density distributions differ.
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Figure 5.6: Distribution of time to first division of healthy cells in comparison to MDS cells. The
median of the time to first division (bold red line, 50% quantile) for healthy cells (57.33±21.10 h) is
slightly higher than for MDS cells (48.50±18.71 h). The 25% and 75% quantiles (red lines) overlap
for both conditions, indicating no significant differences. In contrast, the shape of the kernel density
(grey) differs.
Additionally, the length of the cell cycle was analyzed (Figure 5.7). The data points
(blue) are pooled per time frame and are plotted per row. The shape of the rows have
no meaning and is only curvy due for better illustration. For the healthy sample 482
cells and for the MDS sample 213 cells were analyzed. In contrast to the time to first
division, the median of cell cycle duration (time between two divisions) is slightly
shorter for the healthy cells (23.67±14.34 h) than for the MDS cells (27.0±13.18 h).
Further, the shapes of the kernel density estimation are similar (grey). The 25%
and 75% quantiles are distributed analogically, which can be seen by the calculated
inter-quartile range (the difference between the 75% and the 25% quantiles), which
is for both cell types 13 h.
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Figure 5.7: Distribution of cell cycle duration of healthy and MDS cells. The distribution of the
kernel density estimation (grey) of the cell cycle duration distribution for healthy and MDS cells
is quite similar, as well as the inter-quartile range (difference between 25% and 75% quantiles, red
lines), which is for both cell types 13 h. The 50% quantile (bulk red line) of MDS cells (27.0±13.18
h) is slightly higher than for the healthy cells (23.67±14.34 h).
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In literature, it was reported that the first division takes longer than the following
divisions [188, 196, 197]. This could be due to a trauma phase due to the thawing,
sample preparation, sorting, seeding and medium change. Also our results showed
a longer time to first division than the following divisions (cell cycle durations) by
comparison of Figure 5.6 and Figure 5.7.
Further, the apoptosis rate was determined, defined by the end of a cell track. In
the sample of healthy cells 3% and for the MDS cells 10% of cells died. Further
quantification with apoptosis markers are planned for a defined end point assessment.
5.5.4 Outlook
The preliminary results for the comparison between healthy cells and MDS cells show
neither a significant difference in time points of the first division nor in the cell cycle
length. It is noteworthy to say that the statistics of the one analyzed experiment
(one MDS and one healthy sample) was not very high for both samples and further
experiments are needed for reliable statements. Due to variable brightness levels,
cell movement and seeding density, the automated segmentation, identification and
tracking of the cells was not possible so far and manual tracking with tTt was ap-
plied.
In forthcoming experiments a low seeding density (likely one starting cell per well),
the avoidance of bubbles and differences in brightness (between the wells and over
time), as well as low movement of the cells should allow the automated data analysis
and the separate annotation of cell fates (division, apoptosis). Lineage trees could
then be created and used for deeper analysis of the stem cell behavior.
Moreover, the samples were fixed after the 7 day measurement for future determina-
tion of differentiation stages. Still, little is known about the correlation between cell
cycle length and differentiation. Thus, single-cell time-lapse measurements provide
an essential insight into the development of the myelodysplastic syndrome and po-
tential approaches for chemotherapy to increase the life span and quality of patients.
102
Chapter 6
Conclusion and Outlook
In the present work, pair-wise event-time correlations of fluorescence markers were
shown to be a powerful tool for the investigation of apoptosis signaling cascades.
The chronological order of key players in different cell death pathways was assessed
for the identification of novel target sites for chemotherapy.
The key contributors of the downstream signal transduction in apoptosis were illus-
trated with specific fluorescence markers. The events of lysosomal membrane per-
meabilization (LMP), the mitochondria outer membrane permeabilization (MOMP),
the level of reactive oxygen species (ROS), which are cellular stress indicators, and
the subsequent oxidative burst (OxBurst) as well as the release of calcium ions were
observed in the early phase (initiation) phase of apoptosis.
In the late phase of apoptosis (execution), the onset of the caspase-3/7 activity
(CASP), the flip of the membrane lipid phosphatidylserine (PhS-Flip) as well as the
final permeabilization of the plasma membrane (PMP) are important checkpoints
on the pathway to cell death.
The photochemistry of the markers and the mode of action inside the cell was ex-
amined and the single-cell fluorescence traces over time were analyzed for specific
features, which are characteristic for the particular marker. The time courses were
then put into the biological context of the marker. Further, phenomenological func-
tions were assessed to reflect the time courses and with a maximum-likelihood fitting
routine best fits were estimated. Significant changes in fluorescence were detected
and the so called event times were extracted. For the early markers, the offset of
fluorescence is significant, while for the late markers the onset time points are char-
acteristic for apoptotic incidents. The event times of two markers are then used for
pair-wise correlations to asses the sequence of events in the signaling cascade.
Insight was gained into the cellular interaction with 58 nm amino-modified polystyrene
nanoparticles (PS-NH2 NPs) with pair-wise correlations of early phase markers. The
nanotoxicity study showed that a low concentration of PS-NH2 NPs triggers LMP,
which is leading to MOMP and OxBurst in A549 human lung cancer cells. Further,
with high concentrations of PS-NH2 NPs, an additional pathway to the lysosomal
cascade was observed: the mitochondrial pathway with the event sequence MOMP-
OxBurst-LMP.
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The lysosomal but not the second pathway, triggered by MOMP, was monitored for
the comparing Huh7 hepatocarcinoma cell line.
Further, the ROS rate was correlated with MOMP and LMP. It was found that
MOMP is correlated with the ROS rate in both NP concentrations. In contrast, no
correlation between LMP and the ROS rate was detected.
In the next chapter, the chronological order of the events MOMP, OxBurst and cal-
cium release were investigated in A549 cells treated with the combinatorial chemother-
apy of Etoposide (ETO) and the chemosensitizer PS89. Chemosensitizers are discov-
ered to increase the vulnerability of cancer cells, which are often resistant to common
cytostatica. Further, sensitizer enable a concentration reduction of the cytostatica,
which are causing massive toxicity and side effects. For the single ETO and PS89
as well as for the combination for both the same order of events was examined:
OxBurst follows MOMP, almost coincidently, which is leading to the calcium ion
release out of the stressed endoplasmic reticulum. Moreover, the effect enhancement
was scrutinized, since synergistic (more than additive) effects would be desirable.
In addition to this, the ROS rate, which is proportional to the slope of the CellROX
curve, as well as the area under the curve (AUC) of a ratiometric calcium indicator,
which is representing the amount of released calcium ions, should be analyzed and
correlated with the events MOMP, OxBurst and calcium release.
In the last part of this work, a suitable material for microwells was sought. Microw-
ells, which are microenvironments densely packed in arrays, provide a convenient
experimental setup for a high-throughput readout of suspension cells. Two main
criteria must be fulfilled: low autofluorescence for fluorescence readouts and high
biocompability. Seven materials were tested and PDMS conclusively complies both
requirements.
Thus, the monitoring of stem cell proliferation and apoptosis was performed in PDMS
microwells. Therefore, healthy stem cells as well as stem cells with the myelodys-
plastic syndrome (MDS) were observed in parallel for around 7 days. First outcomes
show that the time to first division is in average longer than the cell cycle duration
for both the healthy and the MDS cells. The time to first division as well as the cell
cycle duration was similar in both samples. The apoptosis rate for the healthy cells
was slightly lower than in MDS cells.
In summary, single-cell time-lapse measurements enable the resolution of signaling
transduction cascades in a dynamic and a high-throughput manner. Average based
bulk measurements mask the presence of potential sub-populations and do not allow
to resolve the heterogeneity in cellular response.
Moreover, pair-wise event time correlations facilitate the assessment of relations
between the events within a signaling cascade. The cellular heterogeneity in response
(noise) can be investigated and further the strength of the correlations, as well as
the time delays between the events, can be inspected.
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6.1 3D Microwells for Adherent Cells in Apoptosis
Studies
2D micro-structured surfaces are a straightforward, cost-effective and mostly repro-
ducible setup for the observation of many different phenomena such as cell migration,
cell-to-cell-communication, gene expression etc. Hundreds of cells can be observed
in parallel with a high time resolution in a high-throughput manner. However, in
the nanotoxicity (Chapter 3) and the combinatorial chemotherapy study (Chapter
4), a non negligible fraction of cells detached during the observation time. Over the
process of apoptosis, where the formation of apoptotic bodies is characteristic, the
relief of cells was recognized to be adverse. The statistics decreased by loosing cells
and a slight bias could be created by discarding time traces of detaching cells.
Thus, the embedding of adherent cells in 3D microwells could counter act this issue.
As discussed in Chapter 5, different potential materials are conceivable. In addition,
three more materials could be chosen: the cyclo olefin polymer (COP), the cyclo
olefin-copolymer (COC) as well as the index-matched polymer MY-134 MC, which
is cured by ambient humidity. Both cyclic olefin polymers are auspicious, since they
are low in autofluorescence, microwells can easily be manufactured by etching or hot
embossing and show an high biocompatibility.
The surface of such micro-molded or hot-embossed microwells have to be chemically
modified to guarantee the controlled adhesion of the cells. The group of Maniura et
al. developed a promising approach for microwell functionalization [183]. In short,
the plasma cleaned PDMS microwells were incubated with a fibronectin (FN) solu-
tion and the surface is coated completely with the protein. Further, glutaraldehyde
(GA) is bonded to another layer of PDMS via an aminosilane. The GA covered
stamp was repeatedly placed on top of the FN coated microwells. After incubation,
the FN on the bridges between the wells is removed due to reaction of FN with
GA. Next, a solution of cell-repellent pluronic was applied to the microwells. After
rinsing, the cells adhere purposefully only inside the wells and not on the bridges
in between. The bifunctionalized microwells represent an ideal environment for the
observation of cells in apoptosis studies, but also for the performance of ELISAs or
the detection of immune response, e.g. secreted cytokines.
Pluronic Fibronectin
COC/COP
Figure 6.1: Schematic of specific microwell functionalization. The microwells, which are hot-
embossed or molded with cyclo olefin polymers (COP) or cyclo olefin-copolymer (COC), are func-
tionalized inside the wells with cell-friendly fibronectin (blue). The area between the wells is
passivated with pluronic (green) to avoid unspecific adhesion.
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6.2 The Future of Deep Machine Learning in
Biological Data
For a precise determination of signaling cascades, a thorough data analysis has to be
guaranteed. Here, the single cells were selected semi-automated in a custom written
ImageJ plugin. The assortment of the desired cells by discarding of detaching, dou-
bling, floating and migrating cells is tedious as well as time and click intensive. Next
to the local confinement of the cells, which can be provided by the used micropat-
terned slides [10] or microfluidics [198], an automated readout of the cells increases
the faster availability and a higher accuracy of single-cell data. Therefore, modern
machine learning, especially deep learning methods such as neural network architec-
tures were used for the recognition of cell counting, detection and morphology as well
as for image reconstruction [199]. Also the classification of cells can be achieved with
supervised machine learning [200]. Furthermore, in drug discovery the advantages of
machine learning algorithms can be used for a label-free detection of drug responses
[201]. Thus, machine learning was already implemented in several different fields of
natural science. For our purposes, the recently published generic deep-learning-based
software U-Net, seems to be promising for the detection and segmentation of cells
[202]. The freely available ImageJ plugin is pre-trained to segment single cells and
can be adapted for individual needs. The plugin is not restricted to specific data, but
can be trained on new data, thus providing a broad applicability within biomedical
image data. Only one or two representative images in high quality are needed for
training, not big data sets as usually required in the past. Further, it is stated that
both, unskilled researchers as well as experienced users, can train the program for
their demands. Thus, U-Net represents a suitable, adaptable, fast and convenient
opportunity to analyze single cells for the generation of reliable time traces. Hence-
forth, also for the fitting routine and the extraction of event times, neural networks
can be beneficial. In the future, machine learning methods such as deep learning
and neural network architectures will be essential for data analysis.
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Appendix A
Methods and Standard Protocols
A.1 Cell Culture
A549 Cell Culture
Human lung carcinoma epithelial cells, adherent
Sources: The one with the higher passage is from Carsten Rudolph, Klinikum, 2006,
most likely from ATCC, cultured in MEM; the one with the low passage is ordered
from DSMZ, thus A549 ATCC® CCL-185™, 2018; cultured in DMEM
Culture media:
• MEM/DMEM GlutaMAX Gibco
• 10% FCS
Doubling time: ~31h h
Passaging:
1. Suck off the old media from the T25 flask (yellow closed cap, with protein
bottom)
2. Wash cells with 5 mL PBS
3. Suck PBS off and add 500 µL 0.5% EDTA/Trypsin
4. Incubate for 3 min at 37 °C and 5% CO2
5. If the cells are rounded, but not detached, hit the flask gently to get them in
solution
6. Add 4.5 mL media to stop trypsinisation and re-suspend them thoroughly
7. Take out 20 µL CS for Neubauer counting chamber and count them (see WIKI
how to count)
8. Centrifuge them at 800 rpm for 3 min
9. Suck off the media and re-suspend the cell pellet again in 5 mL media
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Dilute the cell suspension as the following: 1:3 for two days (e.g. Mo-
Wd), 1:4 over the weekend
Freezing:
• 1.5 mL of final Cryomedium (with cells) per cryovial, preparation of 6 vials
Totalvolume: 9 mL. 1:1 dilution of CS and Cryomedium 4.5 mL Cry-
omedium:
• 900 µL DMSO (20%, 10% final), 1.35 mL FCS (30%, final: 15%) and 2.25 mL
CM (50%, final: around 75% with cells). Put it on ice.
• Label cryovials
• Prepare 4.5 mL of a cell suspension with 4 Mio cells/mL
• Crymedium mixed with CS final cell concentration: Around 2 Mio cells/mL,
so ~3 Mio cells per Cryovial
Thawing:
• Suspend the frozen cells drop by drop carefully in 9 mL of pre-warmed CM
(MEM/DMEM GlutaMAX, 10% FCS)
• Centrifuge for 3 min, 700 rpm
• Re-suspend in 10 mL CM, seed in a T75 flask (due to the big pellet). If it is a
smaller pellet than re-suspend the pellet in 5 mL and seed them in a T25 flask
• CM change at the following day
• Split them two days after freezing, three days if they are not 70-80% conflu-
ent after two days (centrifuge for 3 min, 800 rpm, seed 20 000 cells/cm2, see
passaging)
Figure A.1: A549 cells with 5x objective (left) and 20x objective (right).
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Huh7 Cell Culture
Human liver carcinoma (Hepatoma)
Source: I.A.Z., Munich
General:
• Culture in T25 Sarstedt flask (yellow lids)
• 5 mL media per T25 flask
• mean generation time ~30 h
Cell culture medium:
• RPMI 1640 + GlutaMAX Gibco
• 10% FCS
• 5 mM HEPES
• 1 mM Sodiumpyruvate
Passaging:
1. remove old media
2. washing with ~5 mL PBS
3. 0.5 mL 0.5% Trypsin/EDTA per T25 for 2 min in incubator (additional 1 min
if cells still adherent)
4. re-suspend with additional 4.5 mL fresh cell culture medium
5. collect cell suspension in 15 mL reaction tube
6. counting cells using Neubauer counting chamber centrifugation 800 rcf/3 min/
RT
7. seeding of cells in needed concentration in new T25 flask with a total volume
of 5 mL
• due to cell metabolism it’s normal that there are fringy cells after longer cul-
tivation (pH change of media)
• a medium exchange after 48 h of cultivation is recommended
131
Appendix A Methods and Standard Protocols
Freezing:
1. 1.5 mL of final Cryomedium (with cells) per cryovial, preparation of 6 vials
• Totalvolume: 9 mL. 1:1 dilution of CS and Cryomedium 4.5 mL Cry-
omedium:
2. 900 µL DMSO (20%, 10% final), 1.35 mL FCS (30%, final: 15%) and 2.25 mL
CM (50%, final: around 75% with cells). Work on ice.
3. Label cryovials
4. Prepare 4.5 mL of a cell suspension with 4 Mio cells/mL
5. Crymedium mixed with CS final cell concentration: Around 2 Mio cells/mL,
so ~3 Mio cells per Cryovial
Thawing:
1. Suspend the frozen cells drop by drop carefully in 9 mL of pre-warmed CM
2. Centrifuge for 3 min, 700 rpm
3. Re-suspend in 10 mL CM, seed in a T75 flask (due to the big pellet). If it is a
smaller pellet than re-suspend the pellet in 5 mL and seed them in a T25 flask
4. CM change at the following day
5. Split them two days after freezing, three days if they are not 70-80% conflu-
ent after two days (centrifuge for 3 min, 800 rpm, seed 20 000 cells/cm2, see
passaging)
Figure A.2: Huh7 cells with 5x objective (left) and 20x objective (right).
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MOLM-13 Cell Culture
Acute myeloid leukemia (AML), suspension cell line Source: DSMZ, provided by
Prof. Fuat Oduncu chair in the Medical School on 28.01.14 (collaborateur of Elisavet
Chatzopoulou)
Doubling time: ~ 19-20 h.
Medium:
• RPMI GlutaMAX Gibco
• 20% FCS, but can also be changed to 10% FCS
Passaging:
1. Mix the cell suspension and pipet it in a 15 mL falcon
2. Take out 20 µL for the Neubauer counting chamber (see WIKI how to count)
3. Centrifuge at 800 rpm for 3 min
4. Suck off the supernatant and re-suspend the cell pellet again in 5 mL media
5. Dilute the cell suspension as the following:
• 200 000 cells/mL (mostly ~ 1:14) for two days (Mo-Wd, Wd-Fr)
• 150 000 cells/mL over the weekend (Fr-Mo)
Freezing:
1. Centrifugation for 3 min at 800 rcf as usual
2. Resuspend the cell suspension in a volume of Cryo media to have finally ~ 3
Mio cells/mL.
3. Cryomedium: 70% CM (RPMI 1640 with 10-20% FCS), 20% FCS and 10%
DMSO.
4. Overnight in -80°C, afterwards storage in N2 tank.
Thawing:
1. Take the cryovial out of the liquid nitrogen (gloves, goggles!)
2. Warmed up in the hands, then completely in the water bath
3. Suspend cells in 9 mL of MOLM CM (Gibco RPMI GlutaMAX and 10-20%
FCS)
4. Centrifuge for 3 minutes at 700 rpm
5. Re-suspend pellet in 10 mL CM (big pellet)
6. Seed in T75 flask
7. Change the media after one day
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Jurkat Cell Culture
Human peripheral blood T lymphocytes, acute T cell leukemia
Source: Prof. Vollmar, Biological Pharmacy, DMSZ authenticated and mycoplasma
tested, ACC 282
Doubling time: ~ 24 h
Medium:
• RPMI 1640 GlutaMAX
• 10% FCS
• 1 mM sodiumpyruvate
Passaging:
• optimum cell density between 0.1 x 10ˆ6 cells/mL - 1 x 10ˆ6 cells/mL (max
1.5 x 10ˆ6 cells/mL)
• split every two days
• only centrifuge if the media should be changed completely, for example for
experiments. Therefore, centrifuge at 400 g, 5 min at room temperature. Re-
suspend in fresh media.
• If the cells are happy, cell aggregates or isles of cells are visible
• If the cells are stressed, dead cells are visible as black dots on the bottom of
the flask, e.g. after exposure to cytotoxic solutions or after thawing.
Freezing:
• let the cells grow very dense in three T75 flasks
• count the cells while centrifuging the cell suspension at 400 g for 5 min
• dilute the cells to 2 Mio cells/mL to have finally 1 Mio cells/mL in the cryo
vial
• For 6 Cryovials a 1,6 ml:
Ratio 1:1 of cell suspension and cryo media:
• 2,5 mL 10% FCS media
• 2 mL FCS ~20% FCS finally
• 0,5 mL DMSO ~ 5% finally
4.8 mL of this mixture and 4.8 mL of cell suspension
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• Important: work on ice! And freeze gently and slowly (use purple cryo vial
container)
Thawing:
• Re-suspend the cells in 10 mL 20% FCS media
• Centrifuge for 5 min at 400 g
• Re-suspend the cells in 5 mL 20% FCS media
• Seed in T25 flask
• One or two days after freezing: change the media (maybe again in 20% FCS
media)
• let them grow longer than usual; optimum > 0.5 x 10ˆ6 cells/mL and >90%
viability
• centrifuge the first passages to get rid of cell fragments
• culture is then performed in 10% FCS media (see above)
Figure A.3: Healthy Jurkat cells form aggregates, which are shown in 5x magnification (left) and
20x magnification (right).
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A.2 Microscale Plasma-Initiated Protein
Patterning (µPIPP)
Reagents:
• PLL-PEG (2) (2mg/mL) in 150 mM NaCl and 10 mM Hepes (Gibco), pH =
7,4 (PLL (20)-g (3.5)-PEG (2), abbreviated PLL-PEG(2), SuSoS) store at 4°C
• FN (1 mg/mL) in PBS (Yoproteins) store at 4°C
• Dimethylsiloxan monomer
• Silicon elastomer curing agent (crosslinker)
• Sterile PBS
• Ethanol
• Milli Q water
• Isopropanol for cleaning the surfaces
FN and PLL-PEG(2) are stored in the s.p.s.-Box (surface patterning
stuff) in the fridge in the membrane lab
Equipment:
• µ-slide 8 well, uncoated (ibidi) or ibidi foil uncoated and sticky 8well slide
• Si-wafer with structures
• (sterile) hood
• Tweezers
• Cutter, razor blades, cutting board
• Pipettes
• Plasma cleaner
• Desiccator
• Petri dishes
How to prepare the PDMS-stamp:
• Weighing: 11:1 mixture of PDMS (10 m/m monomer, 1 m/m crosslinker)
(you need 10 g for one complete wafer)
• Get rid of bubbles with the desiccator for 0.5 h
• Blow PDMS crumbs, dust and so on with the air pistol from the wafer
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• Pour the PDMS onto the Si-wafer with 3 mm thickness
• Place the wafer into the desiccator for another 0.5 h (or longer if needed)
• Cure overnight in the 50°C oven
How to cut the PDMS-stamp:
• Cut with the scalpel eight squares out of the casting
• Be careful: the Si-wafer can break, so don’t use too much pressure
• Turn and put them on the cutting mat, the structure is now facing you
• Every edge of the square has to be cut to let the plasma flow underneath, use
the blade here
• Cut each square in half
• Clean the blade with a tissue and isopropanol after every cut
Place two stamps in each well and make sure that plasma is accessible to the struc-
tures; the structure is now on the bottom of the slide parts which are not covered
by the stamp get hydrophilized.
Check attachment of the stamp in your dish with the stereo microscope before the
plasma process:
1 = area with not attached structures (light)
2 = area with structures attached to the dish (dark)
3 = particles under the stamp
Do not mark anything with an edding before the plasma treatment, afterwards it is
okay.
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Put the sample into the plasma cleaner (side of the stamp parallel to the tableside):
• Times:
– 7 min pump,
– 2 min flood with gas
– 3 min plasma process
– Pressure: 0.2-0.44 mbar (before process), flow = ~5 (only adjustable when
GAS-button is pressed)
– Power: 70 % at 4.5 (35 W) or 100% at 9.9 for 50 W (depends on plasma
cleaner)
PLL-PEG treatment:
• Put the stamps right after plasma cleaning in the hood
• Incubate the lid of the slide with ethanol for 5 minutes, afterwards for 1 minute
with Milli Q
• Add a drop PLL-PEG(2) close to each stamp (4 µL per stamp); capillary action
will attract the liquid underneath the stamp. Don´t touch the stamp with the
tip of your pipette.
• Incubate for at least 25 min
Alternative: You can also use the ibidi untreated foils, place the stamps, plasma
treat the foils add the PLL-PEG and rinse the foil once with 800 µL MilliQ after
removing the stamps. Let the foil dry and glue a sticky 8 well slide onto it. Store it
at RT. Add the FN solution directly before seeding the cells.
Fibronectin treatment
• Add 300 µL PBS in each well, remove the stamps in one pull and strictly avoid
drying of the substrate
• FN working solution (35 µg/mL for A549): dilute FN-Stock solution (1 mg/mL)
1:28.6 in PBS
• For Huh7 cells, e.g. usually 50 µg/mL are used
• Remove PBS and add 180 µL FN working solution in each well
• Incubate for 45 min
Afterwards dilute FN with PBS, wash three times with 300 µL PBS each well and
leave them in 240 µL PBS for storage over night at 4 °C.
Incubate with medium before seeding cells.
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A.3 Protocol for the Fabrication of 3D PDMS
Multi-Cell-Wells
Equipment:
• Desiccator
• Oven with 50 °C
• Two normal bar clamps
• Bar clamp, where increase the pressure by not seizing but by clamping (e.g.
from ibidi)
• Two metal plates
• Plate of gum or similar
• Ibidi foils, bigger than the normal microscope ones
• 5 mL syringe with needle
• Tweezers
• POM wafer
• PDMS (10:1)
Procedure:
1. Prepare 5.5 mL of PDMS solution (5 mL of PDMS monomer and 0,5 mL
crosslinker)
2. Fill it in the syringe (with the open end closed with the needle and the safety
cap) and desiccate it for 30-45 min to remove bubbles. Let the syringe open;
do not close it with the stamp.
3. Fill the bubble free PDMS, with the needle very close to the structure, in the
wafer.
4. Let the PDMS settle down for 1 h.
5. Remove bubbles with a needle if there are still some.
6. Remove the foil from the ibidi foil and place now the clean site gently on the
wafer with the PDMS. The best way is to hold the foil on one side and to place
it on the structures gradually. You can follow the procedure; the PDMS will
suck onto the foil. The ibidi foil guarantees a smooth bottom of the structures
to ensure the adhesion afterwards on the glass bottom of the dish.
7. Place the gum foil on top of the ibidi foil. This will distribute the pressure
more even and balance some irregularities in the metal plates.
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8. Place the sandwich between the two metal plates.
9. Fix the sandwich with the clip bar clamp directly above and underneath the
POM wafer. With this type of bar clamp, it is easier not to get the sandwich
out of place.
10. As soon as this clamp is fixed, place the other two bar clamps next to the first
bar clamp.
11. Now you can remove the first bar clamp.
12. Let the structure harden overnight at room temperature. Take care that ex-
cessive PDMS can be released and a tissue underneath can be helpful.
13. Harden this formation in the oven overnight.
14. Remove the clamps and peel off the foils gently.
15. Place the tweezers in one edge of the structure and pull out the structures out
of the wafer.
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Concentrations of the Fluorescence Markers
Marker Concentration
MOMP
TMRM 10 nM
Mito Tracker Deep red 0.0066%
Oxidative Stress/Burst
CellROX Deep Red 100 nM
CellROX orange 100 nM
CellROX green 100 nM
LMP
Lysotracker Deep Red 75 nM
Calcium level
Calbryte-630 1 µM
Calbryte-590 1 µM
Calbryte-520 1 µM
Caspase 3/7 Activation
CellEvent Caspase 3/7 Green 3%
Phosphatidylserine Flip
pSIVA-IANBD 2%
PMP
Propidium Iodide 1%
Toto-3 Iodide 1 µM
Table A.1: Concentrations of Fluorescence Markers.
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Absorption-and Emissionmaxima of the Fluorescence Markers
Marker Absorbance [nm] Emission [nm] Filter
MOMP
TMRM 548 574 YFP
Mito Tracker Deep red 644 665 Cy5
Oxidative Stress/Burst
CellROX Deep Red 640 665 Cy5
CellROX orange 545 565 YFP
CellROX green 485 520 GFP
LMP
Lysotracker Deep Red 647 688 Cy5
Calcium level
Calbryte-630 608 626 Cy5
Calbryte-590 573 588 YFP
Calbryte-520 492 514 GFP
Caspase 3/7 Activation
CellEvent Caspase 3/7 Green 502 530 GFP
Phosphatidylserine Flip
pSIVA-IANBD 478 525 GFP
PMP
Propidium Iodide 535 617 YFP
Toto-3 Iodide 642 660 Cy5
Table A.2: Absorption- and emission maxima of the used fluorescence marker and the correspond-
ing filter.
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Exposure Times of the Fluorescence Markers
Marker Exposure Time
MOMP
TMRM 300 ms
Mito Tracker Deep red 300 ms
Oxidative Stress/Burst
CellROX Deep Red 300 ms
CellROX orange 300 ms
CellROX green 300 ms
LMP
Lysotracker Deep Red 150 ms
Calcium level
Calbryte-630 150 ms
Calbryte-590 150 ms
Calbryte-520 150 ms
Caspase 3/7 Activation
CellEvent Caspase 3/7 Green 300 ms
Phosphatidylserine Flip
pSIVA-IANBD 300 ms
PMP
Propidium Iodide 300 ms
Toto-3 Iodide 150 ms
Table A.3: Exposure times of fluorescence markers.
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